medical concept | Q111796709 |
P673 | eMedicine ID | 448623 |
P4235 | PatientsLikeMe treatment ID | radical-cystectomy |
Q44386807 | "Never events": Centers for Medicare and Medicaid Services complications after radical cystectomy |
Q45989119 | "The devil is in the details": randomized trial of robotic versus open radical cystectomy. |
Q46423726 | 'Successful' chemo- and radiotherapy prior to radical cystectomy does not necessarily correlate with clinical course in small cell carcinoma of the bladder |
Q56928489 | 1213 THE EVALUATION OF THE LEARNING CURVE ASSOCIATED WITH ROBOTIC RADICAL CYSTECTOMY: INITIAL 100 CASES |
Q53126609 | 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. |
Q46148920 | 25-year experience in the management of invasive bladder cancer by radical cystectomy |
Q93349334 | 30-day readmission after radical cystectomy: Identifying targets for improvement using the phases of surgical care |
Q70275093 | 4,000 RAD preoperative irradiation followed by prompt radical cystectomy for invasive bladder carcinoma: a prospective study of patient tolerance and pathologic downstaging |
Q56928491 | 82 COST ANALYSIS OF ROBOTIC-ASSISTED RADICAL CYSTECTOMY VERSUS OPEN RADICAL CYSTECTOMY UTILIZING A PROSPECTIVE, RANDOMIZED COHORT |
Q88956151 | 90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series |
Q40508734 | 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study |
Q50193856 | A Case of Secondary Extramammary Paget's Disease Aroundthe Cutaneous Stoma after Radical Cystectomy |
Q92045177 | A Comparative Propensity-Score Matched Analysis of Perioperative Outcomes of Intracorporeal versus Extracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium |
Q98990592 | A Meta-analysis of Radical Radiotherapy or Radical Cystectomy for Patients with Bladder Cancer Muscle Invaded |
Q40196162 | A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy. |
Q37053761 | A Multi-Center International Study Assessing the Impact of Differences in Baseline Characteristics and Perioperative Care Following Radical Cystectomy |
Q40702603 | A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy |
Q90747869 | A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy |
Q38893318 | A Prospective Randomized Trial of the Effects of Early Enteral Feeding after Radical Cystectomy |
Q47301928 | A Prospective, Randomized, Clinical Trial on the Effects of a Valveless Trocar on Respiratory Mechanics During Robotic Radical Cystectomy: A Pilot Study. |
Q101053854 | A Qualitative Assessment of Patient Satisfaction with Radical Cystectomy for Bladder Cancer at a Single Institution: How Can We Improve? |
Q55311343 | A Retrospective Study Comparing Surgical and Early Oncological Outcomes between Intracorporeal and Extracorporeal Ileal Conduit after Laparoscopic Radical Cystectomy from a Single Center. |
Q90686086 | A Retrospective Study of Patients Undergoing Radical Cystectomy and Receiving Peri-Operative Naloxegol or Alvimopan: Comparison of Length of Stay |
Q49793011 | A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy. |
Q41484110 | A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL). |
Q91024100 | A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients |
Q97893038 | A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy |
Q73235865 | A case of urethral recurrence found 15 years after radical cystectomy |
Q72606701 | A classification after radical cystectomy of patients with bladder cancer associated with schistosomiasis |
Q39424758 | A clinicopathologic study of gynecologic organ involvement at radical cystectomy for bladder cancer. |
Q42671705 | A comparative study between open and laparoscopic approach in radical cystectomy with orthotopic ileal neobladder |
Q34417428 | A comparative study of fast-track versus [corrected] conventional surgery in patients undergoing laparoscopic radical cystectomy and ileal conduit diversion: Chinese experience |
Q99713739 | A comparison between limited bowel preparation and comprehensive bowel preparation in radical cystectomy with ileal urinary diversion: a systematic review and meta-analysis of randomized controlled trials |
Q42621069 | A comparison of early complications between open and robot-assisted radical cystectomy |
Q39451070 | A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy |
Q83709768 | A contemporary standard for morbidity and outcome after radical cystectomy |
Q38054266 | A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens |
Q57253190 | A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future research |
Q46676805 | A critical analysis of perioperative mortality from radical cystectomy. |
Q80442089 | A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome |
Q81037386 | A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome |
Q82229800 | A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome |
Q90225546 | A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging |
Q34225949 | A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy |
Q42644348 | A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy. |
Q44428810 | A feasibility study of peritoneum preservation in radical cystectomy with extraperitonealization of orthotopic neobladder for invasive high-grade bladder cancer: a preliminary analysis |
Q36642888 | A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density. |
Q37641597 | A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis |
Q41705006 | A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy |
Q30938056 | A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice? |
Q57220010 | A missing silk strip during laparoscopic radical cystectomy and bilateral nephroureterectomy |
Q36029574 | A model to predict the outcome of the bilharzial bladder cancer patient after radical cystectomy |
Q54940104 | A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. |
Q77608295 | A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer |
Q80063768 | A multimodal perioperative plan for radical cystectomy and urinary intestinal diversion: effects, limits and complications of early artificial nutrition |
Q40237184 | A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study |
Q100511762 | A new index (A/G) associated with early complications of radical cystectomy and intestinal urinary diversion |
Q93077664 | A new modification of tubeless cutaneous ureterostomy following radical cystectomy |
Q45179878 | A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors |
Q69026348 | A new radical cystectomy for advanced or multifocal urinary bladder cancer |
Q91826049 | A new ureteroileal anastomosis technique in modified ileal orthotopic bladder substitution after radical cystectomy |
Q30981992 | A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy |
Q38817683 | A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy |
Q94683799 | A novel prevention bundle to reduce incisional infections after radical cystectomy |
Q38596001 | A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy |
Q39623533 | A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy |
Q100695669 | A perioperative management to reduce rate of urinary tract infection for patient underwent radical cystectomy with ileal conduit diversion |
Q43188531 | A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results. |
Q83877649 | A plea for a uniform surveillance schedule after radical cystectomy |
Q85319597 | A plea for uniform terminology for patients with urothelial carcinoma treated with chemotherapy prior to radical cystectomy: induction versus neoadjuvant chemotherapy |
Q43847642 | A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer |
Q73738131 | A predictive model of survival after radical cystectomy for carcinoma of the bladder |
Q33641978 | A preliminary oncologic outcome and postoperative complications in patients undergoing robot-assisted radical cystectomy: Initial experience |
Q33904099 | A prospective evaluation of surgical outcomes of laparoscopic transperitoneal radical cystectomy/anterior pelvic exenteration: our surgical technique and experience |
Q37594340 | A prospective randomised controlled trial of laparoscopic vs open radical cystectomy for bladder cancer: perioperative and oncologic outcomes with 5-year follow-upT Lin et al. |
Q40325970 | A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy. |
Q48342930 | A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer. |
Q46001051 | A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. |
Q43780702 | A randomized trial of robot-assisted laparoscopic radical cystectomy |
Q36314809 | A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable. |
Q60552864 | A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph n |
Q37124229 | A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy |
Q72151816 | A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch |
Q43684222 | A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder |
Q41893474 | A standardized protocol for identifying and counting lymph nodes harvested by pelvic lymph node dissection at the time of radical cystectomy |
Q35071431 | A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire |
Q81473808 | A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire |
Q90750289 | A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy |
Q52569036 | A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer. |
Q38938343 | A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer |
Q37839415 | A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate |
Q50165363 | A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer |
Q47325390 | A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy |
Q73924520 | A technique of transrectal ultrasound guided transperineal percutaneous drainage of pelvic abscess after radical cystectomy |
Q33431065 | A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients |
Q51373293 | A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial results. |
Q51564304 | A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial results. |
Q82933310 | A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: revisiting the initial experience, and results in 104 patients |
Q47102708 | AB011. Laparoscopic radical cystectomy, modified Wallace ileal conduit retrospectively. |
Q46633375 | AB014. Laparoscopic radical cystectomy and intracorporeal orthotopic ileal neobladder with bilateral isoperistaltic afferent limbs: initial experience. |
Q47123038 | AB044. Application of rapid bowel rehabilitation programme in radical cystectomy and ileal neobladder. |
Q45785451 | AB045. Extended lymphadenectomy versus non-extended lymphadenectomy in radical cystectomy for bladder cancer: a meta-analysis. |
Q45785425 | AB047. Clinic therapeutic effect of sigmoid orthotopic neobladder after radical cystectomy. |
Q46631309 | AB053. Laparoscopic pelvic lymph node dissection during radical cystectomy: strategy and clinical outcomes. |
Q46632349 | AB054. An improved technique for bladder cancer: pure laparoscopic radical cystectomy with orthotopic U-shape ileal neobladder using titanium staples. |
Q45785022 | AB066. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy. |
Q45784691 | AB103. Overexpression of RNF2 is an independent predictor of outcome in patients with urothelial carcinoma of the bladder underwent radical cystectomy. |
Q46631813 | AB117. Analysis of perioperative outcome and complications following radical cystectomy: a single center retrospective study of 1,212 patients in two decades. |
Q46627403 | AB117. Laparoscopic versus open radical cystectomy for elderly patients over 75-year-old: a single center comparative analysis. |
Q46631938 | AB120. Early radical cystectomy in BCG naive pathological non-muscle invasive bladder cancer: results from a retrospective study with 164 cases. |
Q45786241 | AB129. Clinical analysis about 21 cases of different urinary diversion after radical cystectomy |
Q45784493 | AB172. Laparoscopic radical cystectomy and intracorporeal orthotopic ileal neobladder with bilateral isoperistaltic afferent limbs: initial experience. |
Q47855073 | ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder |
Q98293781 | ASO Author Reflections: Prognostic Nutritional Index-A Simple Evaluation that May Help Reduce the Risk of Postoperative Pulmonary Complications in Radical Cystectomy |
Q49709096 | Abdominal Sacrocolpopexy for Repair of Pelvic Organ Prolapse After Radical Cystectomy |
Q54719358 | Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. |
Q92352730 | Accuracy of American College of Surgeons National Surgical Quality Improvement Program Universal Surgical Risk Calculator in Predicting Complications Following Robot-Assisted Radical Cystectomy at a National Comprehensive Cancer Center |
Q70794101 | Accuracy of computer tomography in urinary bladder cancer. Study of 74 patients following radical cystectomy |
Q53059423 | Accuracy of urethral frozen section during radical cystectomy for bladder cancer. |
Q91396152 | Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy |
Q87346801 | Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy |
Q41255492 | Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality |
Q95941418 | Acute Kidney Injury following Enhanced Recovery after Surgery (ERAS) in Patients Undergoing Radical Cystectomy |
Q50159822 | Acute acalculous cholecystitis after radical cystectomy |
Q46671308 | Acute acalculous cholecystitis after radical cystectomy: a report of two cases. |
Q64991350 | Acute kidney injury following radical cystectomy and urinary diversion: predictors and associated morbidity. |
Q80760148 | Acute normovolemic hemodilution for radical retropubic prostatectomy and radical cystectomy |
Q59649561 | Adenocarcinoma Versus Urothelial Carcinoma of the Urinary Bladder: Comparison Between Pathologic Stage at Radical Cystectomy and Cancer-specific Mortality |
Q46840883 | Adherence to surveillance guidelines after radical cystectomy: a population-based analysis |
Q79919302 | Adjustable continence therapy for the treatment of urinary incontinence after radical cystectomy and orthotopic neobladder in women |
Q40610039 | Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort |
Q35856850 | Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder Cancer |
Q38610028 | Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. |
Q47231814 | Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer |
Q47393991 | Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial |
Q44789122 | Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting |
Q40860545 | Adjuvant chemotherapy following radical cystectomy |
Q73139168 | Adjuvant chemotherapy for non-organ confined disease after radical cystectomy |
Q87091388 | Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer |
Q97877838 | Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent |
Q64979120 | Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. |
Q33396809 | Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial |
Q38218163 | Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients |
Q43806537 | Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience |
Q53721312 | Adjuvant radiotherapy after radical cystectomy and ileal orthotopic neobladder. |
Q36338035 | Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study |
Q33630045 | Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial. |
Q55064633 | Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy? |
Q88555461 | Adopting Enhanced Recovery Programmes in Radical Cystectomy: Can We Afford Not To? |
Q68215944 | Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective Study |
Q79369638 | Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy |
Q38640776 | Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy. |
Q46332516 | Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy |
Q44989449 | Age and bupivacaine plasma concentrations following radical cystectomy. |
Q93170984 | Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy |
Q84883989 | Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database |
Q40219984 | Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy |
Q43662823 | Age, tumour stage, and preoperative serum albumin level are independent predictors of mortality after radical cystectomy for treatment of bladder cancer in Hong Kong Chinese |
Q57238997 | Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer |
Q39939847 | Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer |
Q51729078 | Air embolism during radical cystectomy with ileal conduit urinary diversion. |
Q60907292 | Alexis Wound Retractor for Radical Cystectomy: A Safe and Effective Method for Retraction |
Q38434405 | Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial |
Q64246701 | Alvimopan for post-radical cystectomy ileus: what should we know? |
Q85501098 | Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis |
Q24186081 | Alvimopan for recovery of bowel function after radical cystectomy |
Q49357124 | Alvimopan for recovery of bowel function after radical cystectomy |
Q36360289 | Alvimopan for recovery of bowel function after radical cystectomy. |
Q37057032 | Alvimopan in an Enhanced Recovery Program Following Radical Cystectomy |
Q91730541 | Alvimopan is Associated with a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy |
Q84390151 | Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion |
Q91342763 | Alvimopan usage increasing following radical cystectomy |
Q44342565 | Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial |
Q36285089 | An Evaluation of the Timing of Surgical Complications Following Radical Cystectomy: Data From the American College of Surgeons National Surgical Quality Improvement Program |
Q58594897 | An Update in Enhanced Recovery Following Radical Cystectomy |
Q36710334 | An analysis of preoperative delays prior to radical cystectomy for bladder cancer in Quebec |
Q37319815 | An audit of early complications of radical cystectomy using Clavien-Dindo classification |
Q88116203 | An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy |
Q56928484 | An evaluation of adjuvant chemotherapy eligibility rates among patients undergoing radical cystectomy |
Q67971124 | An ileal neobladder for a female patient after a radical cystectomy to ensure voiding from the urethra: a case report |
Q40664979 | An improved technique for bladder cancer: Pure laparoscopic radical cystectomy with orthotopic U-shape ileal neobladder using titanium staples |
Q33941669 | Analgesic opioid dose is an important indicator of postoperative ileus following radical cystectomy with ileal conduit: experience in the robotic surgery era. |
Q77949463 | Analysis of early complications after radical cystectomy: results of a collaborative care pathway |
Q39839417 | Analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system. |
Q37685561 | Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology |
Q46532844 | Analysis of histopathological prognostic factors in patients who underwent radical cystectomy in cancer of the bladder |
Q42625988 | Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. |
Q45292570 | Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam-piperacillin (1:4 ratio) for prevention of postoperative infections after radical cystectomy |
Q40750987 | Analysis of life-threatening complications during perioperative period in patients undergoing radical cystectomy with orthotopic neobladder |
Q87444365 | Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes |
Q82742274 | Analysis of prognostic factors in patients with transitional cell carcinoma of the bladder treated with radical cystectomy |
Q46611293 | Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort |
Q51290828 | Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. |
Q92591908 | Analysis of surgeon biometrics during open and robotic radical cystectomy with electromyography and motion capture analysis |
Q39578304 | Analysis of the perioperative and five-year oncological outcome of two hundred cases of open radical cystectomy: a single center experience |
Q38064344 | Anatomic basis of radical cystectomy and orthotopic urinary diversion in female patients |
Q50781326 | Anatomic robot-assisted radical cystectomy. |
Q46298528 | Anatomic study of pelvic urethra in women: value of its conservation in radical cystectomy |
Q44582202 | Anesthesia and perioperative care in radical cystectomy |
Q48921514 | Anesthesia management of laparoscopic radical cystectomy and orthotopic bladder surgery with a robotic-assisted surgical system |
Q78816405 | Antegrade extraperitoneal approach to radical cystectomy and ileal neobladder |
Q91666707 | Anterior enterocele: a cause of recurrent prolapse after radical cystectomy |
Q87757107 | Anterior fascial fixation does not reduce the parastomal hernia rate after radical cystectomy and ileal conduit |
Q60920106 | Anterior versus posterior approach laparoscopic radical cystectomy: a retrospective analysis |
Q97556708 | Appendiceal conduit: A novel technique to be applied after radical cystectomy: A case study report |
Q64899507 | Application of enhanced recovery after surgery in patients undergoing radical cystectomy. |
Q67953748 | Application of smooth Teflon clip to inferior vena cava during radical cystectomy to prevent postoperative pulmonary embolism |
Q36619292 | Are bladder cancer patients with pT0 disease following radical cystectomy cured of cancer? |
Q69621957 | Are frozen-section examinations of ureteral margins required for all patients undergoing radical cystectomy for bladder cancer? |
Q82933347 | Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer |
Q38963972 | Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy. |
Q93347303 | Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States |
Q44509337 | Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer |
Q77182067 | Assessment of morbidity and functional results in bladder replacement with Hautmann ileal neobladder after radical cystectomy: a clinical experience in 55 highly selected patients |
Q80994999 | Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer |
Q91590487 | Assessment of transurethral resection of the bladder specimens with pT1 high-grade urothelial carcinoma for the predictor features of muscularis propria invasion on radical cystectomy specimens |
Q38770148 | Association Between Preoperative Albumin Levels and Length of Stay after Radical Cystectomy |
Q64075488 | Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis |
Q89914536 | Association Between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes Following Radical Cystectomy: Systematic Review and Meta-Analysis |
Q61443903 | Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy |
Q38972582 | Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy |
Q97527303 | Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study |
Q92487407 | Association between perioperative morbidity and mortality after radical cystectomy: an opportunity to understand the complication snowball effect |
Q43742712 | Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy |
Q48293504 | Association between urinary diversion and quality of life after radical cystectomy |
Q46071112 | Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional Study |
Q53086009 | Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. |
Q41148310 | Association of distance to treatment facility on quality and survival outcomes after radical cystectomy for bladder cancer |
Q104288840 | Association of intraoperative hypothermia with oncologic outcomes following radical cystectomy |
Q73366498 | Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder |
Q54345476 | Association of procedure volume with radical cystectomy outcomes in a nationwide database. |
Q90043400 | Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization |
Q37165890 | Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. |
Q50160319 | Associations between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer |
Q37485158 | Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database. |
Q47880228 | Associations of specific postoperative complications with costs after radical cystectomy. |
Q93050757 | Atypical Early Recurrence after Robot-Assisted Radical Cystectomy: Port-Site Metastasis |
Q92042223 | Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution |
Q100750717 | Author Reply Re: Bansal D, Nayak B, Singh P, Nayyar R, Ramachandran R, Kumar R, Seth A. Randomized controlled trial to compare outcomes with and without the enhanced recovery after surgery protocol in patients undergoing radical cystectomy. Indian J |
Q40214112 | Avoiding complications with radical cystectomy |
Q90929714 | BCG instillation versus radical cystectomy for high-risk NMIBC with squamous/glandular histologic variants |
Q44129192 | BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy |
Q59341100 | BLADDER PRESERVATION MULTIMODALITY THERAPY AS AN ALTERNATIVE TO RADICAL CYSTECTOMY FOR TREATMENT OF MUSCLE INVASIVE BLADDER CANCER |
Q57111098 | Bacillus Calmette-Guérin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy |
Q46519956 | Balancing disease and risk in octogenarians undergoing radical cystectomy |
Q41085821 | Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy |
Q84739590 | Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy |
Q104556347 | Bayesian network analysis of open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer |
Q78250824 | Behavior of the rectosigmoid bladder after radical cystectomy and sigmoid colostomy |
Q78284128 | Behavior of the rectosigmoid bladder after radical cystectomy and sigmoid colostomy |
Q72842622 | Behaviour and urodynamic properties of orthotopic ileal bladder substitute after radical cystectomy |
Q37710569 | Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit. |
Q93157213 | Beneficial effect of fluid warming in elderly patients with bladder cancer undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy |
Q44803113 | Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis |
Q37053991 | Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy |
Q80374514 | Benefit of radical cystectomy in the elderly patient with significant co-morbidities |
Q93125729 | Benefits and Complications during the Stay at an Early Rehabilitation Facility after Radical Cystectomy and Orthotopic Ileum Neobladder Reconstruction |
Q36352060 | Benefits of laparoscopic prostate-sparing radical cystectomy |
Q38316142 | Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. |
Q57130426 | Better compliance contributes to better nocturnal continence with orthotopic ileal neobladder than ileocolonic neobladder after radical cystectomy for bladder cancer |
Q46690466 | Bilateral vocal cord paralysis after radical cystectomy in a patient with a history of bulbar polio |
Q69984128 | Biochemical and morphologic studies of the prostate gland in men subjected to radical cystectomy |
Q48298615 | Biphasic decline in renal function after radical cystectomy with urinary diversion |
Q73675357 | Bladder Replacement and Urinary Diversion After Radical Cystectomy |
Q81588108 | Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy |
Q98287639 | Bladder cancer following renal transplantation: experiences with radical cystectomy and adjuvant radiotherapy |
Q38644602 | Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy |
Q38141129 | Bladder cancer in geriatric patients. Alternatives to radical cystectomy. |
Q53742526 | Bladder cancer in men and women treated by radiation therapy and/or radical cystectomy. |
Q44989926 | Bladder cancer: Conditional survival after radical cystectomy |
Q86641725 | Bladder cancer: biomarker panel predicts recurrence after radical cystectomy |
Q87458555 | Bladder cancer: faster recovery after radical cystectomy with alvimopan |
Q84039276 | Bladder cancer: nomogram aids clinical decision making after radical cystectomy |
Q71833944 | Bladder cancer: results of radical cystectomy for invasive and recurrent superficial tumors |
Q84911432 | Bladder cancer: robot-assisted laparoscopic radical cystectomy: a single-center experience |
Q44357692 | Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant therapy modalities |
Q71525424 | Bladder carcinoma: results with preoperative radiation therapy and radical cystectomy |
Q57050821 | Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies |
Q81817884 | Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy |
Q84999374 | Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer |
Q42514626 | Bladder replacement after radical cystectomy using detubularized right colonic segment |
Q45891355 | Bladder replacement by detubed ileo-caecal graft after radical cystectomy |
Q68067245 | Bladder replacement by entero-cystoplasty after radical cystectomy for bladder cancer--the urethral Kock pouch |
Q68974871 | Bladder replacement by ileocystoplasty following radical cystectomy |
Q39143350 | Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy |
Q39890311 | Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy |
Q35748056 | Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device |
Q41255396 | Blood transfusion and hemostatic agents used during radical cystectomy |
Q37642096 | Body image following radical cystectomy and ileal neobladder or conduit in korean patients |
Q42604246 | Bowel preparation and peri-operative management for radical cystectomy in Turkey: Turkish Urooncology Association multicenter survey |
Q89122590 | Building the Case for Adjuvant Chemotherapy After Radical Cystectomy: Commentary on: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer |
Q104280541 | Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter? |
Q44546663 | Burden and timing of venothrombolic events in patients younger than 65 years undergoing radical cystectomy for bladder cancer |
Q102067204 | C-reactive Protein/Albumin Ratio and Acute Kidney Injury after Radical Cystectomy among Elderly Patients: A Propensity Score-Matched Analysis |
Q37407271 | C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy |
Q43143687 | CORRIGENDUM: A Comparative Study of Fast-Track Versus Conventional Surgery in Patients Undergoing Laparoscopic Radical Cystectomy and Ileal Conduit Diversion: Chinese Experience |
Q39677557 | COUNTERPOINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection? |
Q37424615 | CT findings in urinary diversion after radical cystectomy: postsurgical anatomy and complications |
Q99578183 | Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution retrospective analysis |
Q81270822 | Can excretory urography detect upper urinary tract tumors after radical cystectomy for urothelial cancer? |
Q100492539 | Can frozen-section analysis of ureteric margins at the time of radical cystectomy predict upper tract recurrence? |
Q53110548 | Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy? |
Q90416201 | Can robotic-assisted radical cystectomy provide patients with a smaller trauma and faster recovery period? A systematic review and meta-analysis of comparative trials |
Q50910865 | Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy? |
Q38605252 | Cancer and All-Cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-Making |
Q83116462 | Cancer specific outcomes in patients with pT0 disease following radical cystectomy |
Q60622169 | Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy |
Q45387855 | Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density |
Q77493702 | Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder |
Q44028972 | Carcinoma of the bladder: Treatment by radical cystectomy |
Q47831641 | Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy. |
Q30440468 | Care of the patient undergoing radical cystectomy with a robotic approach. |
Q77351993 | Causes of increased hospital stay after radical cystectomy in a clinical pathway setting |
Q78516965 | Causes of increased length of stay following radical cystectomy |
Q54967645 | Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care. |
Q38876688 | Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer |
Q44381729 | Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible |
Q54960847 | Challenges facing regionalization of radical cystectomy. |
Q34192945 | Challenging boundaries: an enhanced recovery programme for radical cystectomy |
Q37610511 | Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer |
Q58818806 | Changes in body composition, muscle function and energy expenditure after radical cystectomy |
Q44771172 | Changes in patient characteristics and outcomes for radical cystectomy in England |
Q82237310 | Changes in the upper urinary tract after radical cystectomy and urinary diversion: a comparison of antirefluxing and refluxing orthotopic bladder substitutes and the ileal conduit |
Q91949440 | Characterising 'bounce-back' readmissions after radical cystectomy |
Q88010554 | Characteristics and Associated Factors of Postoperative Pulmonary Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer: A National Surgical Quality Improvement Program Study |
Q80274704 | Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy |
Q43870448 | Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort |
Q51576729 | Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. |
Q51601159 | Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. |
Q47233707 | Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma |
Q50645475 | Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients. |
Q104744465 | Characterization of perioperative androgen profiles in men with bladder cancer undergoing radical cystectomy |
Q38833117 | Characterization of perioperative infection risk among patients undergoing radical cystectomy: Results from the national surgical quality improvement program. |
Q92191703 | Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk |
Q92544846 | Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database |
Q33448166 | Chewing gum has a stimulatory effect on bowel motility in patients after open or robotic radical cystectomy for bladder cancer: a prospective randomized comparative study |
Q38272281 | Choroidal and cutaneous metastasis from urothelial carcinoma of the bladder after radical cystectomy: a case report and literature review. |
Q50495236 | Chronic urinary retention after radical cystectomy and orthotopic neobladder in women: Risk factors and relation to time. |
Q90955652 | Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre ex |
Q71697406 | Clearance of serum PSA after open surgery for benign prostatic hypertrophy, radical cystectomy, and radical prostatectomy |
Q38655076 | Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy |
Q38594015 | Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation. |
Q89056133 | Clinical Significance of Incidental Prostatic Carcinoma on Radical Cystectomy Histology Specimens: a Clinicopathological and Survival Analysis |
Q45022059 | Clinical analysis of bladder cancer patients treated by radical cystectomy |
Q46858107 | Clinical analysis of bladder cancer patients undergoing radical cystectomy |
Q43756593 | Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy |
Q41471527 | Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy |
Q99566106 | Clinical efficacy and safety of enhanced recovery after surgery for patients treated with radical cystectomy and ileal urinary diversion: a systematic review and meta-analysis of randomized controlled trials |
Q35618646 | Clinical evaluation of patients treated with a detubularised isolated ureterosigmoidostomy diversion after radical cystectomy. |
Q36090092 | Clinical experience of laparoscopic-assisted radical cystectomy with continent ileal reservoir |
Q36328773 | Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder |
Q96223110 | Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review |
Q37053896 | Clinical outcome of radical cystectomy for patients with pT4 bladder cancer |
Q83335128 | Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder |
Q101061348 | Clinical outcomes of a cohort of patients with bulky, clinically node-positive bladder cancer undergoing radical cystectomy in the contemporary era |
Q51756460 | Clinical outcomes of patients with pT0 bladder cancer after radical cystectomy: a single-institute experience. |
Q93122518 | Clinical outcomes of robot-assisted radical cystectomy and continent urinary diversion |
Q85726345 | Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens |
Q84378687 | Clinical predictive factors of poor outcome in patients with stage pT0 disease at radical cystectomy |
Q91916718 | Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience |
Q37447069 | Clinical prognostic factors for radical cystectomy in bladder cancer |
Q38140068 | Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review. |
Q74216421 | Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy |
Q34786617 | Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder |
Q40739560 | Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate |
Q30784290 | Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base |
Q90571307 | Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model |
Q36864718 | Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis |
Q92029546 | Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis |
Q82664109 | Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder |
Q84437364 | Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy |
Q57071535 | Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy |
Q46385900 | Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy |
Q46506619 | Combined general and epidural anaesthesia versus general anaesthesia for radical cystectomy |
Q90750294 | Combined reporting of surgical quality, cancer control and functional outcomes of robot-assisted radical cystectomy with intracorporeal orthotopic neobladder into a novel trifecta |
Q86033904 | Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase |
Q89029849 | Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy." |
Q86365585 | Commentary on "Impact of statin use on oncologic outcomes in patients with urothelial carcinoma ofthe bladder treated with radical cystectomy." da Silva RD, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Chade D, Guglielmetti GB, Pycha A, Lotan Y, Kar |
Q44199136 | Commentary on "Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder." Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto |
Q41713681 | Commentary on "Robot-assisted laparoscopic vs open radical cystectomy: Comparison of complications and perioperative oncological outcomes in 200 patients." Kader AK, Richards KA, Krane LS, Pettus JA, Smith JJ, Hemal AK, Division of Urology, UC San D |
Q38116604 | Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagianno |
Q57020510 | Comments on Brimo F, Downes MR, Jamaspishvili T, Berman D, Barkan G, Athanazio D, Abro S, Visram K, Yilmaz A, Solanki S, Hahn E, Siemens R, Kassouf W, Trpkov K. Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy. His |
Q44084230 | Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder |
Q50942157 | Comorbidity relationship to outcome of radical cystectomy in Chinese: a single institution study with the ACE-27 comorbidity index. |
Q93220405 | Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study |
Q93348927 | Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer |
Q38835752 | Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder |
Q40069486 | Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer-Do Outcomes Differ? |
Q34467381 | Comparative analysis of early perioperative outcomes following radical cystectomy by either the robotic or open method. |
Q51897069 | Comparative analysis of laparoscopic and robot-assisted radical cystectomy with ileal conduit urinary diversion. |
Q51386151 | Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. |
Q40381359 | Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder |
Q89826168 | Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis |
Q92233819 | Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective anal |
Q92896579 | Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer |
Q47249826 | Comparative effectiveness of robot-assisted vs. open radical cystectomy |
Q50930128 | Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a. |
Q36953757 | Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. |
Q44237046 | Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer |
Q91014519 | Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis |
Q45336033 | Comparative study of morbidity and mortality between ileal conduit and ureterosigmoidostomy after radical cystectomy for bladder neoplasm. |
Q34747411 | Comparative study of various forms of urinary diversion after radical cystectomy in muscle invasive carcinoma urinary bladder |
Q35582575 | Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial |
Q90326600 | Comparing Provider-Led Sexual Health Counseling of Male and Female Patients Undergoing Radical Cystectomy |
Q89337029 | Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer |
Q87071909 | Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy |
Q90807508 | Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence |
Q96767851 | Comparing peri-operative complications between laparoscopic and robotic radical cystectomy for bladder cancer |
Q41581386 | Comparing the Effects of Combined General/Epidural Anaesthesia and General Anaesthesia on Serum Cytokine Levels in Radical Cystectomy. |
Q71956921 | Comparison between results of ileal conduit and continent ileal bladder (VIP), after radical cystectomy |
Q68355713 | Comparison between short-course high-dose preoperative irradiation with immediate radical cystectomy and salvage cystectomy after full-dose irradiation |
Q90468770 | Comparison of 2-Year Oncological Outcome and Early Recurrence Patterns in Patients with Urothelial Bladder Carcinoma Treated with Open or Robot-Assisted Radical Cystectomy with an Extracorporeal Urinary Diversion |
Q53504464 | Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed. |
Q42238126 | Comparison of 90-day complications between ileal conduit and neobladder reconstruction after radical cystectomy: a retrospective multi-institutional study in Japan |
Q92538945 | Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer |
Q102055473 | Comparison of Laparoendoscopic Single-Site and Laparoscopic Radical Cystectomy for Male Patients with Bladder Cancer: Perioperative and Oncologic Outcomes |
Q91863552 | Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes |
Q98954116 | Comparison of Major Complications at 30 and 90 days Following Radical Cystectomy |
Q100395997 | Comparison of Outcomes Between Radical Radiotherapy and Radical Cystectomy in Muscle Invasive Bladder Cancer in a Cancer Specialized Unit of a Developing Country |
Q89136920 | Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation |
Q53354088 | Comparison of Perioperative Morbidity of Radical Cystectomy With Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients. |
Q88914640 | Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis |
Q90993391 | Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy |
Q97566135 | Comparison of a Significant Decline in the Glomerular Filtration Rate between Ileal Conduit and Ileal Neobladder Urinary Diversions after Radical Cystectomy: A Propensity Score-Matched Analysis |
Q38783985 | Comparison of anesthetic management and outcomes of robot-assisted versus open radical cystectomy |
Q44227310 | Comparison of complications from radical cystectomy between old-old versus oldest-old patients |
Q42619234 | Comparison of early postoperative morbidity after robot-assisted and open radical cystectomy: results of a prospective observational study. |
Q43294016 | Comparison of epidural and intravenous patient controlled analgesia in patients undergoing radical cystectomy. |
Q82984571 | Comparison of hand-assisted laparoscopic and open radical cystectomy for bladder cancer |
Q39153843 | Comparison of initial experiences of robot-assisted radical cystectomy with those of laparoscopic for bladder cancer |
Q90081438 | Comparison of intracorporeal and extracorporeal urinary diversions after laparoscopic radical cystectomy in females with bladder cancer |
Q51584341 | Comparison of modified Taguchi and Bricker ureteral reimplantation techniques after radical cystectomy. |
Q41998977 | Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis |
Q51053993 | Comparison of pathological staging and grading of urothelial bladder carcinoma in post-transurethral resection and post-radical cystectomy specimens. |
Q89800313 | Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis |
Q64884209 | Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis. |
Q91620708 | Comparison of perioperative outcomes and complications of robot assisted radical cystectomy with extracorporeal vs intracorporeal urinary diversion |
Q37028090 | Comparison of perioperative outcomes for epidural versus intravenous patient-controlled analgesia after radical cystectomy |
Q92546431 | Comparison of perioperative outcomes in robot-assisted radical cystectomy and laparoscopic radical cystectomy |
Q37257074 | Comparison of postoperative acute kidney injury between ileal conduit and neobladder urinary diversions after radical cystectomy: A propensity score matching analysis |
Q48066795 | Comparison of radical cystectomy and chemoradiotherapy in patients with locally advanced bladder cancer |
Q54549413 | Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer. |
Q47326201 | Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy |
Q100511765 | Comparison of renal function after open radical cystectomy, extracorporeal robot assisted radical cystectomy, and intracorporeal robot assisted radical cystectomy |
Q38784370 | Comparison of robotic-assisted and open radical cystectomy in a community-based, non-tertiary health care setting |
Q84372934 | Comparison of surgical stress response to laparoscopic and open radical cystectomy |
Q79866954 | Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer |
Q39921660 | Comparison of the clinical effectiveness of 3D and 2D imaging systems for laparoscopic radical cystectomy with pelvic lymph node dissection |
Q52678462 | Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis. |
Q102209786 | Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study |
Q36183644 | Comparison of two kinds of cutaneous ureterostomy using in radical cystectomy |
Q38889141 | Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy |
Q52965436 | Complete laparoscopic approach for radical cystectomy and continent urinary diversion (sigma rectum pouch). |
Q31024148 | Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer |
Q83314613 | Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer |
Q41305192 | Complications after ileal conduit: Urinary diversion-associated complications after radical cystectomy |
Q31047164 | Complications after radical cystectomy: analysis of population-based data |
Q42276444 | Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. |
Q38646225 | Complications and health-related quality of life after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis of four RCTs. |
Q51625691 | Complications and mortality after radical cystectomy for bladder transitional cell cancer. |
Q37105651 | Complications and oncologic outcomes following robot-assisted radical cystectomy: What is the real benefit? |
Q47809069 | Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy. |
Q91313538 | Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort |
Q37501415 | Complications following radical cystectomy for bladder cancer in the elderly |
Q73430784 | Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score |
Q38443264 | Complications from robot-assisted radical cystectomy: Where do we stand? |
Q79822974 | Complications in laparoscopic radical cystectomy. The South American experience with 59 cases |
Q81479579 | Complications in radical cystectomy performed at a teaching hospital |
Q49356663 | Complications instead of improved survival and local freedom from recurrence after early radical cystectomy in muscle-invasive bladder cancer compared to multimodal maintenance therapy |
Q104285701 | Complications of Ileal Conduits after Radical Cystectomy: Interventional Radiologic Management |
Q26772314 | Complications of Radical Cystectomy and Orthotopic Reconstruction |
Q40829428 | Complications of a single stage radical cystectomy and ileal conduit diversion: review of 214 cases |
Q35830345 | Complications of laparoscopic radical cystectomy during the initial experience. |
Q39853533 | Complications of radical cystectomy and correlation with nutritional assessment |
Q35525667 | Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades |
Q71334948 | Complications of radical cystectomy for carcinoma of the bladder |
Q78645458 | Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease |
Q36790510 | Complications of radical cystectomy. |
Q71180121 | Complications of radical cystectomy: impact of the timing of perioperative chemotherapy |
Q71494477 | Complications of single-stage radical cystectomy and ileal conduit |
Q40365823 | Complications of ureteroileal conduit with radical cystectomy: review of 336 cases |
Q50016406 | Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan |
Q91208921 | Comprehensive characterization of perioperative reoperation following radical cystectomy |
Q53923251 | Computed Tomography Loopogram: A Novel Technique for Upper Tract Evaluation After Radical Cystectomy. |
Q69755482 | Computerized tomography: an unreliable method for accurate staging of bladder tumors in patients who are candidates for radical cystectomy |
Q89036843 | Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy |
Q79163021 | Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy |
Q92663523 | Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis |
Q88013005 | Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy |
Q57582151 | Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens |
Q37053926 | Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study |
Q71536563 | Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy |
Q53101324 | Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. |
Q59649528 | Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy |
Q51768028 | Contemporary 90-day mortality rates after radical cystectomy in the elderly. |
Q88344201 | Contemporary Preoperative and Intraoperative Management of the Radical Cystectomy Patient |
Q78645471 | Contemporary concepts of radical cystectomy and the treatment of bladder cancer |
Q38833271 | Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer |
Q38206405 | Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer |
Q36111236 | Contemporary management of the urethra in patients after radical cystectomy for bladder cancer |
Q40121742 | Contemporary open radical cystectomy: analysis of perioperative outcomes |
Q44829874 | Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience |
Q41428274 | Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study |
Q88498839 | Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study |
Q98509221 | Contemporary treatment patterns for Non-Muscle Invasive Bladder Cancer: Has the Use of Radical Cystectomy changed in the BCG Shortage Era? |
Q46026027 | Contemporary trends of in-hospital complications and mortality for radical cystectomy. |
Q91643806 | Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients |
Q91517907 | Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy |
Q38661971 | Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer |
Q40553448 | Continent and orthotopic urinary diversion following radical cystectomy. Should these reconstructive procedures now be considered standard of care? |
Q53630444 | Continent urinary diversion after radical cystectomy: 3 years' experience. |
Q91447931 | Continuous Erector Spinae Plane and Intrathecal Opioid Analgesia: Novel Regimen Avoiding Thoracic Epidural Analgesia and Systemic Morphine in Open Radical Cystectomy: A Case Series |
Q51853959 | Controlled hypotensive anesthesia to reduce blood loss in radical cystectomy for bladder cancer. |
Q38559138 | Controversies in Robotics: Open Versus Robotic Radical Cystectomy |
Q41346526 | Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study |
Q96953057 | Coronavirus (COVID-19) Pandemic and Radical Cystectomy |
Q91406203 | Correction to: Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy |
Q60556407 | Correction: Multifactorial, Site-Specific Recurrence Models after Radical Cystectomy for Urothelial Carcinoma: External Validation in a Cohort of Korean Patients |
Q92667812 | Correction: Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study |
Q53325245 | Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma. |
Q61952795 | Correlation between malnutrition, body mass index and complications in patients with urinary bladder cancer who underwent radical cystectomy |
Q90958451 | Correlation between organ-specific co-morbidities and complications in bladder cancer patients undergoing radical cystectomy |
Q38460001 | Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens |
Q49099007 | Corrigendum re: "Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group" [Eur Urol 2017;71:723-6]. |
Q46847991 | Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]. |
Q96637842 | Corrigendum to Xanthogranulomatous Ureteritis Mimicking Ureteral Involvement by Cancer in a Radical Cystectomy Specimen |
Q38672150 | Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer |
Q38062887 | Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy |
Q42695341 | Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy. |
Q51767288 | Cost analysis of robotic versus open radical cystectomy for bladder cancer. |
Q34123987 | Cost benefits of intraoperative cell salvage in radical cystectomy |
Q91191968 | Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs |
Q96748475 | Cost comparison of laparoscopic versus robot-assisted radical cystectomy |
Q90392164 | Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort |
Q27021586 | Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC |
Q84415859 | Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer |
Q38226736 | Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer |
Q81515542 | Costs of radical cystectomy |
Q87132740 | Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT |
Q40502548 | Critical Analysis of Hospital Readmission and Cost Burden After Robot-Assisted Radical Cystectomy |
Q39445151 | Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery? |
Q42632953 | Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors |
Q84106224 | Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy |
Q40805887 | Critical review of radical cystectomy and indicators of prognosis. |
Q38791867 | Current Status of Robot-Assisted Radical Cystectomy and Intracorporeal Urinary Diversion |
Q26779973 | Current Status of Robot-Assisted Radical Cystectomy: What is the Real Benefit? |
Q35898119 | Current Strategies to Enhance Recovery following Radical Cystectomy: Single Centre Initial Experience |
Q90227024 | Current Zero clamping technique during radical cystectomy |
Q99718829 | Current evidence for robotic surgery in radical cystectomy |
Q36982116 | Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus |
Q92303630 | Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer |
Q37826124 | Current status and outcomes of robot-assisted laparoscopic radical cystectomy and urinary diversion. |
Q70794125 | Current status of adjuvant chemotherapy after radical cystectomy for deeply invasive bladder cancer |
Q89701039 | Current status of laparoscopic and robot-assisted nerve-sparing radical cystectomy in male patients |
Q38114947 | Current status of minimally invasive radical cystectomy: an outcome-based comparison |
Q37624387 | Current status of robot-assisted radical cystectomy |
Q38030860 | Current status of robot-assisted radical cystectomy for bladder cancer |
Q38203741 | Current status of robotic and laparoscopic techniques in radical cystectomy and diversion procedures for bladder cancer: review |
Q38564954 | Current status of robotic assisted radical cystectomy with intracorporeal ileal neobladder for bladder cancer |
Q92679701 | Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy) |
Q39469634 | Cutaneous ureterostomy with definitive ureteral stent as urinary diversion option in unfit patients after radical cystectomy. |
Q95654609 | Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy |
Q96639067 | D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy |
Q90169903 | De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study |
Q51783821 | Decrease in incidence of surgical site infections in contemporary series of patients with radical cystectomy. |
Q92552533 | Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer |
Q38982801 | Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis |
Q78953922 | Decreasing blood loss in patients treated with radical cystectomy: a prospective randomizes trial using a new stapling device |
Q61454788 | Decreasing incidence of venous thromboembolic events after radical cystectomy: are we finally improving? |
Q46452421 | Decreasing operative time and incontinence rates in patients treated with radical cystectomy and urethral diversion: a prospective randomized trial using a new suturing device (CAPIO). |
Q59798082 | Decreasing rates of venous thromboembolism after radical cystectomy: an encouraging trend and more work is still needed |
Q40542218 | Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs |
Q51337185 | Deep venous thrombosis in patients undergoing salvage radical cystectomy. |
Q45217289 | Defining Morbidity of Robot-Assisted Radical Cystectomy Using a Standardized Reporting Methodology |
Q91648791 | Defining a "High Volume" Radical Cystectomy Hospital: Where Do We Draw the Line? |
Q81733374 | Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology |
Q98193361 | Defining postoperative ileus and associated risk factors in patients undergoing radical cystectomy with an Enhanced Recovery After Surgery (ERAS) program |
Q50769053 | Defining the minimum hospital case-load to achieve optimum outcomes in radical cystectomy. |
Q104749697 | Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board |
Q38067928 | Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review |
Q93143623 | Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study |
Q70508209 | Definitive and adjunctive external irradiation in bladder cancer without radical cystectomy |
Q96349426 | Delayed blood transfusion is associated with mortality following radical cystectomy |
Q42630735 | Delayed massive hemorrhage due to external iliac artery pseudo-aneurysm and uretero-iliac artery fistula following robotic radical cystectomy and intracorporeal Studer pouch reconstruction: Endovascular management of an unusual complication. |
Q91661214 | Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes |
Q79075055 | Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage |
Q92165244 | Delays in radical cystectomy for muscle-invasive bladder cancer |
Q97566419 | Detailed Analysis of Urinary Tract Infections after Robot-Assisted Radical Cystectomy |
Q51375032 | Detailed histological investigation of the female urethra: application to radical cystectomy. |
Q38843266 | Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer |
Q39063627 | Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer |
Q38969871 | Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy |
Q88152991 | Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy |
Q48881544 | Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival |
Q46493694 | Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. |
Q82362861 | Detection of nuclear matrix protein 22 and survivin baseline level in patients after radical cystectomy |
Q39636706 | Determinants of radical cystectomy operative time |
Q45771451 | Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort |
Q88144236 | Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy |
Q72733771 | Detubularized sigmoid colon for bladder replacement after radical cystectomy |
Q44681885 | Detubularized sigmoid neobladder versus detubularized W-shaped ileal neobladder as a bladder substitute after radical cystectomy for carcinoma of the urinary bladder: a study of 60 patients. |
Q92110322 | Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy |
Q97417439 | Development and Cross-Validation of a Nomogram for Chronic Kidney Disease Following Robot-Assisted Radical Cystectomy |
Q37551255 | Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy |
Q99403825 | Development and Validation of a Model for Predicting Urethral Recurrence in Male Patients with Muscular Invasive Bladder Cancer After Radical Cystectomy Combined with Urinary Diversion |
Q47401845 | Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis. |
Q44042378 | Development and external validation of lymph node density cut-off points in prospective series of radical cystectomy and pelvic lymph node dissection |
Q41647263 | Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy |
Q30470690 | Development and implementation of a clinical pathway for radical cystectomy and urinary system reconstruction |
Q100667174 | Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study |
Q44276267 | Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study |
Q52321739 | Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men. |
Q92664281 | Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy |
Q57192145 | Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer |
Q50225627 | Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy. |
Q84919645 | Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy |
Q38722878 | Development of a patient and institutional-based model for estimation of operative times for robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. |
Q46468318 | Development, validation and clinical application of Pelvic Lymphadenectomy Assessment and Completion Evaluation: intraoperative assessment of lymph node dissection after robot-assisted radical cystectomy for bladder cancer. |
Q38865764 | Diabetes and elevated urea level predict for uretero-ileal stricture after radical cystectomy and ileal conduit formation |
Q80608260 | Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients |
Q40356169 | Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy. |
Q60606984 | Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy |
Q41176058 | Diagnostic accuracy of intraoperative frozen sections during radical cystectomy does not affect disease-free or overall survival: a study of 364 patients with urothelial carcinoma of the urinary bladder |
Q67906837 | Diagnostic and therapeutic aspects of impotence secondary to radical cystectomy and prostatectomy |
Q50207486 | Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients |
Q90708863 | Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients |
Q91766029 | Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration |
Q90354874 | Different models for prediction of radical cystectomy postoperative complications and care pathways |
Q82293052 | Differential complication rates following radical cystectomy in the irradiated and nonirradiated pelvis |
Q52995953 | Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. |
Q61917185 | Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases |
Q46474298 | Discharge patterns after radical cystectomy: contemporary trends in the United States |
Q79772772 | Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy |
Q82479264 | Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort |
Q83229154 | Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort |
Q52650771 | Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index. |
Q74327063 | Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy |
Q36221402 | Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort |
Q43814020 | Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer |
Q49763935 | Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer |
Q69729875 | Dissection of the prostatic apex for radical cystectomy and detubed ileocystoplasty |
Q43346730 | Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a Swedish population-based study |
Q51045913 | Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. |
Q37053768 | Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference |
Q51150690 | Do blood groups have effect on prognosis of patients undergoing radical cystectomy? |
Q38508249 | Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy? |
Q57124420 | Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? |
Q92671226 | Do patients benefit from total intracorporeal robotic radical cystectomy?: A comparative analysis with extracorporeal robotic radical cystectomy from a Korean multicenter study |
Q44617181 | Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy? |
Q36099770 | Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy? |
Q87670762 | Does Implementing an Enhanced Recovery After Surgery Protocol Increase Hospital Charges? Comparisons From a Radical Cystectomy Program at a Specialty Cancer Center |
Q92347120 | Does Postoperative Rehabilitation for Radical Cystectomy Call for Enhanced Recovery after Surgery? A Systematic Review and Meta-analysis |
Q84570608 | Does extended lymph node dissection affect the lymph node density and survival after radical cystectomy? |
Q79369809 | Does extended lymphadenectomy increase the morbidity of radical cystectomy? |
Q37530304 | Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer? |
Q43582440 | Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? |
Q37915525 | Does initial learning curve compromise outcomes for robot-assisted radical cystectomy? A critical evaluation of the first 60 cases while establishing a robotics program |
Q48907275 | Does intubated uretero-ureterocutaneostomy provide better health-related quality of life than orthotopic neobladder in patients after radical cystectomy for invasive bladder cancer? |
Q38123653 | Does minimally invasive surgery for radical cystectomy provide similar long-term cancer control as open radical surgery? |
Q84819296 | Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis |
Q38007021 | Does patient age affect survival after radical cystectomy? |
Q87999862 | Does preoperative neutrophil/lymphocyte rate have an effect on survival of the bladder cancer patients who received radical cystectomy? |
Q49763383 | Does previous abdominal surgery adversely affect perioperative and oncologic outcomes of laparoscopic radical cystectomy? |
Q51671138 | Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium. |
Q35151984 | Does radical cystectomy improve overall survival in octogenarians with muscle-invasive bladder cancer? |
Q41669681 | Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer? |
Q61454750 | Does robotic radical cystectomy impede oncological outcome in bladder cancer patients? |
Q35590489 | Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer? |
Q92508902 | Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts |
Q38857368 | Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. |
Q41737126 | Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? |
Q83219199 | Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? |
Q51817927 | Does the presence of significant risk factors affect perioperative outcomes after robot-assisted radical cystectomy? |
Q56978842 | Does the robot have a role in Radical Cystectomy ? |
Q38720755 | Dose dense MVAC prior to radical cystectomy: a real-world experience |
Q35393098 | Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival |
Q28262766 | Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease |
Q38884339 | Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage |
Q92737329 | Dynamic readmission prediction using routine postoperative laboratory results after radical cystectomy |
Q40157239 | EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer |
Q27853185 | ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy |
Q76647643 | EXPERIENCE WITH PREOPERATIVE IRRADIATION FOLLOWED BY RADICAL CYSTECTOMY FOR THE TREATMENT OF BLADDER CANCER |
Q58705132 | Early Complications and Mortality following Radical Cystectomy: Associations with Malnutrition and Obesity |
Q46501148 | Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. |
Q90446893 | Early Oncological and Functional Outcomes of Prostate Capsule Sparing Cystectomy Compared with Standard Radical Cystectomy |
Q92817960 | Early Postoperative Morbidity of Robotic Versus Open Radical Cystectomy in Obese Patients |
Q39212852 | Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group |
Q84773055 | Early and Late Perioperative Outcomes Following Radical Cystectomy: 90-Day Readmissions, Morbidity and Mortality in a Contemporary Series |
Q42245322 | Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type |
Q80215567 | Early and late treatment-related morbidity following radical cystectomy |
Q51474671 | Early and late treatment-related morbidity following radical cystectomy. |
Q47880272 | Early discharge and post-discharge outcomes in patients undergoing radical cystectomy for bladder cancer |
Q41992357 | Early metastasis to anterior abdominal wall following radical cystectomy: A rare presentation |
Q61952798 | Early mortality after radical cystectomy in Poland |
Q44656811 | Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion |
Q33874673 | Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer |
Q42677000 | Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy |
Q89986167 | Early recovery after surgery for radical cystectomy: comprehensive assessment and meta-analysis of existing protocols |
Q83563523 | Early removal of nasogastric tube is beneficial for patients undergoing radical cystectomy with urinary diversion |
Q83229181 | Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival |
Q85068603 | Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival |
Q87129996 | Editorial Comment from Dr Abe to Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a |
Q89542726 | Editorial Comment from Dr Abe to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort |
Q48197068 | Editorial Comment from Dr Schmid to Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a. |
Q89542412 | Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort |
Q90209747 | Editorial Comment on: Does the Use of the Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open to Robotic Counterparts by Tzelves et al. (From: Tzelves L, Skolarikos A, |
Q88630835 | Editorial Comment on: Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy by Ko et al |
Q91895856 | Editorial Comment to Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort |
Q92303526 | Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer |
Q48073701 | Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status |
Q53794403 | Editorial Comment to Improved technique for intracorporeal neobladder-urethral anastomosis in laparoscopic radical cystectomy. |
Q92139323 | Editorial Comment to Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan |
Q54216248 | Editorial Comment to Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database. |
Q88032421 | Editorial Comment to Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer |
Q91253468 | Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer |
Q94567160 | Editorial Comment: Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts |
Q42342910 | Editorial Concerning "Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy". |
Q56975518 | Editorial comment from Dr Schiavina et al. to Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy |
Q44741716 | Editorial comment from Dr Smith to Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy |
Q95433772 | Editorial comment on "Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database" |
Q43622722 | Editorial comment on "Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database". |
Q81733379 | Editorial comment on: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology |
Q94705631 | Editorial comment on: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology |
Q80158626 | Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors |
Q94523393 | Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors |
Q81669753 | Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience |
Q81585164 | Editorial comment on: Recoverability of erectile function in post-radical cystectomy patients: subjective and objective evaluations |
Q53187173 | Editorial comment on: characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. |
Q81056965 | Editorial comment on: laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis |
Q51888692 | Editorial comment on: laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis. |
Q81117620 | Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience |
Q51888167 | Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience. |
Q54066342 | Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience. |
Q85919318 | Editorial comment to (18) F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study |
Q84251965 | Editorial comment to The clinical significance of urine cytology after a radical cystectomy for urothelial cancer |
Q84701249 | Editorial comment to development and external validation of lymph node density cut-off points in prospective series of radical cystectomy and pelvic lymph node dissection |
Q82329569 | Editorial comment to extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival |
Q86595250 | Editorial comment to radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: oncological outcomes |
Q85003082 | Editorial comment to stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy |
Q57103719 | Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis |
Q83537284 | Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder |
Q64928207 | Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. |
Q89639755 | Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer-an evaluation of radical cystectomy versus trimodal therapy costs |
Q87230245 | Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy |
Q41079735 | Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the Bladder |
Q41720279 | Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution |
Q47827570 | Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort |
Q41112633 | Effect of Intraoperative Red Blood Cell Transfusion on Postoperative Complications After Open Radical Cystectomy: Old Versus Fresh Stored Blood. |
Q37530344 | Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact? |
Q98897301 | Effect of Neurovascular Bundle Sparing Radical Cystectomy on Postoperative Continence and Sexual Function: A Systematic Review and Meta-Analysis |
Q50128548 | Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer. |
Q92099836 | Effect of Preperitoneal Versus Epidural Analgesia on Postoperative Inflammatory Response and Pain Following Radical Cystectomy: A Prospective, Randomized Trial |
Q51826006 | Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years. |
Q54255211 | Effect of a Radical Cystectomy Care Pathway on Postoperative Length of Stay and Outcomes. |
Q46517220 | Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer |
Q35848937 | Effect of alvimopan on accelerates gastrointestinal recovery after radical cystectomy: A systematic review and meta-analysis |
Q85235285 | Effect of alvimopan on return of bowel function after robot-assisted radical cystectomy |
Q91186407 | Effect of centralization on complex surgical care: A population-based case study of radical cystectomy |
Q50552337 | Effect of delayed radical cystectomy for invasive bladder tumors on lymph node positivity, cancer-specific survival and total survival. |
Q53085995 | Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. |
Q38163229 | Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. |
Q81212424 | Effect of healthcare provider characteristics on nodal yield at radical cystectomy |
Q91857355 | Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain |
Q68180797 | Effect of ileal conduit on patients' activities following radical cystectomy |
Q90711548 | Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study |
Q34626603 | Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer |
Q58603667 | Effect of variant histology presence and squamous differentiation on oncological results and patient's survival after radical cystectomy |
Q41202141 | Effect on postoperative survival of the status of distal ureteral margin: The necessity to achieve negative margins at the time of radical cystectomy |
Q68252987 | Effective outpatient use of polyethylene glycol-electrolyte bowel preparation for radical cystectomy and ileal conduit urinary diversion |
Q54301231 | Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. |
Q101212265 | Effectiveness of ESPITO analgesia in enhancing recovery in patients undergoing open radical cystectomy when compared to a contemporaneous cohort receiving standard analgesia: an observational study |
Q44426851 | Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy |
Q91856558 | Effectiveness of hyaluronic acid/carboxymethylcellulose in preventing adhesive bowel obstruction after laparoscopic radical cystectomy |
Q92234906 | Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer |
Q51739567 | Effects of Nonsteroidal Anti-Inflammatory Drugs as Patient Controlled Analgesia on Early Bowel Function Recovery after Radical Cystectomy. |
Q36046681 | Effects of dexmedetomidine on anesthesia recovery period and postoperative cognitive function of patients after robot-assisted laparoscopic radical cystectomy |
Q42681854 | Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion During Open Radical Cystectomy. |
Q36993621 | Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial |
Q89025205 | Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial: Erratum |
Q35048726 | Efficacy of (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. |
Q91726837 | Efficacy of Prophylactic Antimicrobial Administration of Tazobactam/Piperacillin for Radical Cystectomy with Urinary Diversion: A Multicenter Study |
Q44433553 | Efficacy of a multiprofessional rehabilitation programme in radical cystectomy pathways: a prospective randomized controlled trial |
Q50667620 | Efficacy of preoperative uro-stoma education on self-efficacy after Radical Cystectomy; secondary outcome of a prospective randomized controlled trial. |
Q46974499 | Efficacy of radical cystectomy plus adjuvant intraarterial chemotherapy with gemcitabine and cisplatin on locally advanced bladder cancer |
Q34337059 | Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC) |
Q84153499 | Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach |
Q100460956 | Electroacupuncture for ileus following laparoscopic radical cystectomy and Bricker urinary diversion: a case report |
Q99211308 | Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes Following Radical Cystectomy |
Q81564856 | Elevated plasma D-dimer as a predictor of postoperative complications after radical cystectomy |
Q51167345 | Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients. |
Q44662104 | En bloc transpubic urethrectomy in conjunction with radical cystectomy for bladder carcinoma in males |
Q36212247 | Endoscopic management of ureterointestinal strictures after radical cystectomy |
Q38846587 | Enhanced Recovery After Robot-assisted Radical Cystectomy: EAU Robotic Urology Section Scientific Working Group Consensus View. |
Q91244736 | Enhanced Recovery After Surgery for Radical Cystectomy |
Q38381401 | Enhanced Recovery After Surgery protocols for radical cystectomy surgery: review of current evidence and local protocols |
Q92873434 | Enhanced Recovery after Radical Cystectomy |
Q49894984 | Enhanced Recovery after Surgery Pathway in Patients Undergoing Open Radical Cystectomy is Safe and Accelerates Bowel Function Recovery |
Q99365971 | Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients? |
Q92522739 | Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences |
Q97095254 | Enhanced recovery after surgery (ERAS) protocols in patients undergoing radical cystectomy with ileal urinary diversions: A randomized controlled trial |
Q48108896 | Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium |
Q47954563 | Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy? |
Q38174824 | Enhanced recovery pathway following radical cystectomy |
Q38229447 | Enhanced recovery programmes for patients undergoing radical cystectomy |
Q42642652 | Enhanced recovery protocol after radical cystectomy for bladder cancer |
Q91002520 | Entero-neovesical fistula after radical cystectomy and orthotopic ileal neobladder: A report of two cases requiring surgical management |
Q38842793 | Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study. |
Q92137478 | Epidural anesthesia may be associated with increased postoperative complications in the elderly population undergoing radical cystectomy: an analysis from the National Surgical Quality Improvement Project (NSQIP) database |
Q44092825 | Erectile dysfunction after radical cystectomy |
Q90071595 | Erectile function after radical cystectomy: Comparing surgical stapler with LigaSure in division of vascular pedicles |
Q69927075 | Erection deficit in patients subjected to a radical cystectomy. Diagnostic evaluation by Doppler and sacral evoked reflexes |
Q90813872 | Erratum to 'Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534] |
Q42580342 | Erratum to: 'Perioperative use of crystalloids in patients undergoing open radical cystectomy: balanced Ringer's maleate versus a glucose 5%/potassium-based balanced solution: study protocol for a randomized controlled trial'. |
Q88809494 | Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86 |
Q42348365 | Erratum to: Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder |
Q86940553 | Erratum to: Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol |
Q87825458 | Erratum to: Robotic radical cystectomy: technical tips and tricks |
Q104575624 | Erratum: Surgical Outcomes of Transvaginal Neobladder-Vaginal Fistula Repair After Radical Cystectomy with Ileal Orthotopic Neobladder: A Case-Control Study [Erratum] |
Q77130802 | Estimated blood loss and transfusion requirements of radical cystectomy |
Q51783490 | Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equations. |
Q36276801 | Estimation of mortality and morbidity risk of radical cystectomy using POSSUM and the Portsmouth predictor equation |
Q83817576 | Estimation of the true number of lymph nodes in lymphadenectomy specimens from radical cystectomy |
Q51015062 | Evaluating sexual function in women after radical cystectomy as treatment for bladder cancer. |
Q51861410 | Evaluating the learning curve for robot-assisted laparoscopic radical cystectomy. |
Q35354332 | Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. |
Q92234846 | Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery |
Q40379924 | Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy |
Q91195134 | Evaluation of Incisional Negative Pressure Wound Therapy in the Prevention of Surgical Site Occurrences After Radical Cystectomy: A New Addition to Enhanced Recovery After Surgery Protocol |
Q103052568 | Evaluation of Uretero-Enteric Anastomotic Strictures after the Introduction of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion-Results from a Large Tertiary Referral Center |
Q36467861 | Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients |
Q59796760 | Evaluation of an enhanced recovery protocol on patients having radical cystectomy for bladder cancer |
Q39337493 | Evaluation of conservative approach in the management of ureteroenteric strictures following radical cystectomy with Bricker ileal conduit: a single-center experience |
Q50905895 | Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. |
Q51424832 | Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery. |
Q51095626 | Evaluation of findings during re-exploration for obstructive ileus after radical cystectomy and ileal-loop urinary diversion: insight into potential technical improvements. |
Q99571476 | Evaluation of health care-associated infections following radical cystectomy |
Q91413318 | Evaluation of laparoscopic approach in radical cystectomy from implementation to consolidation: Internal validation |
Q79926745 | Evaluation of laparoscopic radical cystectomy for loco-regionally advanced bladder cancer |
Q86962363 | Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy |
Q39985082 | Evaluation of the improved tubeless cutaneous ureterostomy technique following radical cystectomy in cases of invasive bladder cancer complicated by peritoneal metastasis |
Q88971116 | Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy |
Q83925415 | Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy |
Q43900072 | Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? |
Q44659554 | Evidence of Atypical Recurrences After Robot-Assisted Radical Cystectomy: A Comprehensive Review of the Literature |
Q33460633 | Evolution of the Southampton Enhanced Recovery Programme for radical cystectomy and the aggregation of marginal gains |
Q93384262 | Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis |
Q48187525 | Examining the role of centralisation of radical cystectomy for bladder cancer |
Q70091998 | Excessive antidiuretic hormone secretion after radical cystectomy |
Q38897266 | Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways-secondary results from a randomized controlled trial |
Q89615823 | Expeditious Radical Cystectomy in Patients with High-risk Bladder Cancer Remains an Important Part of Patient Care |
Q92487429 | Experience of surgeon, hospital, and comprehensive cancer team critical to the outcomes of radical cystectomy and urinary diversion |
Q44487249 | Experience with ureteroenteric strictures after radical cystectomy and diversion: open surgical revision |
Q33668036 | Experiences on 25 cases of radical cystectomy. |
Q53062429 | Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy. |
Q39894250 | Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy. |
Q53287064 | Expression of cell cycle–related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder☆ |
Q39445806 | Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin. |
Q50117644 | Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines |
Q58562395 | Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial |
Q91852357 | Extended hospital stay after radical cystectomy with enhanced recovery protocol |
Q45270402 | Extended lymphadenectomy to the lower paraaortic nodes during radical cystectomy |
Q51790521 | Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy. |
Q38907285 | Extended partial cystectomy with augmentation cystoplasty in urachal adenocarcinoma: An oncologically favorable but underutilized alternative to radical cystectomy |
Q88477452 | Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study |
Q36120392 | Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncology |
Q82327868 | Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival |
Q92172964 | Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes |
Q92184454 | Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy |
Q53128804 | Extended versus superextended lymph-node dissection in radical cystectomy: subgroup analysis of possible recurrence-free survival benefit. |
Q26864095 | Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies |
Q46897455 | Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis |
Q38996290 | Extent of lymphadenectomy in patients with bladder cancer undergoing radical cystectomy - a multi-institutional analysis. |
Q24814634 | Extent of lymphadenectomy in radical cystectomy for bladder cancer |
Q38303587 | Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? |
Q84863400 | Extent of pelvic lymph node dissection during radical cystectomy: where and why! |
Q78860560 | Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy |
Q41402220 | External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy. |
Q92952865 | External iliac artery pseudoaneurysm following radical cystectomy: A report of two cases |
Q41626549 | External iliac vein injury and its repair during laparoscopic radical cystectomy |
Q40568645 | External stent versus double J drainage in patients with radical cystectomy and orthotopic urinary diversion: A randomized controlled trial. |
Q37679546 | External stoma and peristomal complications following radical cystectomy and ileal conduit diversion: a systematic review. |
Q87416628 | External validation of a model to predict locoregional failure after radical cystectomy |
Q39652224 | External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder |
Q83768314 | External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder |
Q44097656 | External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy |
Q51152269 | External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder. |
Q98624882 | Extra-Peritoneal versus Trans-Peritoneal Open Radical Cystectomy - Comparison of Two Techniques in Early Post-Operative Complications |
Q98191262 | Extramammary Paget's disease of the glans penis secondary to urethral recurrence of bladder carcinoma after radical cystectomy: A case report |
Q48309155 | Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians. |
Q52908264 | Extraperitoneal radical cystectomy with extraperitonealization of the ileal neobladder: a comparison to the transperitoneal technique. |
Q37221765 | Extraperitoneal versus transperitoneal laparoscopic radical cystectomy for selected elderly bladder cancer patients: a single center experience |
Q97589478 | FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?† |
Q91602775 | FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy |
Q88843761 | Facing the Fate of the Remnant Urothelium After Radical Cystectomy: There Is Room for Improvement |
Q49645203 | Factors Affecting the Cost of Radical Cystectomy in the USA: Some Centres Are More Equal than Others. |
Q36040453 | Factors Impacting the Occurrence of Local, Distant and Atypical Recurrences after Robot-Assisted Radical Cystectomy: A Detailed Analysis of 310 Patients |
Q63966630 | Factors affecting choice between ureterostomy, ileal conduit and continent reservoir after radical cystectomy: Japanese series |
Q46181356 | Factors affecting one-year survival after radical cystectomy: A prospective study. |
Q46324327 | Factors affecting outcomes after radical cystectomy in African Americans |
Q51354932 | Factors associated with non-orthotopic urinary diversion after radical cystectomy. |
Q92046414 | Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway |
Q90293694 | Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy |
Q46642513 | Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. |
Q82530354 | Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy |
Q82584720 | Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy |
Q35210280 | Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management |
Q96617760 | Factors predicting early mortality after radical cystectomy for urothelial carcinoma in a contemporary cohort of patients |
Q46543034 | Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer. |
Q37702347 | Failure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options |
Q80339394 | Fast and safe closing of urethra during laparoscopic radical cystectomy |
Q43123638 | Fast recovery after radical cystectomy. A multidisciplinary challenge |
Q43177876 | Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients |
Q38132503 | Fast track surgery to reduce short-term complications following radical cystectomy and intestinal urinary diversion with Vescica Ileale Padovana neobladder: proposal for a tailored enhanced recovery protocol and preliminary report from a pilot study |
Q48178668 | Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch |
Q43630602 | Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study |
Q51601748 | Feasibility and outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older patients. |
Q35887917 | Feasibility and safety of radical cystectomy under combined spinal and epidural anesthesia in octogenarian patients with ASA score ≥3: A case series. |
Q40536860 | Feasibility and safety study for the use of wound protectors during robotic radical cystectomy and ileal conduit |
Q90929960 | Feasibility of Laparoscopic Radical Cystectomy in Elderly Patients: A Comparative Analysis of Clinical Outcomes in a Single Institution |
Q49573673 | Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy |
Q43069424 | Feasibility of lymphadenectomy in laparoscopic radical cystectomy |
Q48143698 | Feasibility of radical cystectomy in exclusive spinal and/or epidural anaesthesia |
Q36989813 | Febrile Urinary Tract Infection after Radical Cystectomy and Ileal Neobladder in Patients with Bladder Cancer. |
Q45363607 | Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis |
Q90670438 | Female radical cystectomy patients have a higher risk of surgical site infections |
Q38315456 | Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes |
Q48787779 | Female robotic radical cystectomy |
Q80172853 | Female sexual dysfunction after radical cystectomy: a new outcome measure |
Q30245195 | Female sexual dysfunction post radical cystectomy and urinary diversion |
Q44937326 | Fertility preserving radical cystectomy in a young female with malignant mesenchymal tumour of urinary bladder |
Q35887892 | Few modifiable factors predict readmission following radical cystectomy. |
Q91416818 | Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy |
Q45884122 | Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial |
Q41161677 | Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1? |
Q62626260 | Final robotic frontier: the evolution and current state of robot-assisted radical cystectomy |
Q41837967 | Finding treatment success in patients unfit for radical cystectomy |
Q80828401 | Fine needle aspiration of urethral recurrence of urothelial carcinoma after radical cystectomy presenting as a perineal mass: a case report |
Q89574312 | First experience with a new form of orthotopic ileal neobladder (Leuven N-Pouch) following radical cystectomy |
Q51130110 | Fistula between external iliac artery and ileal conduit after radical cystectomy: a life-threatening complication. |
Q50242005 | Fistulous Complications following Radical Cystectomy for Bladder Cancer: Analysis of a Large Modern Cohort |
Q71050273 | Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group |
Q70807145 | Five-year results of neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy plus radical cystectomy in locally advanced bladder cancer |
Q46836360 | Flow cytometric analysis of the DNA content in the urinary bladder cancers treated by radical cystectomy and pre-operative irradiation |
Q50458622 | Fluorescence-enhanced robotic radical cystectomy using unconjugated indocyanine green for pelvic lymphangiography, tumor marking, and mesenteric angiography: the initial clinical experience. |
Q53636094 | Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy. |
Q38101102 | Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors |
Q82539543 | For Wider Acceptance of Radical Cystectomy and Extended Pelvic Lymphadenectomy |
Q92264551 | Frailty and preoperative risk assessment before radical cystectomy |
Q61454781 | Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer |
Q36923856 | Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy |
Q93193393 | Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments |
Q92597866 | Frailty as a prognostic indicator in the radical cystectomy population: a review |
Q48588271 | Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study |
Q54658640 | Frozen section analysis of ureteral margins in patients undergoing radical cystectomy for bladder cancer: differential impact of carcinoma in situ in the bladder on reliability and impact on tumour recurrence in the upper urinary tract. |
Q39442486 | Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review |
Q90751272 | Functional Status in Patients Requiring Nursing Home Stay After Radical Cystectomy |
Q46044993 | Functional bladder replacement after radical cystectomy in the female: experimental investigation of a new concept. |
Q42638642 | Functional outcomes and complications in patients with bladder cancer undergoing robotic-assisted radical cystectomy with extracorporeal Indiana pouch continent cutaneous urinary diversion |
Q90570382 | Functional outcomes obtained with intracorporeal neobladder after robotic radical cystectomy for cancer: a narrative review |
Q34195084 | Gasless minimum incision access used for extracorporeal orthotopic bladder substitution after laparoscopic radical cystectomy |
Q35089783 | Gastric pouch after simple or radical cystectomy for benign and malignant bladder disease |
Q46208344 | Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol. |
Q38820188 | Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol |
Q80134884 | Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer Centers |
Q52686816 | Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. |
Q91261038 | Gender and Mortality after Radical Cystectomy: Competing Risk Analysis |
Q51712140 | Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. |
Q91951491 | Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion |
Q35796511 | Gender differences in radical cystectomy: complications and blood loss |
Q47259653 | Gender-dependent cancer-specific survival following radical cystectomy |
Q47151888 | Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy. |
Q44793009 | Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. |
Q51177253 | Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. |
Q45904406 | Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. |
Q45362887 | Gender-specific survival following radical cystectomy for pT4 bladder cancer. |
Q51236645 | General anesthesia versus epidural and general anesthesia in radical cystectomy. |
Q42620903 | Getting under the hood of the volume-outcome relationship for radical cystectomy |
Q50066547 | Giant Abdominal Wall Pseudocyst After Open Radical Cystectomy |
Q96025555 | Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial |
Q47433575 | Grading complication following radical cystectomy and ileal conduit for bladder cancer using Clavien grading system |
Q80827069 | Gross hematuria 10 years after radical cystectomy: adenomatous polyp |
Q38159876 | Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations |
Q33438922 | Gum chewing stimulates bowel motility in patients undergoing radical cystectomy with urinary diversion |
Q93335394 | Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries? |
Q51703318 | Gynecologic-tract sparing extra peritoneal retrograde radical cystectomy with neobladder. |
Q88771704 | Gynecological organ involvement at robot-assisted radical cystectomy in females: Is anterior exenteration necessary? |
Q91748676 | HRQOL related to urinary diversion in Radical Cystectomy: a systematic review of recent literature |
Q45059818 | Hand assisted laparoscopic radical cystectomy for cancer bladder |
Q83141074 | Hand-assisted laparoscopic radical cystectomy and extracorporeal urinary diversion: experience with 31 cases |
Q83395777 | Hand-assisted versus pure laparoscopic radical cystectomy: a clinical outcome comparison |
Q47627477 | Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey |
Q47579037 | Health Related Quality of Life in Patients Treated With Radical Cystectomy and Urinary Diversion for Urothelial Carcinoma of the Bladder: Development and Validation of a New Disease Specific Questionnaire |
Q38799838 | Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada |
Q36066874 | Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature |
Q39342758 | Health related quality of life after radical cystectomy in women: orthotopic neobladder versus ileal loop conduit and impact of incontinence |
Q48407728 | Health related quality of life after radical cystectomy: comparative study between orthotopic sigmoid versus ileal neobladders |
Q53129263 | Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder. |
Q74246116 | Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder |
Q87991201 | Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires |
Q33470789 | Health-Related Quality of Life after Radical Cystectomy: A Cross Sectional Study with Matched Pair Analysis on Ileal Conduit Versus Ileal Orthotopic Neobladder Diversion |
Q91761633 | Health-Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial - A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy |
Q35736201 | Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada |
Q91285074 | Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes |
Q46774738 | Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status |
Q81247096 | Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with an ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir: a comparative questionnaire survey |
Q95785032 | Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement |
Q51959681 | Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. |
Q48074927 | Health-related quality of life from a prospective randomised clinical trial of robot-assisted laparoscopic vs open radical cystectomy |
Q55338384 | Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps. |
Q92042684 | Health-related quality of life in patients undergoing radical cystectomy with modified single stoma cutaneous ureterostomy, bilateral cutaneous ureterostomy and ileal conduit |
Q98161481 | Health-related quality of life is not related to laparoscopic or robotic technique in radical cystectomy |
Q42655571 | Health-related quality of life outcomes after robot-assisted and open radical cystectomy using a validated bladder-specific instrument: a multi-institutional study. |
Q93336796 | Health-related quality-of-life after radical cystectomy among Norwegian men and women compared to the general population |
Q48134768 | Hemiparesis after robotic laparoscopic radical cystectomy and ileal conduit formation in steep Trendelenburg position |
Q51603318 | Hemodynamic and oxygenation variables during radical cystectomy. Does the anesthetic technique really matter? |
Q101451384 | High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy |
Q70315138 | High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer |
Q37182805 | High expression of H3K27me3 is an independent predictor of worse outcome in patients with urothelial carcinoma of bladder treated with radical cystectomy |
Q37560686 | High expression of heat shock protein 105 predicts a favorable prognosis for patients with urinary bladder cancer treated with radical cystectomy |
Q39590213 | High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy |
Q52921872 | High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. |
Q41730736 | High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec |
Q40428531 | High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience |
Q95802419 | High mortality rates after radical cystectomy: we must have acceptable protocols and consider the rationale of cutaneous ureterostomy for high-risk patients |
Q38801504 | High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy |
Q33680113 | High-grade hydronephrosis predicts poor outcomes after radical cystectomy in patients with bladder cancer |
Q44261352 | Higher surgeon and hospital volume improves long-term survival after radical cystectomy |
Q35898629 | Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers |
Q91502009 | Histologic variants associated with biological aggressiveness and poor prognosis in patients treated with radical cystectomy |
Q104289649 | Histological investigation of the female vesicourethral junction and adjacent tissues for nerve-sparing radical cystectomy |
Q100421252 | Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data |
Q92483703 | Histopathological and perioperative factors influencing the length of hospital stay and patients' outcome after radical cystectomy for urothelial carcinoma |
Q90837502 | Histopathological predictive factors for the overall survival rate in patients with urothelial carcinoma of the bladder treated by radical cystectomy: a Romanian cohort study |
Q88736302 | History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy |
Q47743959 | Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era. |
Q90147978 | Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes |
Q93182743 | Hospital length of stay following radical cystectomy for muscle-invasive bladder cancer: Development and validation of a population-based prediction model |
Q80214045 | Hospital lymph node counts and survival after radical cystectomy |
Q46325754 | Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study |
Q38764012 | Hospital volume and perioperative outcomes for radical cystectomy: a population study |
Q104751874 | Hospital volume is associated with postoperative mortality following radical cystectomy for treatment of bladder cancer |
Q89087278 | Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter? |
Q38653692 | Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis |
Q91806163 | How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder |
Q89955467 | How the Beneficial Effects of Alvimopan Differ With Surgical Approach for Radical Cystectomy |
Q92970919 | How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection |
Q37602822 | How to lower postoperative complications after radical cystectomy - a review |
Q41979875 | How to predict the risk of complication or death after radical cystectomy? |
Q33339210 | Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy |
Q68733920 | Hyperbilirubinemia after single-stage radical cystectomy and ileal loop diversion |
Q98191179 | Hypercalcemia associated with lymph node metastasis following radical cystectomy for bladder cancer |
Q42488078 | Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy |
Q38037276 | ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder |
Q96026810 | IMPLEMENTATION OF A DEDICATED ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM FOR RADICAL CYSTECTOMY PATIENTS IS ASSOCIATED WITH DECREASED POSTOPERATIVE INPATIENT OPIOID USAGE AND PAIN SCORES |
Q84466347 | Identification and management of emptying failure in male patients with orthotopic neobladders after radical cystectomy for bladder cancer |
Q36750736 | Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
Q84933155 | Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens |
Q92898839 | Identifying and Codifying Complications after Radical Cystectomy: Comparison of Administrative Diagnostic and Procedure Codes, and Clinical Chart Review |
Q46689693 | Identifying risk factors for potentially avoidable complications following radical cystectomy |
Q38937090 | Idiographic quality of life assessment before radical cystectomy |
Q73328598 | Ileal conduit diversion after radical cystectomy: pro |
Q36755098 | Ileal conduit post radical cystectomy: modifications of the technique |
Q53276502 | Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis. |
Q38609460 | Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy |
Q42456549 | Ileal neobladder for bladder substitution after radical cystectomy |
Q35902579 | Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis |
Q42492047 | Ileocaecal vs ileal neobladder after radical cystectomy in patients with bladder cancer: a comparative study |
Q91453996 | Ileus and small bowel obstruction after radical cystectomy for bladder cancer: Analysis from the Nationwide Inpatient Sample |
Q36446891 | Immediate Radical Cystectomy for Massive Bleeding of Bladder Cancer |
Q53175159 | Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference? |
Q38202970 | Immediate total parenteral nutrition after radical cystectomy and urinary diversion |
Q33419283 | Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial |
Q42237188 | Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer |
Q36624367 | Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical cystectomy: preliminary results |
Q61454753 | Immunonutrition in radical cystectomy: a novel approach to reduce postoperative complications? |
Q63984729 | Impact of Anaesthetist Volume on Radical Cystectomy Outcomes |
Q92850840 | Impact of Body Mass Index and Pretreatment Hemoglobin Level on Prognosis Following Radical Cystectomy for Bladder Cancer in Males and Females |
Q98731887 | Impact of Clinical Response to Neoadjuvant Chemotherapy in the Era of Robot Assisted Radical Cystectomy: Results of a Single-Center Experience |
Q92338808 | Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis |
Q49815092 | Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study |
Q99201835 | Impact of Perioperative Multidisciplinary Rehabilitation Pathway on Early Outcomes after Robot-Assisted Radical Cystectomy: A Matched Analysis |
Q102060646 | Impact of Preoperative Serum Albumin-Globulin Ratio on Disease Outcome After Radical Cystectomy for Urothelial Carcinoma of the Bladder |
Q98293791 | Impact of Prognostic Nutritional Index on Postoperative Pulmonary Complications in Radical Cystectomy: A Propensity Score-Matched Analysis |
Q89957719 | Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up |
Q101451695 | Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis |
Q71963796 | Impact of a Collaborative Care Approach to Radical Cystectomy and Urinary Reconstruction |
Q64319523 | Impact of a change in duration of prophylactic antibiotics on infectious complications after radical cystectomy with a neobladder |
Q49617221 | Impact of a goal directed therapy in the implementation of an ERAS (Enhanced recovery after surgery) protocol in laparoscopic radical cystectomy |
Q36207699 | Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study |
Q47422484 | Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy |
Q90941487 | Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? |
Q42775246 | Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy. |
Q85502780 | Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy |
Q47328870 | Impact of an enhanced recovery after surgery programme in radical cystectomy. A cohort-comparative study |
Q92801209 | Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study |
Q92318762 | Impact of an oral nutrition protocol in patients treated with elective radical cystectomy: a long term follow-up |
Q96813657 | Impact of anemia on the survival of patients undergoing radical cystectomy for bladder cancer |
Q48448129 | Impact of body mass index on clinical and cost outcomes after radical cystectomy |
Q51614697 | Impact of body mass index on radical cystectomy. |
Q34466110 | Impact of body mass index on robot-assisted radical cystectomy |
Q46036751 | Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion. |
Q40714046 | Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer. |
Q46448073 | Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy |
Q86698424 | Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer |
Q93038948 | Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies |
Q45905367 | Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. |
Q40906007 | Impact of histopathological variant on the outcome of patients treated by radical cystectomy |
Q33213908 | Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project |
Q98176445 | Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy |
Q86603999 | Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden |
Q38188120 | Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database |
Q61454786 | Impact of immunonutrition on radical cystectomy immunoresponse and outcomes; opportunity for peri-operative optimization |
Q89999032 | Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far? |
Q30989295 | Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program |
Q46121062 | Impact of marital status in patients undergoing radical cystectomy for bladder cancer |
Q38090151 | Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy |
Q40427194 | Impact of neoadjuvant chemotherapy on complications of minimally invasive radical cystectomy |
Q90293717 | Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy |
Q102060647 | Impact of neuraxial analgesia on outcomes following radical cystectomy: A systematic review |
Q43569010 | Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder |
Q40701908 | Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011. |
Q46543785 | Impact of pre-operative MRI-measured membranous urethral length on urinary continence after radical cystectomy and orthotopic substitution: clinical and urodynamic evaluation |
Q41351075 | Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study |
Q95407126 | Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma |
Q34466543 | Impact of previous abdominal surgery on robot-assisted radical cystectomy |
Q79297916 | Impact of primary tumour characteristics on the survival of patients with lymph node metastases in bladder cancer following radical cystectomy |
Q41965520 | Impact of provider volume on operative mortality after radical cystectomy in a publicly funded healthcare system |
Q85598854 | Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy |
Q36276796 | Impact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience |
Q47880226 | Impact of stapling devices on radical cystectomy: comparative study between low- and high-volume surgeons |
Q45951908 | Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. |
Q40541109 | Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study |
Q42689150 | Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC). |
Q45014323 | Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis |
Q36176989 | Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis |
Q41273357 | Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy |
Q97524376 | Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival |
Q51878931 | Impact of tumour volume on surgical and pathological outcomes after robot-assisted radical cystectomy. |
Q43567433 | Impaired cardiopulmonary reserve in an elderly population is related to postoperative morbidity and length of hospital stay after radical cystectomy |
Q97892964 | Impairment and Longitudinal Recovery of Older Adults Treated with Radical Cystectomy for Muscle-Invasive Bladder Cancer |
Q97690807 | Implementation of ERAS (Enhanced Recovery After Surgery) protocols for radical cystectomy patients: The pathway to standardization. A systematic review |
Q92952852 | Implementation of ERAS protocol in robot-assisted radical cystectomy with intracorporeal ileal conduit urinary diversion: An outcome analysis beyond the learning curve |
Q91516733 | Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol |
Q47293877 | Implementation of an Enhanced Recovery After Surgery (ERAS) protocol can improve outcomes for patients undergoing radical cystectomy |
Q92792503 | Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: A retrospective cohort study |
Q38203011 | Implementation of the Exeter enhanced recovery programme for patients undergoing radical cystectomy |
Q41685242 | Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer |
Q93182670 | Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation |
Q88639444 | Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care Center |
Q53935751 | Improved perioperative outcome with norepinephrine and a restrictive fluid administration during open radical cystectomy and urinary diversion. |
Q88301433 | Improved surgical outcomes following radical cystectomy at high-volume centers influence overall survival |
Q89224661 | Improved technique for intracorporeal neobladder-urethral anastomosis in laparoscopic radical cystectomy |
Q93034387 | Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index |
Q81292338 | Improving outcomes after radical cystectomy |
Q91617673 | Improving outcomes of radical cystectomy: A call for passive over active regionalization |
Q36606956 | Improving outcomes with radical cystectomy for high-grade invasive bladder cancer |
Q37894684 | Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. |
Q36990721 | Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection |
Q36990725 | Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy |
Q91279636 | In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014 |
Q38655158 | In-depth Critical Analysis of Complications Following Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion |
Q86997025 | In-hospital mortality and failure-to-rescue rates after radical cystectomy |
Q41891611 | In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy |
Q53909910 | Incarcerated femoral hernia after radical cystectomy. |
Q101563320 | Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy |
Q40060285 | Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer |
Q40075778 | Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience |
Q35942093 | Incidence and Risk Factors of Acute Kidney Injury after Radical Cystectomy: Importance of Preoperative Serum Uric Acid Level |
Q39021486 | Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy |
Q39470187 | Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. |
Q64078912 | Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study |
Q88087589 | Incidence and perioperative risk factors for early acute kidney injury after radical cystectomy and urinary diversion |
Q37416794 | Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy |
Q91162478 | Incidence and prognosis of clinically significant incidental prostate cancer after radical cystectomy for bladder cancer |
Q47800647 | Incidence and risk factors for acute kidney injury after radical cystectomy |
Q92706945 | Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy |
Q44229777 | Incidence and risk factors of 30-day early and 90-day late morbidity and mortality of radical cystectomy during a 13-year follow-up: a comparative propensity-score matched analysis of complications between neobladder and ileal conduit |
Q43479662 | Incidence and risk factors of early postoperative paralytic ileus after radical cystectomy and cutaneous ureterostomy with a unilateral and parallel stoma |
Q46015451 | Incidence and risk factors of parastomal hernia in patients undergoing radical cystectomy and ileal conduit diversion. |
Q46679577 | Incidence of and risk factors for surgical site infection in patients with radical cystectomy with urinary diversion |
Q84569181 | Incidence of occult lymph-node metastasis missed by standard pathological examination in patients with bladder cancer undergoing radical cystectomy |
Q45008049 | Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer |
Q89568576 | Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer |
Q50735900 | Incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy. |
Q34626197 | Incidental appendectomy during radical cystectomy--is it necessary? |
Q33990041 | Incidental appendectomy during radical cystectomy: an interdepartmental survey and review of the literature |
Q38798073 | Incisional and Parastomal Hernia following Radical Cystectomy and Urinary Diversion: The University of Southern California Experience |
Q58705124 | Increased Surgical Complications in Smokers Undergoing Radical Cystectomy |
Q75435923 | Increased body mass index predicts increased blood loss during radical cystectomy |
Q89567682 | Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy |
Q45065686 | Indication of radical cystectomy in patients with carcinoma of the bladder |
Q74130933 | Indications for admission to the surgical intensive care unit after radical cystectomy and urinary diversion |
Q40239210 | Indications for urethrectomy in men undergoing single stage radical cystectomy for bladder cancer. |
Q91322087 | Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer |
Q39470406 | Infectious complications in transfused patients after radical cystectomy |
Q90252974 | Inferior epigastric artery pseudoaneurysm secondary to port placement during a robot-assisted laparoscopic radical cystectomy |
Q50539369 | Influence and Impact of Cognitive Trajectories on Outcome in Patients Undergoing Radical Cystectomy: An Observational Study. |
Q52803559 | Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study. |
Q41667481 | Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer |
Q91566799 | Influence of Simple and Radical Cystectomy on Sexual Function and Pelvic Organ Prolapse in Female Patients: A Scoping Review of the Literature |
Q84023302 | Influence of body mass index on operability, morbidity and disease outcome following radical cystectomy |
Q93055230 | Influence of preoperative hydronephrosis and ureteral orifice involvement in the survival of patients undergoing radical cystectomy: A retrospective comparative study |
Q38477324 | Influence of stage discrepancy on outcome in patients treated with radical cystectomy. |
Q100382341 | Inguinal lymph node metastasis of bladder carcinoma after radical cystectomy: A case report and review of literature |
Q102140554 | Initial Experience with Intracorporeal Laparoscopic Radical Cystectomy and Detaenial Sigmoid Neobladder Reconstruction |
Q83774606 | Initial experience of robot-assisted radical cystectomy with total intracorporeal urinary diversion: comparison with extracorporeal method |
Q35777579 | Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion |
Q33792772 | Initial experiences with robot-assisted laparoscopic radical cystectomy |
Q41467236 | Initial experiences with the enhanced recovery after surgery (ERAS) protocol in open radical cystectomy |
Q38049697 | Innovations in radical cystectomy and pelvic lymph node dissection |
Q45077187 | Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy |
Q98176101 | Integrated Treatment by an Ostomy Care Team of a Complicated Mucocutaneous Separation After Radical Cystectomy With Ileal Conduit Urinary Diversion: A Case Report |
Q71301660 | Integrated preoperative irradiation and radical cystectomy |
Q51839920 | Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy. |
Q46044976 | Intermediate-term oncologic outcomes of robot-assisted radical cystectomy for urothelial carcinoma |
Q89949508 | Internal audit of an enhanced recovery after surgery protocol for radical cystectomy |
Q91091256 | Internal double-J stent was associated with a lower incidence of ureteroileal anastomosis stricture than external ureteral catheter for patients undergoing radical cystectomy and orthotopic neobladder: A systematic review and meta-analysis |
Q90587233 | Internal hernia from the interureteric space after robot-assisted radical cystectomy and urinary diversion: Two case reports |
Q46514410 | Internal urinary diversion following radical cystectomy for bladder cancer |
Q37131247 | Internal versus external ureteric stents for uretero-ileal anastomosis after laparoscopic radical cystectomy with orthotopic neobladder: A prospective comparative study |
Q39148271 | International Robotic Radical Cystectomy Consortium: A way forward |
Q46165799 | International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy |
Q46506621 | Interventional radiology methods of treating ureteral strictures developed on anastomoses after the radical cystectomy in Mainz pouch II and ileal conduit derivation |
Q91219276 | Intestinal malrotation in a patient who underwent radical cystectomy and ileal conduit construction: A case report |
Q40319613 | Intestinal neobladder fistula after radical cystectomy and orthotopic ileal neobladder |
Q86639048 | Intestinal perforation after radical cystectomy due to drain: case report |
Q69520094 | Intestinal strictures complicating preoperative radiation therapy followed by radical cystectomy |
Q85305371 | Intra-arterial chemotherapy for pelvic recurrence after radical cystectomy for bladder urothelial cancer |
Q73354092 | Intra-operative autotransfusion in radical cystectomy |
Q42042323 | Intra-operative cell salvage in radical cystectomy |
Q92912184 | Intra-operative norepinephrine administration and cancer-related outcomes following radical cystectomy for bladder cancer: A cohort study |
Q91300208 | Intracorporeal Studer Pouch Formation with Balbay's Technique Following Robotic Radical Cystectomy for Bladder Cancer: Experience with 22 Cases with Oncologic and Functional Outcomes |
Q102219068 | Intracorporeal Urinary Diversion in Robotic Radical Cystectomy |
Q47232375 | Intracorporeal robot-assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains. |
Q100530122 | Intracorporeal urinary diversion during robot-assisted radical cystectomy using indocyanine green |
Q96577524 | Intracorporeal versus extracorporeal urinary diversion after robotic-assisted radical cystectomy: evidence from a systematic review and pooled analysis of observational studies |
Q102320771 | Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review |
Q98567961 | Intraoperative Only versus Extended Duration Use of Antimicrobial Prophylaxis for Infectious Complications in Radical Cystectomy with Intestinal Urinary Diversion |
Q102387027 | Intraoperative Ureteral Stent Use at Radical Cystectomy is Associated with Higher 30-Day Complication Rates |
Q69971680 | Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder |
Q80273322 | Intraoperative cell salvage during radical cystectomy does not affect long-term survival |
Q42617099 | Intraoperative continuous norepinephrine infusion combined with restrictive deferred hydration significantly reduces the need for blood transfusion in patients undergoing open radical cystectomy: results of a prospective randomised trial |
Q61449312 | Intraoperative hypothermia is a significant prognostic predictor of radical cystectomy especially for stage II muscle-invasive bladder cancer |
Q78213560 | Intravesical therapy with pertussis toxin before radical cystectomy in patients with bladder cancer: a Phase I study |
Q85222296 | Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy |
Q40600708 | Introducing an enhanced recovery programme to an established totally intracorporeal robot-assisted radical cystectomy service |
Q80482485 | Introduction of an enhanced recovery protocol for radical cystectomy |
Q46746626 | Introduction of an enhanced recovery protocol to reduce short-term complications following radical cystectomy and intestinal urinary diversion with vescica ileale Padovana neobladder |
Q39174669 | Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme |
Q72346596 | Invasion depth is the most important prognostic factor for transitional-cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy |
Q37169732 | Invasive T1 bladder cancer: indications and rationale for radical cystectomy |
Q84538821 | Invasive bladder cancer and the role of follow-up: should we consider the match over at radical cystectomy or should we play for extra time? |
Q45981130 | Invasive bladder carcinoma treated by radical cystectomy: survival of patients |
Q36662333 | Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report |
Q37988362 | Investigation of anal sphincter function following Mainz pouch type II urinary diversion after radical cystectomy. |
Q73591411 | Involvement of internal genitalia in female patients undergoing radical cystectomy for bladder cancer: a clinicopathologic study of 37 cases |
Q74073433 | Involvement of the anterior urethra in male patients with transitional cell-carcinoma of the bladder undergoing radical cystectomy with simultaneous urethrectomy |
Q91921152 | Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy? |
Q92638623 | Is Fast Track protocol a safe tool to reduce hospitalization time after radical cystectomy with ileal urinary diversion? Initial results from a single high-volume centre |
Q38635958 | Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies |
Q38449423 | Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer? |
Q98882653 | Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution |
Q91855585 | Is Routine Removal of the Ovaries Advisable during Radical Cystectomy? |
Q43635639 | Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: factors resulting in pT0 radical cystectomy specimens |
Q52968595 | Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? |
Q95820547 | Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? |
Q61454764 | Is experience with extracorporeal urinary diversion following robotic assisted radical cystectomy necessary before transitioning to intracorporeal urinary diversion? |
Q44220342 | Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy? |
Q36227512 | Is frozen section analysis of the urethra at the time of radical cystectomy and orthotopic neobladder urinary diversion mandatory? |
Q38458428 | Is frozen section analysis of ureteral margins at time of radical cystectomy useful? |
Q91617410 | Is hysterectomy beneficial in radical cystectomy for female patient with urothelial carcinoma of bladder? A retrospective analysis of consecutive 112 cases from a single institution |
Q43633132 | Is incidental appendectomy necessary during radical cystectomy? |
Q35558116 | Is it necessary to insert nasogastric tube routinely after radical cystectomy with urinary diversion? A meta-analysis |
Q61454749 | Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
Q81504156 | Is less radical cystectomy better, and how can we be sure? |
Q42683443 | Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases |
Q84056546 | Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer? |
Q68280600 | Is radical cystectomy indicated in patients with regional lymphatic metastases? |
Q35093233 | Is radical cystectomy mandatory in every patient with variant histology of bladder cancer |
Q51368850 | Is robot-assisted radical cystectomy justified in the elderly? A comparison of robotic versus open radical cystectomy for bladder cancer in elderly ≥75 years old. |
Q52684398 | Is robot-assisted radical cystectomy superior to standard open radical cystectomy? An Indian perspective. |
Q45798358 | Is robot-assisted radical cystectomy the right way to reduce complications in patients undergoing radical cystectomy? |
Q51874164 | Is robotic radical cystectomy an appropriate treatment for bladder cancer? Short-term oncologic and clinical follow-up in 50 consecutive patients. |
Q57052071 | Is robotic radical cystectomy ready for prime time? |
Q38647825 | Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care? |
Q42151861 | Is sparing the prostate still considered radical cystectomy? The case against prostate-sparing cystectomy for bladder cancer |
Q38675168 | Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients? |
Q45958003 | Is the complication rate of radical cystectomy predictive of the complication rate of other urological procedures? |
Q45074979 | Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation? |
Q86101245 | Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy? |
Q39146600 | Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database |
Q46033293 | Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. |
Q79451533 | Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease |
Q41515177 | LAPAROSCOPIC AND OPEN RADICAL CYSTECTOMY FOR BLADDER CANCER |
Q40795695 | Laparo-endoscopic single-site radical cystectomy with orthotopic urinary diversion: Technique, feasibility, and the 3-year follow-up. |
Q47887500 | Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis |
Q84582215 | Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up |
Q50523333 | Laparoendoscopic single-site radical cystectomy and urinary diversion: initial experience in China using a homemade single-port device. |
Q41287583 | Laparoscopic Radical Cystectomy Versus Extraperitoneal Radical Cystectomy: Is the Extraperitoneal Technique Rewarding? |
Q93369434 | Laparoscopic Radical Cystectomy With Extracorporeal Neobladder: Our Initial Experience |
Q37201133 | Laparoscopic Radical Cystectomy and Ileal Neobladder for Muscle Invasive Bladder Cancer in Combination with One Stage Prophylactic Laparoscopic Sacrospinal Fixation to Avoid Future Pelvic Organ Prolapse |
Q37426968 | Laparoscopic Radical Cystectomy in the Elderly - Results of a Single Center LRC only Series. |
Q40962834 | Laparoscopic Radical Cystectomy in the Elderly Patients |
Q40967148 | Laparoscopic Versus Open Radical Cystectomy for Patients Older than 75 Years: a Single-Center Comparative Analysis |
Q33327621 | Laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis |
Q52001791 | Laparoscopic and robotic radical cystectomy. |
Q46094778 | Laparoscopic assisted radical cystectomy with ileal neobladder: a comparison with the open approach |
Q81798344 | Laparoscopic assisted radical cystectomy: the montsouris experience after 84 cases |
Q85202175 | Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes |
Q78412953 | Laparoscopic hand assisted radical cystectomy with ileal conduit urinary diversion |
Q91148112 | Laparoscopic intracorporeal ileal conduit after laparoscopic radical cystectomy: A modified technique to facilitate ureteroenteric anastomosis |
Q98191223 | Laparoscopic pelvic organ prolapse repair by mesh interposition following radical cystectomy |
Q51483624 | Laparoscopic prostate-sparing radical cystectomy: the Montsouris technique and preliminary results. |
Q35643013 | Laparoscopic radical cystectomy |
Q44850440 | Laparoscopic radical cystectomy |
Q48918269 | Laparoscopic radical cystectomy |
Q80580920 | Laparoscopic radical cystectomy |
Q80042286 | Laparoscopic radical cystectomy and bilateral ureteric ligation for muscle-invasive bladder cancer in a patient on hemodialysis |
Q74246032 | Laparoscopic radical cystectomy and continent orthotopic ileal neobladder performed completely intracorporeally: the initial experience |
Q80612671 | Laparoscopic radical cystectomy and extracorporeal urinary diversion: a single center experience of 48 cases with three years of follow-up |
Q42618212 | Laparoscopic radical cystectomy and ileal conduit reconstruction: preliminary experience |
Q102328082 | Laparoscopic radical cystectomy and nephroureterectomy en bloc resection with lomboaortic and pelvic lymph node dissection |
Q36046107 | Laparoscopic radical cystectomy and urinary diversion |
Q35871198 | Laparoscopic radical cystectomy and urinary diversion: fad or future? |
Q81174299 | Laparoscopic radical cystectomy and urinary diversion: fad or future? |
Q51749022 | Laparoscopic radical cystectomy combined with bilateral nephroureterectomy and specimen extraction through the vagina. |
Q83254501 | Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience |
Q42623016 | Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years |
Q42604402 | Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes |
Q93016462 | Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort |
Q42655882 | Laparoscopic radical cystectomy in the female |
Q83929384 | Laparoscopic radical cystectomy with and without orthotopic bladder replacement |
Q36046098 | Laparoscopic radical cystectomy with continent urinary diversion |
Q73924448 | Laparoscopic radical cystectomy with continent urinary diversion (rectal sigmoid pouch) performed completely intracorporeally: the initial 5 cases |
Q42640118 | Laparoscopic radical cystectomy with continent urinary diversion (rectosigmoid pouch) performed completely intracorporeally: an intermediate functional and oncologic analysis |
Q80352565 | Laparoscopic radical cystectomy with continent urinary diversion (rectosigmoid pouch) performed completely intracorporeally: an intermediate functional and oncologic analysis |
Q43726012 | Laparoscopic radical cystectomy with extended pelvic lymph node dissection for bladder urothelial carcinoma: complications and oncologic outcomes in 210 cases |
Q81448907 | Laparoscopic radical cystectomy with extracorporeal ileal conduit urinary diversion for treatment of Chinese bladder cancer patients |
Q57110953 | Laparoscopic radical cystectomy with extracorporeal ileal neobladder for muscle-invasive urothelial carcinoma of the bladder: technique and short-term outcomes |
Q96577526 | Laparoscopic radical cystectomy with extracorporeal urinary diversion: an Italian single center experience with 10-year outcomes |
Q42674591 | Laparoscopic radical cystectomy with extracorporeal urinary diversion: preliminary experience |
Q36046078 | Laparoscopic radical cystectomy with ileal conduit diversion |
Q39354064 | Laparoscopic radical cystectomy with ileal conduit diversion: the first case report in Thailand. |
Q28256192 | Laparoscopic radical cystectomy with ileal conduit urinary diversion |
Q51056203 | Laparoscopic radical cystectomy with ileal neobladder and rectum pouch: the initial experience of 28 cases in China. |
Q50109472 | Laparoscopic radical cystectomy with intracorporeal ileal conduit diversion: five cases with a 2-year follow-up |
Q92552573 | Laparoscopic radical cystectomy with intracorporeal ileal conduit: one center experience and clinical outcomes |
Q53328706 | Laparoscopic radical cystectomy with intracorporeal orthotopic ileal neobladder: technique and clinical outcomes. |
Q51360876 | Laparoscopic radical cystectomy with intracorporeally constructed Y-shaped orthotopic ileal neobladder using nonabsorbable titanium staples exclusively. |
Q37626497 | Laparoscopic radical cystectomy with novel orthotopic neobladder with bilateral isoperistaltic afferent limbs: initial experience |
Q42596407 | Laparoscopic radical cystectomy with orthotopic gastric neobladder: technique and initial outcomes |
Q42664282 | Laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer: oncologic results of 171 cases with a median 3-year follow-up |
Q47397626 | Laparoscopic radical cystectomy with orthotopic ileal neobladder in the female: report of 14 cases. |
Q47766839 | Laparoscopic radical cystectomy with orthotopic ileal neobladder: a report of 85 cases |
Q51555964 | Laparoscopic radical cystectomy with orthotopic ileal neobladder: report of 33 cases. |
Q74780088 | Laparoscopic radical cystectomy with orthotopic neobladder |
Q60045402 | Laparoscopic radical cystectomy with pelvic re-peritonealization: the technique and initial clinical outcomes |
Q40678031 | Laparoscopic radical cystectomy with prostate capsule sparing. Initial experience |
Q39417429 | Laparoscopic radical cystectomy with total intracorporeal ileal neobladder: first case report in Thailand |
Q35742700 | Laparoscopic radical cystectomy with urinary diversion |
Q74780064 | Laparoscopic radical cystectomy with urinary diversion: completely intracorporeal technique |
Q95784991 | Laparoscopic radical cystectomy with urinary diversion: completely intracorporeal technique |
Q36730075 | Laparoscopic radical cystectomy with urinary diversion: what is the optimal technique? |
Q81036369 | Laparoscopic radical cystectomy-where are we really? |
Q53209479 | Laparoscopic radical cystectomy. |
Q37793760 | Laparoscopic radical cystectomy. Where do we stand? |
Q27000412 | Laparoscopic radical cystectomy: a 5-year review of a single institute's operative data and complications and a systematic review of the literature |
Q42611488 | Laparoscopic radical cystectomy: an Italian survey. |
Q37442714 | Laparoscopic radical cystectomy: current status, outcomes, and patient selection |
Q82041375 | Laparoscopic radical cystectomy: formidable challenge to the gold standard |
Q42660056 | Laparoscopic radical cystectomy: initial experience using the single-incision triangulated umbilical surgery (SITUS) technique |
Q50033992 | Laparoscopic radical cystectomy: innovations and classics |
Q37095976 | Laparoscopic radical cystectomy: long-term outcomes |
Q33819916 | Laparoscopic radical cystectomy: neobladder or ileal conduit, debate still goes on |
Q57107336 | Laparoscopic right hemicolectomy for metachronous ascending colon cancer with preservation of an ileal conduit constructed after previous radical cystectomy for bladder cancer |
Q33717058 | Laparoscopic versus open radical cystectomy for elderly patients over 75-year-old: a single center comparative analysis. |
Q46510192 | Laparoscopic versus open radical cystectomy for muscle-invasive bladder cancer: a single institute comparative analysis |
Q33688743 | Laparoscopic versus open radical cystectomy for patients with bladder cancer over 75-year-old: a prospective randomized controlled trial |
Q42640381 | Laparoscopic versus open radical cystectomy for the management of bladder cancer: mid-term oncological outcome |
Q33623496 | Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies |
Q89693336 | Laparoscopic versus open radical cystectomy in the treatment of locally advanced T3 and T4 bladder cancer: Perioperative and Mid-term oncological outcomes |
Q79483564 | Laparoscopic-assisted nephroureterectomy after radical cystectomy for transitional cell carcinoma |
Q51171513 | Laparoscopic-assisted radical cystectomy with U-shaped orthotopic ileal neobladder constructed using nonabsorbable titanium staples. |
Q40521952 | Laparoscopically assisted transvaginal radical cystectomy |
Q90452799 | Large Single Institution Comparison of Perioperative Outcomes and Complications of Open Radical Cystectomy, Intracorporeal Robot-Assisted Radical Cystectomy and Robotic Extracorporeal Approach |
Q50718028 | Late Oncological Occurrences Following Radical Cystectomy in Patients with Bladder Cancer |
Q92958756 | Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes |
Q91617467 | Late Recurrences Following Radical Cystectomy Have Distinct Prognostic and Management Considerations |
Q98197076 | Late complications of robot-assisted radical cystectomy with totally intracorporeal urinary diversion |
Q38944943 | Late intestinal obstruction after radical cystectomy and urinary diversion: urological and oncological perspectives. |
Q46197567 | Late recurrence after radical cystectomy: patterns, risk factors and outcomes |
Q39618396 | Learning from our patients: complications and the future of radical cystectomy for bladder cancer. |
Q41446293 | Lee mortality index as comorbidity measure in patients undergoing radical cystectomy |
Q64910618 | Left ureteral tumor five years after radical cystectomy associated with duplication of inferior vena cava: a case report |
Q91916172 | Letter to the Editor RE: Venkatramani and Parekh, Editorial Comment on: Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts |
Q35178498 | Life-threatening rupture of an external iliac artery pseudoaneurysm caused by necrotizing fasciitis following laparoscopic radical cystectomy: a case report |
Q51704610 | Ligasure versus sutures in bladder replacement with Montie ileal neobladder after radical cystectomy. |
Q73753930 | Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy |
Q82688604 | Limited, extended, superextended, megaextended pelvic lymph node dissection at the time of radical cystectomy: what should we perform? |
Q104075723 | Liposomal bupivacaine decreases post-operative length of stay and opioid use in patients undergoing radical cystectomy |
Q86089221 | Local and systemic recurrence patterns of urothelial cancer after radical cystectomy |
Q35921613 | Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors |
Q51691515 | Local recurrence in patients after radical cystectomy and orthotopic ileal neobladder: impact on function. |
Q53352606 | Local recurrence of bladder cancer occurring eight years after radical cystectomy. |
Q44246782 | Local urethral recurrence after radical cystectomy and orthotopic bladder substitution in women: a prospective study. |
Q92114345 | Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy |
Q49700228 | Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder |
Q51038905 | Long term complications following ileal conduit urinary diversion after radical cystectomy. |
Q91299966 | Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy |
Q91692221 | Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center Study |
Q92899631 | Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer |
Q47902259 | Long-term Health-related Quality of Life Outcomes Following Radical Cystectomy |
Q91327411 | Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL) |
Q42687016 | Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology |
Q48093762 | Long-term changes in renal function outcomes following radical cystectomy and urinary diversion |
Q42640085 | Long-term evaluation of oncologic and functional outcomes after laparoscopic open-assisted radical cystectomy: a matched-pair analysis. |
Q84794273 | Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey |
Q38796570 | Long-term functional outcomes after radical cystectomy with ileal bladder substitute: does the definition of continence matter? |
Q33627559 | Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution. |
Q38488664 | Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. |
Q92692214 | Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study |
Q46259441 | Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer |
Q45913209 | Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma. |
Q97093351 | Long-term outcomes of incidental prostate cancer at radical cystectomy |
Q53322873 | Long-term outcomes of radical cystectomy with preservation of prostatic capsule. |
Q42686709 | Long-term outcomes of robot-assisted radical cystectomy for bladder cancer |
Q46168241 | Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy |
Q85772422 | Long-term renal function outcomes after radical cystectomy |
Q45438263 | Long-term renal function outcomes in bladder cancer after radical cystectomy. |
Q94570699 | Long-term results of a single-center prospective randomized trial assessing efficacy of a shortened course of adjuvant chemotherapy after radical cystectomy in patients with locally advanced bladder cancer |
Q42595663 | Long-term results of orthotopic neobladder reconstruction after radical cystectomy |
Q38374204 | Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. |
Q60304906 | Long-term urinary tract effect of ileal conduit after radical cystectomy compared with bladder preservation: a nationwide, population-based cohort study with propensity score-matching analysis |
Q50858205 | Long-term urodynamic and functional analysis of orthotopic "W" ileal neobladder following radical cystectomy. |
Q33967578 | Long-term urodynamic evaluation of laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer |
Q48104965 | Long-term women-reported quality of life after radical cystectomy and orthotopic ileal neobladder reconstruction |
Q38988320 | Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy |
Q85109899 | Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens |
Q36998797 | Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance |
Q45202138 | Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy |
Q39640899 | Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer |
Q37282825 | Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy |
Q64885857 | Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. |
Q48121488 | Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion. |
Q37802932 | Lower extremity neuropathy after robot assisted laparoscopic radical prostatectomy and radical cystectomy |
Q37502768 | Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer |
Q77775673 | Lower urinary tract substitution after radical cystectomy with urethral mucosa and submucosa removal in females with trigonal and/or bladder neck involvement |
Q36749513 | Lunar phases and zodiac signs do not influence quality of radical cystectomy--a statistical analysis of 452 patients with invasive bladder cancer |
Q41432861 | Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template |
Q53080227 | Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. |
Q45348244 | Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy |
Q31141557 | Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. |
Q36452450 | Lymph node dissection during laparoscopic (LRC) and open (ORC) radical cystectomy due to muscle invasive bladder urothelial cancer (pT2-3, TCC). |
Q47252660 | Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database. |
Q38124003 | Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent |
Q46587989 | Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study |
Q46220955 | Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study--a single center experience |
Q28588025 | Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery |
Q81338036 | Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy |
Q53157159 | Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. |
Q45819570 | Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma |
Q33669763 | Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. |
Q42665316 | Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium |
Q68335528 | Lymphadenectomy during radical cystectomy for bladder cancer |
Q38104493 | Lymphadenectomy for bladder cancer at the time of radical cystectomy |
Q62778138 | Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes |
Q80179110 | Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy |
Q39010863 | Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. |
Q58107187 | Lymphovascular invasion have a similar prognostic value as lymph node involvement in patients undergoing radical cystectomy with urothelial carcinoma |
Q84218618 | Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? |
Q43196454 | Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial |
Q46226093 | Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder |
Q46906313 | Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy |
Q43622475 | Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy |
Q81992819 | Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens |
Q42699174 | MID-TERM ONCOLOGICAL OUTCOME AND TECHNICAL MODIFICATIONS FOR LAPAROSCOPIC RADICAL CYSTECTOMY AT OUR INSTITUTION: 60 CASES ANALYSIS. |
Q53682198 | MP61-02 BALANCING ONCOLOGIC BENEFIT WITH RISK OF COMPLICATIONS: THE EXTENT PELVIC LYMPH NODE DISSECTION DURING RADICAL CYSTECTOMY |
Q81238546 | Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival |
Q90938405 | Major Oncological Surgery (Radical Cystectomy) in Octogenarians- is it Safe? |
Q78110643 | Major surgery (radical cystectomy with urethrectomy) in a patient with von Willebrand's disease type I. Reliability and limits of hemocoagulative tests |
Q53060401 | Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes. |
Q38606356 | Management of Challenging Urethro-ileal Anastomosis During Robotic Assisted Radical Cystectomy with Intracorporeal Neobladder Formation |
Q50443131 | Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice. |
Q90707523 | Management of Pelvic Organ Prolapse After Radical Cystectomy |
Q92585813 | Management of anticoagulation and antiplatelet agents in the radical cystectomy patient |
Q50979459 | Management of benign ureteral strictures following radical cystectomy and urinary diversion for bladder cancer. |
Q64041381 | Management of cavernous abdominal wall defects post radical cystectomy in adult exstrophy complex |
Q80395918 | Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy |
Q83984300 | Management of concomitant ureteral carcinoma in situ at radical cystectomy |
Q36256764 | Management of neobladder-vaginal fistula and stress incontinence following radical cystectomy in women: a review |
Q39095748 | Management of rectal injuries during radical cystectomy |
Q71278137 | Management of the urethra in men undergoing radical cystectomy for bladder cancer |
Q67369490 | Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma |
Q69696860 | Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma |
Q93534600 | Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma |
Q71667873 | Management of urethral recurrence after radical cystectomy and neobladder creation by urethroscopic resection and fulguration |
Q43498380 | Marital status: a gender-independent risk factor for poorer survival after radical cystectomy |
Q99567062 | Massive intra-abdominal recurrence after robotic-assisted radical cystectomy: A case report and critical appraisal of literature |
Q38003772 | Matched comparison of robotic-assisted and open radical cystectomy |
Q69729845 | May radical cystectomy be able to cure advanced bladders' transitional cell carcinoma (T.C.C.) with lymph node spread? |
Q100395217 | Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer |
Q78645604 | Meckel's diverticulum as the site of implanting ureter to the Bricker segment after radical cystectomy |
Q43086764 | Mesenteric Fibromatosis Mimicking Tumor Recurrence Following Radical Cystectomy and Bladder Replacement. |
Q100548157 | Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients |
Q40814194 | Metabolic changes associated with radical cystectomy |
Q53091821 | Metabolic syndrome, obesity, and radical cystectomy complications: a clavien classification system-based analysis. |
Q93355662 | Metastatic Small Cell Carcinoma of the Urinary Bladder That Recurred in the Vagina 6 Years after Radical Cystectomy: A Case Report |
Q40674227 | Methods of urinary diversion following radical cystectomy |
Q83409506 | Mid-term oncological control after laparoscopic radical cystectomy in men: a single-centre experience |
Q92253656 | Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis |
Q83167983 | Mini-laparotomy approach to radical cystectomy |
Q51889659 | Minimally invasive radical cystectomy for bladder cancer? |
Q51931298 | Minimally invasive radical cystectomy. |
Q90869907 | Minimally invasive versus open radical cystectomy for bladder cancer: A systematic review and meta-analysis |
Q97529048 | Minimally invasive versus open radical cystectomy: long term oncologic outcomes compared |
Q90195881 | Minimally invasive vs open radical cystectomy in patients with bladder cancer: A systematic review and meta-analysis of randomized controlled trials |
Q50922313 | Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution. |
Q92758028 | Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials |
Q73266952 | Modification of the surgical technique in radical cystectomy |
Q36207083 | Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience |
Q46557919 | Modified N-shaped ileal neobladder after radical cystectomy |
Q92548670 | Modified U-Shaped ileal neobladder designed for facilitating neobladder-urethral anastomosis in extracorporeal reconstruction after robotic-assisted radical cystectomy |
Q92735253 | Modified colpocleisis for repair of pelvic organ prolapse post-radical cystectomy |
Q42486949 | Modified le bag pouch after radical cystectomy: continence, urodynamic results and morbidity. |
Q92047927 | Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors |
Q44881898 | Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder. |
Q90132125 | Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection |
Q100566922 | Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians - results from the EAU Robotic Urology Section (ERUS) Scientific Working Group |
Q42613073 | Morbidity and mortality of octogenarians following open radical cystectomy using a standardized reporting system |
Q69595656 | Morbidity and mortality of radical cystectomy (1971-78 and 1978-85) |
Q47828680 | Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. |
Q96341602 | Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer |
Q90348403 | More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder |
Q51021321 | More on robot-assisted laparoscopic radical cystectomy. |
Q104137748 | Mortality after radical cystectomy is strongly related to the institution's volume of surgeries |
Q36015796 | Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting |
Q45075575 | Mortality associated with feeding catheter jejunostomy after radical cystectomy |
Q86604375 | Mortality following radical cystectomy: a good start, but how low can we go? |
Q37125906 | Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. |
Q89609782 | Mortality prediction model for patients with bladder urothelial tumor after radical cystectomy |
Q68279088 | Motion picture: rectal bladder with Gersuny procedure after radical cystectomy |
Q87767417 | Moving Towards Widespread Implementation of Enhanced Recovery Protocols for Radical Cystectomy |
Q82808484 | Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients |
Q92552014 | Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index |
Q46391819 | Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder |
Q82082555 | Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy |
Q33462438 | Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: secondary reported outcome of a randomized controlled trial |
Q63984763 | Multidomain Quantitative Recovery Following Radical Cystectomy for Patients Within the Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus Open Radical Cystectomy Randomised Controlled Trial: The First 30 Patients |
Q51687818 | Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma. |
Q33769119 | Multifactorial, site-specific recurrence models after radical cystectomy for urothelial carcinoma: external validation in a cohort of Korean patients |
Q91661194 | Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference? |
Q92665279 | Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial |
Q80485523 | Multimodal perioperative plan for radical cystectomy and intestinal urinary diversion. I. Effect on recovery of intestinal function and occurrence of complications |
Q82952674 | Multimodality treatment versus radical cystectomy: bladder sparing at cost of life? |
Q53790877 | Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy. |
Q52543514 | Multivariate evaluation of determinants affecting regional lymph node metastasis and survival in bladder cancer patients who underwent radical cystectomy. |
Q45140061 | Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy |
Q57488165 | Muscle Invasive Bladder Cancer (MIBC) - The Gold Standard Radical Cystectomy or Bladder Preserving Approach, YES or NO? |
Q43913506 | Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy |
Q38195977 | NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder |
Q57283036 | National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging |
Q91981786 | National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013 |
Q50071456 | National Surgical Quality Improvement Program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversion |
Q97528815 | National Trends and Impact of Regionalization of Radical Cystectomy on Survival Outcomes in Patients with Muscle Invasive Bladder Cancer |
Q39708611 | National comparison of oncologic quality indicators between open and robotic-assisted radical cystectomy |
Q55332437 | National database of patients treated with radical cystectomy provides a current standard and comparison for future technologies. |
Q42662417 | National trends in the utilization of robotic-assisted radical cystectomy: an analysis using the Nationwide Inpatient Sample |
Q50174879 | Natural History and Predictors of Parastomal Hernia after Robot-Assisted Radical Cystectomy and Ileal Conduit Urinary Diversion |
Q38930776 | Natural History, Predictors and Management of Ureteroenteric Strictures after Robot Assisted Radical Cystectomy |
Q36487162 | Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort |
Q36636971 | Natural history of positive urinary cytology after radical cystectomy |
Q96961248 | Near-infrared fluorescence imaging of ureters with intravenous indocyanine green during radical cystectomy to prevent ureteroenteric anastomotic strictures |
Q73138805 | Neoadjuvant CMV chemotherapy plus radical cystectomy in locally advanced bladder cancer: the impact of pathologic response on long-term results |
Q92487425 | Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study |
Q90628430 | Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC |
Q91784901 | Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience |
Q41601417 | Neoadjuvant Platinum-Based Chemotherapy is an Independent Predictor for Preoperative Thromboembolic Events in Bladder Cancer Patients Undergoing Radical Cystectomy |
Q98186253 | Neoadjuvant chemotherapy before radical cystectomy: why we must adhere? |
Q101352138 | Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis |
Q38661975 | Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology |
Q45066764 | Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer |
Q52863343 | Neoadjuvant chemotherapy-related histologic changes in radical cystectomy: assessment accuracy and prediction of response. |
Q72539459 | Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study |
Q50060639 | Neoadjuvant dose dense MVAC versus GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy |
Q45792869 | Neobladder-rectal fistula as early postoperative complication of radical cystectomy and orthotopic neobaldder construction |
Q68269454 | Nephroureterectomy after radical cystectomy |
Q39595233 | Nerve Sparing, Robot-Assisted Radical Cystectomy with Intracorporeal Bladder Substitution in the Male |
Q53504677 | Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. |
Q51778651 | Nerve-sparing laparoscopic radical cystectomy: technique and initial outcomes. |
Q51761721 | Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients. |
Q48271152 | Nerve-sparing radical cystectomy has a beneficial impact on urinary continence after orthotopic bladder substitution, which becomes even more apparent over time. |
Q33559656 | Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder |
Q46456410 | Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder |
Q51823993 | Neurovascular preservation in female orthotopic radical cystectomy significantly improves sexual function. |
Q61852812 | Neutral Third Party versus Treating Institution for Evaluating Quality of Life after Radical Cystectomy |
Q87990514 | Neutrophil-lymphocyte ratio evaluation in patients undergoing radical cystectomy |
Q39869134 | Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy |
Q36654421 | Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy |
Q45832723 | New retractor facilitates exposure of the vascular pedicles in Chinese men with complex pelvis during radical cystectomy |
Q38924850 | No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care |
Q57123782 | No advantage is gained by preoperative bowel preparation in radical cystectomy and ileal conduit: a randomized controlled trial of 86 patients |
Q90291492 | No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study |
Q64246715 | No survival difference between super extended and standard lymph node dissection at radical cystectomy: what can we learn from the first prospective randomized phase III trial? |
Q46630430 | Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis |
Q98282778 | Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium |
Q80212552 | Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder |
Q53013621 | Nomograms provide improved accuracy for predicting survival after radical cystectomy. |
Q54729569 | Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy. |
Q53123583 | Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy? |
Q36312300 | Non-muscle-invasive bladder cancer: the role of radical cystectomy |
Q74618402 | Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group |
Q97542709 | Novel "double-pulling" technique for neobladder-urethral anastomosis in laparoscopic radical cystectomy |
Q37661376 | Novel closing method using subcutaneous continuous drain for preventing surgical site infections in radical cystectomy. |
Q104756045 | Nursing Implication of People Treated by Radical Cystectomy Postsurgery and Rehabilitation |
Q90466677 | Nutrition risk and assessment process in patients with bladder cancer undergoing radical cystectomy |
Q37240903 | Nutritional predictors of complications following radical cystectomy |
Q48609390 | ORTHOTOPIC URINE DERIVATION AFTER RADICAL CYSTECTOMY (REVIEW) |
Q97592249 | Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer |
Q44519064 | Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy |
Q45250550 | Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy |
Q95497413 | Obstruction of ileal loop in bricker type bladder after laparoscopic radical cystectomy |
Q72330862 | Obstruction of the rectosigmoid and sigmoid flexure after radical cystectomy for cancer of the bladder |
Q43475595 | Older patients suffer from adverse histopathological features after radical cystectomy |
Q87495189 | Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy |
Q41648995 | Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea |
Q40507279 | Oncologic Outcomes of Robot-Assisted Radical Cystectomy: Results of a High-Volume Robotic Center |
Q85994910 | Oncologic outcome after laparoscopic radical cystectomy without neoadjuvant or adjuvant therapy with a median follow-up of 32 months |
Q39280988 | Oncologic outcome and urinary function after radical cystectomy for rhabdomyosarcoma in children: role of the orthotopic ileal neobladder based on 15-year experience at a single center. |
Q43552944 | Oncologic outcomes achieved by radical cystectomy |
Q93047468 | Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis |
Q45325031 | Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study |
Q42640080 | Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis |
Q38207349 | Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience |
Q43573519 | Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years |
Q48729142 | Oncologic surveillance following radical cystectomy: an individualized risk-based approach |
Q35922856 | Oncologic surveillance in bladder cancer following radical cystectomy: A systematic review and meta-analysis |
Q58093745 | Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea |
Q42603628 | Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion |
Q40812479 | Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches |
Q95583410 | Oncological Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of Bladder |
Q51907972 | Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy. |
Q37926212 | Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status |
Q47655843 | Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial |
Q36714745 | Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women |
Q91141659 | Oncological and functional outcomes of robot-assisted radical cystectomy in bladder cancer patients in a single tertiary center: Can these be preserved throughout the learning curve? |
Q38791133 | Oncological and functional outcomes of sexual function-preserving cystectomy compared with standard radical cystectomy in men: A systematic review. |
Q83387450 | Oncological followup after radical cystectomy for bladder cancer-is there any benefit? |
Q97589130 | Oncological outcome according to attainment of pentafecta after robot assisted radical cystectomy among bladder cancer patients using KORARC database (730 multicenter robot radical cystectomy database) |
Q98879971 | Oncological outcome according to attainment of pentafecta after robot assisted radical cystectomy among bladder cancer patients using KORARC database (730 multicenter robot radical cystectomy database) BJU Int 2020 Jul 8. doi: 10.1111/ bju.15178 |
Q46521700 | Oncological outcome after radical cystectomy and orthotopic bladder substitution in women |
Q86926187 | Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy |
Q37677307 | Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches |
Q92684853 | Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort |
Q38245360 | Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy |
Q51506783 | Oncological outcomes of robot-assisted radical cystectomy. |
Q41239316 | One-Stage Radical Cystectomy for Bladder Carcinoma: Operative Mortality, Cost/Benefit Analysis |
Q67535551 | One-stage radical cystectomy for bladder carcinoma: operative mortality, cost/benefit analysis |
Q54969979 | Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxis. |
Q47717680 | Open radical cystectomy in England: the current standard of care - an analysis of the BAUS cystectomy audit and HES data |
Q90765571 | Open radical cystectomy is a reliable surgery with acceptable complication rates in elderly male patients: a retrospective, tertiary hospital-based study |
Q36925426 | Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer |
Q58804612 | Open radical cystectomy: lessons from the British Association of Urological Surgeons (BAUS) registry |
Q38639574 | Open radical cystectomy: still the gold standard for muscle invasive bladder cancer |
Q37090683 | Open surgical repair of ureteral strictures and fistulas following radical cystectomy and urinary diversion. |
Q81482242 | Open to debate. The motion: seminal-nerve sparing radical cystectomy is an efficacious and safe treatment for selected bladder cancer patients |
Q42617656 | Open versus laparoscopy-assisted radical cystectomy: results of a prospective study. |
Q89287585 | Open versus robot-assisted radical cystectomy: 30-day perioperative comparison and predictors for cost-to-patient, complication, and readmission |
Q35223315 | Open versus robotic radical cystectomy with intracorporeal Studer diversion |
Q100750709 | Open versus robotic radical cystectomy: Results from the 3-year follow-up of the RAZOR trial |
Q42602543 | Open-assisted laparoscopic radical cystectomy using an ileal neobladder with intracorporeal urethra-neobladder anastomosis: technique and early experiences |
Q101053860 | Optimal Delivery of Follow-Up Care After Radical Cystectomy for Bladder Cancer |
Q80058785 | Optimal nutrition should improve the outcome and costs of radical cystectomy |
Q37469467 | Optimal timing of radical cystectomy for patients with T1 bladder cancer. |
Q54132494 | Optimal timing of radical cystectomy for patients with invasive transitional cell carcinoma of the bladder. |
Q39813009 | Optimal timing of radical cystectomy in T1 high-grade bladder cancer |
Q58594892 | Optimizing Nutrition Prior to Radical Cystectomy |
Q98721089 | Optimizing Women's Sexual Function and Sexual Experience After Radical Cystectomy |
Q43047312 | Optimizing a frail elderly patient for radical cystectomy with a prehabilitation program. |
Q39279633 | Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. |
Q53515170 | Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. |
Q84170751 | Optimizing the approach for lymph node dissection during laparoscopic radical cystectomy |
Q40505991 | Options in replacement cystoplasty following radical cystectomy: high hopes or successful reality |
Q33859644 | Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy |
Q53889052 | Orthotopic bladder substitution after radical cystectomy: 5 years of experience with a novel personal modification of the ileal s pouch. |
Q48914165 | Orthotopic bladder substitution following radical cystectomy in women: comparative study between sigmoid and ileal neobladders |
Q55439119 | Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action. |
Q51273969 | Orthotopic continent urinary diversion after radical cystectomy in pediatric patients with genitourinary rhabdomyosarcoma. |
Q86503594 | Orthotopic detaenial sigmoid neobladder after radical cystectomy: technical considerations, complications and functional outcomes |
Q36588194 | Orthotopic genital sparing radical cystectomy in pre-menopausal women with muscle-invasive bladder carcinoma: A prospective study |
Q72703108 | Orthotopic ileal bladder substitute after radical cystectomy: urodynamic features |
Q46146643 | Orthotopic ileal bladder substitution following radical cystectomy using the linear-cutter stapling device. |
Q72539450 | Orthotopic ileal neobladder in female patients after radical cystectomy: 2-year experience |
Q74622695 | Orthotopic ileocolic neobladder reconstruction following radical cystectomy: history, technique and results of the Johns Hopkins experience, 1986-1998 |
Q35004341 | Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions |
Q73266895 | Orthotopic neobladder reconstruction after radical cystectomy |
Q48418997 | Orthotopic neobladder reconstruction after radical cystectomy in patients with a solitary functioning kidney: clinical outcome and evaluation |
Q37627282 | Orthotopic sigmoid neobladder after radical cystectomy: assessment of complications, functional outcomes and quality of life in 82 Japanese patients |
Q48108963 | Orthotopic urinary diversion after radical cystectomy in treatment of muscle invasive bladder cancer |
Q41665800 | Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique |
Q36413302 | Our experiences with robot-assisted laparoscopic radical cystectomy: orthotopic neobladder by the suprapubic incision method |
Q83900992 | Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed |
Q80553123 | Outcome after radical cystectomy with limited or extended pelvic lymph node dissection |
Q47278323 | Outcome and quality of life in patients operated on with radical cystectomy and three different urinary diversion techniques |
Q37197518 | Outcome following radical cystectomy and bladder-preservation therapy in patients with invasive carcinoma of urinary bladder |
Q44800643 | Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy |
Q73107007 | Outcome in patients with seminal vesicle invasion after radical cystectomy |
Q52719951 | Outcome of Mainz II Pouch Urinary Diversion after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer: Our Experience. |
Q41368214 | Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy |
Q46722034 | Outcome of anterior vaginal wall sparing during female radical cystectomy with orthotopic urinary diversion |
Q34528663 | Outcome of patients undergoing radical cystectomy for invasive bladder cancer |
Q37171971 | Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. |
Q73316409 | Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy |
Q54399364 | Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. |
Q85264951 | Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients |
Q77711389 | Outcome of radical cystectomy for bladder cancer according to the disease type at presentation |
Q34045519 | Outcome of radical cystectomy for invasive bladder cancer |
Q50881510 | Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients. |
Q47897350 | Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy |
Q43469590 | Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control |
Q43600412 | Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy |
Q104747800 | Outcomes and complications of radical cystectomy with ileal conduit urinary diversion: A comparison between open, semi-robotic and totally robotic surgery |
Q93067516 | Outcomes and learning curve for robotic-assisted radical cystectomy: an Australian experience |
Q50493416 | Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. |
Q85377312 | Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis |
Q85409274 | Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis |
Q92012277 | Outcomes following radical cystectomy: a population-based study from Queensland, Australia |
Q80450576 | Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy |
Q47562152 | Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. |
Q90096046 | Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success |
Q37997128 | Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience |
Q37990173 | Outcomes of laparoscopic and robotic radical cystectomy in the elderly patients |
Q36040572 | Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience |
Q44034661 | Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease |
Q46120103 | Outcomes of patients with clinical CIS-only disease treated with radical cystectomy |
Q79621497 | Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy |
Q80792635 | Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy |
Q82737109 | Outcomes of radical cystectomy |
Q35122661 | Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder |
Q79329951 | Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium |
Q53165616 | Outcomes of radical cystectomy in potential candidates for bladder preservation therapy. |
Q46009354 | Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. |
Q51900001 | Outcomes of robot-assisted radical cystectomy: learning curves, margins and lymph node yield |
Q83877588 | Outcomes of single lymph node positive urothelial carcinoma after radical cystectomy |
Q79907953 | Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer |
Q88646235 | Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy |
Q34925757 | Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy |
Q36574137 | Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy |
Q37214749 | P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors |
Q100725158 | PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy |
Q39677562 | POINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection? |
Q72770745 | Panniculectomy in conjunction with radical cystectomy in the obese patient |
Q92295217 | Parastomal Hernia Repair With 3-D Mesh Implants After Radical Cystectomy and Ileal Conduit Urinary Diversion - A Single-center Experience Using a Purpose Made Alloplastic Mesh Implant |
Q26738774 | Parastomal hernias after radical cystectomy and ileal conduit diversion |
Q45015430 | Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial |
Q68001298 | Partial cystectomy: and alternative to radical cystectomy? Apropos of a series of 75 patients |
Q28255916 | Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer |
Q74716114 | Pathologic evaluation of radical cystectomy specimens |
Q80126913 | Pathologic evaluation of radical cystectomy specimens: a cooperative group report |
Q90473137 | Pathologic measures of quality compare favorably in patients undergoing robot-assisted radical cystectomy to open cystectomy cohorts: a National Cancer Database analysis |
Q44648038 | Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy |
Q58552455 | Pathological Profile, Early Complications, Functional and Oncological Outcome after Radical Cystectomy - Ileal Conduit for Bladder Cancer Patients in Sanglah General Hospital between January 2013 and December 2016 |
Q38168391 | Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate. |
Q88673185 | Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort |
Q40489195 | Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study. |
Q92756445 | Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only |
Q53081353 | Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia. |
Q74246103 | Pathological findings of gynecologic organs obtained at female radical cystectomy |
Q83571379 | Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder |
Q45340458 | Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer |
Q37607679 | Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) use |
Q37257437 | Pathology of the prostate in radical cystectomy specimens: a critical review |
Q38990152 | Patient Frailty and Discharge Disposition Following Radical Cystectomy |
Q38592301 | Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy |
Q69386093 | Patient adjustment to an ileal conduit after radical cystectomy |
Q89639811 | Patient decision aids for urinary diversion after radical cystectomy: their potential and pitfalls |
Q91091943 | Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy |
Q92615875 | Patient perspectives of vigorous intensity aerobic interval exercise prehabilitation prior to radical cystectomy: a qualitative focus group study |
Q90375910 | Patient reported and physician recorded bowel dysfunction following colorectal resection and radical cystectomy: a prospective, comparative study |
Q57781881 | Patient's outcome of bladder cancer managed by radical cystectomy with lymphadenectomy at a university hospital |
Q38880286 | Patient-Reported Convalescence and Quality of Life Recovery: A Comparison of Open and Robotic-Assisted Radical Cystectomy |
Q88106451 | Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy |
Q39286841 | Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution--a prospective comparative study |
Q38691499 | Patient-centered risk stratification of disposition outcomes following radical cystectomy |
Q87817634 | Patient-reported outcome after radical cystectomy: translation and psychometric validation of the Swedish version of the Functional Assessment of Cancer Therapy Scale Vanderbilt Cystectomy Index |
Q39351878 | Patient-reported outcomes for patients undergoing radical cystectomy: a prospective case-control study |
Q33879717 | Pattern of failure in bladder cancer patients treated with radical cystectomy: rationale for adjuvant radiotherapy. |
Q88228534 | Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer |
Q49380161 | Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature. |
Q39959318 | Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. |
Q40828065 | Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy. |
Q40750653 | Patterns of care for readmission after radical cystectomy in New York State and the effect of care fragmentation |
Q84916976 | Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer |
Q46523499 | Patterns of recurrence of bladder carcinoma following radical cystectomy. |
Q53671266 | Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience. |
Q92250409 | Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial Carcinoma |
Q39416398 | Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy. |
Q81312575 | Pelvic floor reconstruction before orthotopic bladder replacement after radical cystectomy for bladder cancer |
Q34585907 | Pelvic lymph node dissection and outcome of robot-assisted radical cystectomy for bladder carcinoma |
Q90928632 | Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer |
Q42127319 | Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution |
Q74130836 | Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy |
Q70084404 | Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease |
Q37509611 | Pelvic lymphadenectomy during radical cystectomy: a review of the literature |
Q44633799 | Pelvic recurrence after radical cystectomy without preoperative radiation |
Q53824235 | Pelvic recurrence after radical cystectomy: a call to arms. |
Q57808395 | Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study |
Q82914481 | Penile haemodynamic changes in post-radical cystectomy patients |
Q72592233 | Penile self-injection for impotence in patients after radical cystectomy |
Q69098146 | Penile self-injection for impotence in patients after radical cystectomy-ileal loop |
Q41729156 | Performance status as a significant prognostic predictor in patients with urothelial carcinoma of the bladder who underwent radical cystectomy. |
Q48000121 | Performing radical cystectomy and urinary diversion in regional anesthesia: potential risk reduction in the treatment of bladder cancer |
Q37932064 | Peri- and postoperative outcomes of robot-assisted radical cystectomy (RARC). |
Q64113922 | Peri-Operative Outcomes after Open and Robot-Assisted Radical Cystectomy by Using an Advanced Bipolar Seal and Cut Technology (Caiman®): A Prospective, Comparative, and Multi-Institutional Study |
Q38954368 | Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study |
Q47640057 | Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. |
Q92260104 | Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan |
Q42288559 | Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan |
Q34434982 | Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals. |
Q37579695 | Perineal herniation of an ileal neobladder following radical cystectomy and consecutive rectal resection for recurrent bladder carcinoma |
Q53554545 | Perineural invasion by transitional cell carcinoma of the bladder in patients submitted to radical cystectomy: what is the prognostic value? |
Q41502091 | Perineural invasion in transitional cell carcinoma and the effect on prognosis following radical cystectomy |
Q92871305 | Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study |
Q28088588 | Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis |
Q51742815 | Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial. |
Q91775116 | Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients |
Q57804258 | Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial |
Q91305601 | Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study |
Q50048566 | Perioperative Outcomes and Early Survival in Octogenarians Who Underwent Radical Cystectomy for Bladder Cancer |
Q39806172 | Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study. |
Q39067951 | Perioperative Transfusion of Leukocyte-depleted Blood Products in Contemporary Radical Cystectomy Cohort Does Not Adversely Impact Short-term Survival |
Q50207474 | Perioperative and long-term outcomes after radical cystectomy in hemodialysis patients. |
Q53828681 | Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series. |
Q39874551 | Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: A comparison of two high-volume referral centers |
Q92108155 | Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan |
Q92223309 | Perioperative and oncological outcomes of robot-assisted radical cystectomy in octogenarians |
Q39921800 | Perioperative and survival outcomes of laparoscopic radical cystectomy for bladder cancer in patients over 70 years |
Q46636584 | Perioperative antibiotics in radical cystectomy with ileal conduit urinary diversion: efficacy and risk of antimicrobial prophylaxis on the operation day alone |
Q85261974 | Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? |
Q38843337 | Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database |
Q40596744 | Perioperative change in neutrophil-lymphocyte ratio predicts the overall survival of patients with bladder cancer undergoing radical cystectomy |
Q43996369 | Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer |
Q87466849 | Perioperative complications and 90-day mortality of radical cystectomy in the elderly (75+): a retrospective, multicentre study |
Q56978273 | Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology |
Q95305713 | Perioperative complications and oncological outcomes following radical cystectomy among different racial groups: A long-term, single-center study |
Q42671865 | Perioperative complications and oncological safety of robot-assisted (RARC) vs. open radical cystectomy (ORC). |
Q50753978 | Perioperative complications and surgical oncology outcomes in an initial study from 84 patients submitted to laparoscopic radical cystectomy. |
Q85085320 | Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy |
Q48671881 | Perioperative complications of radical cystectomy in a contemporary series |
Q40927020 | Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study |
Q92968888 | Perioperative management of cold agglutinin autoimmune hemolytic anemia in an older adult undergoing radical cystectomy for bladder cancer |
Q92522000 | Perioperative management of radical cystectomy in the Nordic countries |
Q50692343 | Perioperative morbidity and mortality of octogenarians treated by radical cystectomy-a multi-institutional retrospective study in Japan. |
Q35125738 | Perioperative morbidity of radical cystectomy: A review |
Q47647584 | Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch |
Q92487470 | Perioperative mortality following radical cystectomy: the slippery slope of complications |
Q56777841 | Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder |
Q24197694 | Perioperative nutrition for the treatment of bladder cancer by radical cystectomy |
Q92157594 | Perioperative nutrition for the treatment of bladder cancer by radical cystectomy |
Q92584997 | Perioperative nutrition for the treatment of bladder cancer by radical cystectomy: A Cochrane review summary |
Q85210763 | Perioperative outcome of laparoscopic radical cystectomy: comparison to open radical cystectomy |
Q35777567 | Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they any better? |
Q43754468 | Perioperative outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy |
Q88621745 | Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study |
Q42669950 | Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy |
Q38125925 | Perioperative outcomes in radical cystectomy: how to reduce morbidity? |
Q55283881 | Perioperative outcomes of minimally invasive versus open radical cystectomy: A single-center experience. |
Q39212180 | Perioperative outcomes with laparoscopic radical cystectomy: "pure laparoscopic" and "open-assisted laparoscopic" approaches |
Q92587835 | Perioperative recovery in different urinary reconstruction approaches of radical cystectomy: Are the advantages of laparoscopy consistent? |
Q35960332 | Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer |
Q38379148 | Perioperative strategies to reduce postoperative complications after radical cystectomy |
Q40168355 | Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands. |
Q33462188 | Perioperative use of crystalloids in patients undergoing open radical cystectomy: balanced Ringer's maleate versus a glucose 5%/potassium-based balanced solution: study protocol for a randomized controlled trial |
Q46187716 | Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth |
Q36724794 | Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy? |
Q49788369 | Physician Perceptions of Patient Health: A Comparative Analysis between Urologist and Hospitalist Perceptions of Need for Inpatient Hospitalist Comanagement Following Radical Cystectomy |
Q100645790 | Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy |
Q74830108 | Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder? |
Q33820181 | Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy |
Q40212938 | Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer |
Q51269681 | Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer. |
Q46509021 | Port site metastases after robot-assisted laparoscopic radical cystectomy. |
Q39139626 | Port-Site Metastases After Robotic Radical Cystectomy: A Systematic Review and Management Options |
Q49335592 | Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? |
Q98191373 | Port-site incisional hernia from an 8-mm robotic trocar following robot-assisted radical cystectomy: Report of a rare case |
Q90173492 | Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences |
Q85918736 | Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study |
Q51732754 | Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. |
Q90387196 | Positive ureteric margins at radical cystectomy: Can it be predicted at initial transurethral resection of bladder tumour? |
Q56243455 | Post-Operative Infections among Patients Undergoing Radical Cystectomy at a Tertiary Center |
Q45740660 | Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion. |
Q92741332 | Posterior muscle-fascial reconstruction and knotless urethro-neo bladder anastomosis during robot-assisted radical cystectomy: Description of the technique and its impact on urinary continence |
Q96820247 | Posterior reconstruction during robotic-assisted radical cystectomy with intracorporeal orthotopic ileal neobladder: description and outcomes of a simple step |
Q39021197 | Postoperative Atrial Fibrillation Predicts Long-Term Cardiovascular Events after Radical Cystectomy |
Q49795841 | Postoperative C-reactive protein is a reliable marker to detect complications after radical cystectomy |
Q88072085 | Postoperative Outcomes After Radical Cystectomy in Patients With Prior Pelvic Radiation |
Q38506375 | Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway |
Q38379133 | Postoperative changes in serum CO2 as an indicator of postoperative complications after radical cystectomy |
Q91149088 | Postoperative cognitive dysfunction after robot-assisted radical cystectomy (RARC) with cerebral oxygen monitoring an observational prospective cohort pilot study |
Q90996731 | Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study |
Q51010000 | Postoperative complications and short-term oncological outcomes of patients aged ≥80 years undergoing robot-assisted radical cystectomy. |
Q87711582 | Postoperative ileus after radical cystectomy: looking for answers to an age-old problem |
Q72557138 | Postoperative management of patients undergoing radical cystectomy and urinary diversion |
Q39354964 | Postoperative management of radical cystectomy. Review of the evidence on the prevention and treatment of urological complications |
Q41838264 | Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: A population-based analysis during the years 2000-2009. |
Q79976034 | Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer |
Q102131339 | Postoperative outcomes of Fast Track enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposal |
Q33373072 | Postoperative thrombotic microangiopathy following radical cystectomy for bladder cancer. |
Q93383681 | Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer |
Q89228564 | Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS Population |
Q51051743 | Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. |
Q37221832 | Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. |
Q46965510 | Potential risk factors and outcomes of artificial urinary sphincter placement after radical cystectomy and orthotopic neobladder urinary diversion |
Q96949361 | Practice patterns for extended venous thromboembolism chemoprophylaxis among urologic oncologists after radical cystectomy |
Q33994334 | Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. |
Q70452256 | Predeposit autologous blood transfusions in patients undergoing irradiation and radical cystectomy |
Q57801526 | Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy |
Q91889163 | Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty |
Q92915490 | Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator |
Q44249777 | Predicting individual outcomes after radical cystectomy: an external validation of current nomograms |
Q50195455 | Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy |
Q102323409 | Predicting morbidity and mortality after radical cystectomy using risk calculators: A comprehensive review of the literature |
Q38755792 | Predicting occult lymph node-positive disease at the time of radical cystectomy: a systematic review |
Q89622365 | Predicting perioperative mortality after radical cystectomy: comorbidity assessment tools are only part of the puzzle |
Q37103989 | Predicting survival after radical cystectomy for bladder cancer |
Q44419779 | Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. |
Q53336343 | Predicting the survival of bladder carcinoma patients treated with radical cystectomy. |
Q43903670 | Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort |
Q40772011 | Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study |
Q57064398 | Prediction of acute kidney injury after radical cystectomy and urinary diversion |
Q40233664 | Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making |
Q90271602 | Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology |
Q91289268 | Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades |
Q40288397 | Prediction of mortality after radical cystectomy for bladder cancer by machine learning techniques. |
Q45151298 | Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks |
Q84230099 | Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer |
Q51820528 | Prediction of survival after radical cystectomy for invasive bladder carcinoma: risk group stratification, nomograms or artificial neural networks? |
Q100453382 | Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer |
Q83399508 | Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder |
Q38675035 | Predictive factors for final pathologic ureteral sections on 700 radical cystectomy specimens: Implications for intraoperative frozen section decision-making |
Q86016277 | Predictive factors of evolution of patients after pT0 radical cystectomy due to bladder cancer |
Q47785950 | Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy |
Q93182617 | Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy |
Q104736330 | Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy |
Q89379880 | Predictors of Benign Uretero-enteric Anastomotic Strictures After Radical Cystectomy and Urinary Diversion |
Q104516307 | Predictors of Need for Catheterization and Urinary Retention after Radical Cystectomy and Orthotopic Neobladder in Male Patients |
Q90252734 | Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup |
Q95645642 | Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival |
Q46489162 | Predictors of cancer-specific mortality after disease recurrence following radical cystectomy |
Q41027602 | Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada |
Q47624161 | Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective analysis of 112 female patients |
Q37598208 | Predictors of lymph node involvement in bladder cancer treated with radical cystectomy |
Q91255288 | Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy |
Q36164729 | Predictors of outcome after radical cystectomy for bladder cancer in saudi patients; single institution experience. |
Q64969535 | Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion. |
Q57089334 | Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study |
Q35956231 | Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over time |
Q91469066 | Predictors of surgical site infection after radical cystectomy: should we enhance surgical antibiotic prophylaxis? |
Q45184861 | Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy |
Q30587187 | Predictors of the use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: data from a pilot study of 1756 cases 2004-2011. |
Q40491159 | Preliminary Comparative Effectiveness of Robotic Versus Open Radical Cystectomy in Elderly Patients |
Q34220341 | Preliminary experience with radical cystectomy and w-ileal pouch for muscle invasive transitional cell bladder carcinoma. |
Q73286125 | Preliminary ligation of vascular pedicles in male radical cystectomy |
Q38963720 | Preoperative Anemia and Low Hemoglobin Level Are Associated With Worse Clinical Outcomes in Patients With Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis |
Q58698642 | Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study |
Q40194329 | Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis |
Q63966593 | Preoperative Hydronephrosis Predicts Advanced Bladder Cancer but Is Not an Independent Factor for Cancer-Specific Survival after Radical Cystectomy |
Q38901788 | Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy |
Q88091385 | Preoperative Incidence of Deep Venous Thrombosis in Patients With Bladder Cancer Undergoing Radical Cystectomy |
Q39512178 | Preoperative Nutritional Status and The Impact on Radical Cystectomy Recovery: An International Comparative Study |
Q37046205 | Preoperative Patient Reported Mental Health is Associated with High Grade Complications after Radical Cystectomy. |
Q33755824 | Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study |
Q93047866 | Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome |
Q38359518 | Preoperative and modifiable factors to lower postoperative complications after radical cystectomy |
Q57300536 | Preoperative anemia and extensive transfusion during stay-in-hospital are critical for patient`s mortality: A retrospective multicenter cohort study of oncological patients undergoing radical cystectomy |
Q41127920 | Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy |
Q91968935 | Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy |
Q50126305 | Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? |
Q47594245 | Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. |
Q42365275 | Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer |
Q39165708 | Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion |
Q40168486 | Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases |
Q96226584 | Preoperative frailty and outcome in patients undergoing radical cystectomy |
Q37227652 | Preoperative hydronephrosis as an indicator of survival after radical cystectomy |
Q40083209 | Preoperative immunonutrition prior to radical cystectomy: a pilot study |
Q69688330 | Preoperative irradiation and radical cystectomy for bladder cancer |
Q68690615 | Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder |
Q71502499 | Preoperative irradiation and radical cystectomy in carcinoma of the bladder |
Q69938194 | Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy |
Q53484321 | Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. |
Q34226276 | Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis |
Q46920358 | Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy |
Q50141388 | Preoperative nutritional factors and outcomes after radical cystectomy: A narrative review |
Q79317747 | Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy |
Q39529506 | Preoperative prediction of malignant involvement of resected ureters in patients undergoing radical cystectomy for bladder cancer |
Q92037583 | Preoperative predictors of early death risk in bladder cancer patients treated with robot-assisted radical cystectomy |
Q34373728 | Preoperative serum albumin is associated with mortality and complications after radical cystectomy |
Q84989776 | Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol |
Q88131534 | Preoperatively Dilated Ureters are a Specific Risk Factor for the Development of Ureteroenteric Strictures after Open Radical Cystectomy and Ileal Neobladder |
Q57281756 | Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy |
Q44470687 | Presentation and outcome following radical cystectomy in Hispanics with bladder cancer |
Q46898743 | Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder |
Q39460899 | Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder |
Q79355866 | Preservation of ejaculatory and erectile function after radical cystectomy for urothelial malignancy |
Q39713639 | Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer |
Q78292863 | Preservation of the anterior vaginal wall during female radical cystectomy with orthotopic urinary diversion: technique and results |
Q51272592 | Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: a report on 15 cases with long term follow-up. |
Q46549839 | Preservation of urosexual functions after radical cystectomy |
Q59798041 | Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomy |
Q53062494 | Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. |
Q52701379 | Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer. |
Q102319733 | Prevalence and Predictors of Venous Thromboembolism after Robot-Assisted Radical Cystectomy |
Q45410645 | Prevalence of Clostridium Difficile Infection in Patients After Radical Cystectomy and Neoadjuvant Chemotherapy |
Q62778279 | Prevention and management of complications following radical cystectomy for bladder cancer |
Q37708678 | Prevention and management of complications following radical cystectomy for bladder cancer. |
Q38069959 | Prevention and management of complications following robot-assisted radical cystectomy: lessons learned after >250 consecutive cases |
Q42197292 | Primary Signet-Ring Cell Carcinoma of the Urinary Bladder Successfully Managed with Radical Cystectomy in a Young Patient. |
Q38025151 | Primary and secondary malignant involvement of gynaecological organs at radical cystectomy for bladder cancer: review of literature and retrospective analysis of 360 cases |
Q98191178 | Primary diffuse large B-cell lymphoma of the ileal conduit created after radical cystectomy |
Q68012721 | Prognosis of bladder cancer. III. The value of radical cystectomy in the management of invasive bladder cancer |
Q88091274 | Prognostic Features for Objectively Defined Urinary Continence after Radical Cystectomy and Ileal Orthotopic Neobladder in a Contemporary Cohort |
Q53011547 | Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy. |
Q38672188 | Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy |
Q92379448 | Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy |
Q64075778 | Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals |
Q90754536 | Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis |
Q57934684 | Prognostic Value of Perinodal Lymphovascular Invasion Following Radical Cystectomy for Lymph Node–positive Urothelial Carcinoma |
Q104750286 | Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Muscle-Invasive Bladder Cancer After Radical Cystectomy |
Q89365105 | Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients |
Q53241403 | Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer. |
Q51917175 | Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis. |
Q35891117 | Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy |
Q80412444 | Prognostic factors in a recent series of patients treated with radical cystectomy for bladder cancer |
Q44118200 | Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen |
Q36286292 | Prognostic factors in radical cystectomy affecting survival |
Q77346920 | Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort |
Q50574271 | Prognostic factors, pattern of recurrence and survival in a Danish bladder cancer cohort treated with radical cystectomy. |
Q37426972 | Prognostic features for quality of life after radical cystectomy and orthotopic neobladder. |
Q40946240 | Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy |
Q46569857 | Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy |
Q97549437 | Prognostic impact of preoperative renal function in patients treated with radical cystectomy: a multi-institutional retrospective study |
Q90181678 | Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer |
Q50060622 | Prognostic of older age for patients with invasive-muscle-bladder cancer and treated by radical cystectomy |
Q88728657 | Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy |
Q48960264 | Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy |
Q44207378 | Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy |
Q53135982 | Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy. |
Q39660094 | Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study |
Q52623391 | Prognostic role of delay before radical cystectomy: retrospective analysis of a single-centre cohort with 376 patients. |
Q48239450 | Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy |
Q40170042 | Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy |
Q38476001 | Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy |
Q80993514 | Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer |
Q44588949 | Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy |
Q54668939 | Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder. |
Q38929626 | Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy |
Q35106939 | Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis |
Q45994760 | Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. |
Q96160763 | Prognostic significance of previous tonsillectomy after radical cystectomy for bladder cancer |
Q97093355 | Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer |
Q104288846 | Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer |
Q35063376 | Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy |
Q81647471 | Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy |
Q43866787 | Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy |
Q73263717 | Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens |
Q50943065 | Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy. |
Q41496553 | Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival |
Q84794267 | Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer |
Q56988216 | Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy |
Q83739138 | Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy |
Q95834619 | Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis |
Q90076698 | Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A meta-analysis |
Q100756381 | Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy? |
Q90593425 | Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy |
Q37689089 | Prognostic value of vascular mimicry in patients with urothelial carcinoma of the bladder after radical cystectomy |
Q74562269 | Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder |
Q55263257 | Prognostication in Patients Treated with Radical Cystectomy for Urothelial Bladder Carcinoma: A New Simplified Model Incorporating Histological Variants. |
Q39204644 | Progressive ureteral dilations and retrograde placement of single-j stent guided by flexible cystoscope for management of ureteroenteral anastomotic stricture in patients after radical cystectomy and bricker urinary diversion |
Q38836916 | Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic |
Q48341672 | Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer |
Q91860572 | Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy |
Q93182623 | Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy |
Q40305305 | Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States. |
Q50023179 | Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source |
Q90881098 | Prophylactic mesh used in ileal conduit formation following radical cystectomy: a retrospective cohort |
Q36076583 | Prophylactic radical cystectomy for the management of keratinizing squamous metaplasia of the bladder in a man with tetraplegia |
Q46063382 | Prophylaxis against radiation injury. The use of elemental diet prior to and during radiotherapy for invasive bladder cancer and in early postoperative feeding following radical cystectomy and ileal conduit |
Q37197530 | Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer |
Q38852083 | Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire |
Q48501255 | Prospective Evaluation of Nutritional Factors to Predict the Risk of Complications for Patients Undergoing Radical Cystectomy: A Cohort Study |
Q47264224 | Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. |
Q45931175 | Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model. |
Q44004970 | Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy |
Q44293813 | Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy |
Q48120334 | Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complications |
Q48068728 | Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion. |
Q91685396 | Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion |
Q40798997 | Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis |
Q43255674 | Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results |
Q40168747 | Prospective study comparing laparoscopic and open radical cystectomy: Surgical and oncological results |
Q64996627 | Prospective, randomized clinical trial comparing use of intraoperative transesophageal echocardiography to standard care during radical cystectomy. |
Q80572345 | Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping |
Q40678159 | Prostate capsule sparing radical cystectomy - a safe procedure for few |
Q37905553 | Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome |
Q35201624 | Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial |
Q36417260 | Prostate sparing radical cystectomy--not for all, but an option for some. |
Q38111872 | Prostate-sparing radical cystectomy for selected patients with bladder cancer. |
Q36929046 | Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy |
Q92741420 | Pubis bone osteomyelitys after robotic radical cystectomy with continent intracorporeal urinary diversion: Multidisciplinary approach to a complex situation |
Q44142775 | Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women. |
Q39046515 | Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients |
Q35430308 | Pure intracorporeal laparoscopic radical cystectomy with orthotopic "U" shaped ileal neobladder. |
Q36872870 | Pure laparoscopic radical cystectomy with ileal conduit: a single surgeon's mid-term outcomes |
Q50228976 | Quality Improvement Efforts in Radical Cystectomy: From Prehab to Rehab |
Q37398251 | Quality assurance and benchmarking for radical cystectomy: monitoring early complications and mortality using cumulative summation charts |
Q52591362 | Quality of Life After Radical Cystectomy. |
Q41467522 | Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study. |
Q37261045 | Quality of care in bladder cancer: trends in urinary diversion following radical cystectomy |
Q40784057 | Quality of life after radical cystectomy and orthotopic bladder substitution: a comparison between Italian and Swedish men. |
Q37151228 | Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study |
Q41674534 | Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch |
Q37601666 | Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion--a prospective cohort study with a systematic review of literature |
Q100694851 | Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study |
Q44947181 | Quality of life and overall survival in high risk patients after radical cystectomy with a simple urinary derivation |
Q100389356 | Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion |
Q41602376 | Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch. |
Q35853658 | Quality-of-life outcomes and unmet needs between ileal conduit and orthotopic ileal neobladder after radical cystectomy in a Chinese population: a 2-to-1 matched-pair analysis |
Q93228493 | Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer |
Q76748740 | RADICAL CYSTECTOMY AFTER SUPERVOLTAGE RADIOTHERAPY |
Q45085092 | RETRACTED: Modified U-shaped ileal neobladder after radical cystectomy: assessment of functional outcomes and complications in Chinese patients |
Q91112369 | Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis |
Q92404631 | Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT) |
Q34528679 | Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy |
Q104491416 | Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study |
Q39195419 | Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis |
Q38588919 | Radical Cystectomy Perioperative Care Redesign. |
Q46628912 | Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics |
Q38129878 | Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy. |
Q38788023 | Radical Cystectomy and Cutaneous Ureterostomy in 4 Dogs with Trigonal Transitional Cell Carcinoma: Description of Technique and Case Series |
Q96138552 | Radical Cystectomy and Ileal Conduit Diversion for Bladder Urothelial Carcinoma With Sarcomatoid and Squamous Variants After Renal Transplantation |
Q97881648 | Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis |
Q53107639 | Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer. |
Q42010264 | Radical Cystectomy for Bladder Cancer |
Q41613018 | Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications. |
Q51148960 | Radical Cystectomy for Bladder Cancer in the 70+ Population: A Nation-Wide Registry Analysis of 845 Patients |
Q66910292 | Radical Cystectomy for Carcinoma of the Bladder: 16 Years of Experience |
Q82497905 | Radical Cystectomy for Transitional Cell Carcinoma with Orthotopic Neobladder in Renal Transplant Recipients: Surgical Procedure, Functional and Therapeutic Evaluation |
Q91537078 | Radical Cystectomy in Female Patients - Improving Outcomes |
Q91268702 | Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification? |
Q42350219 | Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No. |
Q42350221 | Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes. |
Q41988453 | Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist Device |
Q100993068 | Radical Cystectomy with Ileal Neobladder in a patient with Hemophilia! A case report |
Q40170914 | Radical Cystectomy without Radiation Therapy for Carcinoma of the Bladder |
Q87148076 | Radical Cystectomy-The Waiting is the Hardest Part…or is it? |
Q42787228 | Radical cystectomy |
Q88212949 | Radical cystectomy |
Q68055718 | Radical cystectomy (anterior exenteration) in the female patient |
Q47144768 | Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study |
Q43636096 | Radical cystectomy - open or robot-assisted? |
Q45872273 | Radical cystectomy - robot assisted ileal conduits: 100 cases |
Q83161547 | Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation |
Q72090784 | Radical cystectomy after coronary artery bypass graft |
Q64093375 | Radical cystectomy and W-shaped ileal orthotopic neobladder reconstruction with serosa-lined tunneled ureteroileal anastomoses: A critical analysis of the short-term voiding patterns and urodynamic and functional outcomes |
Q44656851 | Radical cystectomy and adjuvant chemotherapy |
Q41464467 | Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study |
Q34011444 | Radical cystectomy and bladder substitution. |
Q50935694 | Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. |
Q43629085 | Radical cystectomy and ileal conduit for invasive bladder tumour |
Q73306192 | Radical cystectomy and ileal conduit for invasive bladder tumour |
Q44280979 | Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old: morbidity, functional and oncological long-term results |
Q87381548 | Radical cystectomy and ileal orthotopic bladder substitution after radical retropubic prostatectomy: functional and oncological results |
Q69203114 | Radical cystectomy and ileocaecal bladder reconstruction for carcinoma of the urinary bladder. A study of 130 patients |
Q45981738 | Radical cystectomy and lower urinary tract reconstruction after cardiac allograft transplantation. |
Q80029281 | Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard |
Q41862983 | Radical cystectomy and lymphadenectomy to two patients with pelvic kidney: surgical pitfalls and considerations |
Q51171441 | Radical cystectomy and orthotopic bladder replacement in females. |
Q34900101 | Radical cystectomy and orthotopic bladder substitution using ileum |
Q38148941 | Radical cystectomy and orthotopic bladder substitution: surgical tricks and management of complications |
Q37988532 | Radical cystectomy and orthotopic ileal bladder substitution with serous lined extramural ureteral reimplantation--report of 8 cases |
Q46438603 | Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: oncological outcomes. |
Q34202585 | Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique |
Q41962984 | Radical cystectomy and pelvic lymphadenectomy with ileal conduit urinary diversion and abdominal wall reconstruction: an interesting case of multidisciplinary management |
Q91864696 | Radical cystectomy and subsequent ureterohysterostomy in a bitch |
Q37610934 | Radical cystectomy and surgical quality of care |
Q38176436 | Radical cystectomy and the implications of comorbidity |
Q51448218 | Radical cystectomy and urinary diversion in women: impact on sexual function. |
Q88577191 | Radical cystectomy and venous thromboembolism: are we doing enough? |
Q53835137 | Radical cystectomy at Roswell Park Memorial Institute. Preoperative and post operative observations. |
Q104284619 | Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference? A Swedish nationwide analysis |
Q92807586 | Radical cystectomy complications and perioperative mortality |
Q46216660 | Radical cystectomy for BCG failure: has the timing improved in recent years? |
Q84478166 | Radical cystectomy for BCG failure: has the timing improved in recent years? |
Q73499966 | Radical cystectomy for advanced carcinoma of the bladder |
Q74625251 | Radical cystectomy for advanced carcinoma of the bladder |
Q74661052 | Radical cystectomy for advanced carcinoma of the bladder |
Q35070782 | Radical cystectomy for bladder cancer after definitive prostate cancer treatment |
Q43564933 | Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy |
Q44240471 | Radical cystectomy for bladder cancer: 10-year survival |
Q37197485 | Radical cystectomy for bladder cancer: A single center experience. |
Q48723492 | Radical cystectomy for bladder cancer: a qualitative study of patient experiences and implications for practice |
Q82978248 | Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery |
Q37663875 | Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients |
Q36111220 | Radical cystectomy for bladder cancer: the case for early intervention |
Q67872452 | Radical cystectomy for carcinoma of bilharzial bladder. Technique and results |
Q70474334 | Radical cystectomy for carcinoma of the bilharzial bladder |
Q67455041 | Radical cystectomy for carcinoma of the bladder |
Q69068991 | Radical cystectomy for carcinoma of the bladder in the elderly patient |
Q46599382 | Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later |
Q73512849 | Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases |
Q44209236 | Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes? |
Q46255975 | Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients |
Q71067351 | Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction |
Q45163433 | Radical cystectomy for historical and pathologic T1, N0, M0 (stage A) transitional cell cancer. Need for adjuvant systemic chemotherapy? |
Q74034991 | Radical cystectomy for invasive bladder cancer in the octogenarian |
Q77536720 | Radical cystectomy for invasive bladder cancer--a local experience |
Q33968539 | Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies |
Q46470892 | Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure |
Q50153553 | Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis |
Q72629059 | Radical cystectomy for invasive squamous cell bladder cancer in a renal transplant patient |
Q68746191 | Radical cystectomy for invasive tumors of the bladder in patients over 70 years of age |
Q102058471 | Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival |
Q92968881 | Radical cystectomy for management of inflammatory myofibroblastic tumor of the urinary bladder: A rare case report |
Q92055481 | Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results |
Q59649551 | Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study |
Q36771798 | Radical cystectomy for primary bladder malignancy: a 10 year review. |
Q46737967 | Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience |
Q50075582 | Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes |
Q68267087 | Radical cystectomy for residual of recurrent tumour after definitive radiotherapy (salvage cystectomy) |
Q41058919 | Radical cystectomy for stage T3b bladder cancer |
Q54218047 | Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. |
Q35014729 | Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience |
Q44726875 | Radical cystectomy for the treatment of infiltrating bladder carcinoma. Analysis of 15 years |
Q51777769 | Radical cystectomy for transitional cell carcinoma of the bladder. Long-term survival in high risk patients. |
Q36790519 | Radical cystectomy for urothelial cancer of the bladder: contemporary advances. |
Q51356161 | Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. |
Q37516493 | Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome |
Q95837487 | Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder |
Q86855345 | Radical cystectomy in Australia |
Q38170798 | Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series |
Q100297918 | Radical cystectomy in a cohort of octogenarians managed in the ERAS era |
Q68054559 | Radical cystectomy in bladder cancer: mortality and morbidity. A series of 123 cases |
Q53558529 | Radical cystectomy in eldery. |
Q57822536 | Radical cystectomy in frail octogenarians in thoracic continuous spinal anesthesia and analgesia: a pilot study |
Q41486474 | Radical cystectomy in octogenarian patients: a difficult decision to take. |
Q36181060 | Radical cystectomy in octogenarians |
Q37732786 | Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits? |
Q36126900 | Radical cystectomy in patients aged > or = 75 years: an updated review of patients treated with curative and palliative intent. |
Q74237266 | Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality |
Q69729847 | Radical cystectomy in patients over 70 years |
Q82296466 | Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality |
Q56767943 | Radical cystectomy in patients over 80 years old in Quebec: A population-based study of outcomes |
Q37728241 | Radical cystectomy in patients previously treated for localized prostate cancer. |
Q38629461 | Radical cystectomy in patients with disseminated disease: An assessment of perioperative outcomes using the National Surgical Quality Improvement Program database |
Q38054199 | Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis |
Q44455639 | Radical cystectomy in presence of fused "cake" kidney |
Q35150659 | Radical cystectomy in regionally advanced bladder cancer |
Q81556604 | Radical cystectomy in septuagenarian patients with bladder cancer |
Q47109760 | Radical cystectomy in the elderly - Is this a safe treatment option? |
Q54046642 | Radical cystectomy in the elderly patient. |
Q42637271 | Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series |
Q44596927 | Radical cystectomy in the elderly: Comparison of survival between younger and older patients |
Q34420950 | Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients |
Q81170521 | Radical cystectomy in the elderly: comparison of survival between younger and older patients |
Q43445003 | Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care |
Q41640834 | Radical cystectomy in the octogenarian |
Q69787511 | Radical cystectomy in the treatment of advanced bladder cancer |
Q40519150 | Radical cystectomy in the treatment of bladder cancer in Iceland: A population-based study |
Q45620809 | Radical cystectomy in the treatment of bladder cancer: oncological outcome and survival predictors |
Q45967681 | Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. |
Q92737313 | Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes |
Q74322449 | Radical cystectomy is safe in elderly patients at high risk |
Q37378993 | Radical cystectomy is the treatment of choice for invasive bladder cancer |
Q47570039 | Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators |
Q34251619 | Radical cystectomy over the age of 75 is safe and increases survival. |
Q91510218 | Radical cystectomy pentafecta: a proposal for standardisation of outcomes reporting following robot-assisted radical cystectomy |
Q95332008 | Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study |
Q92084645 | Radical cystectomy under continuous antiplatelet therapy with acetylsalicylic acid |
Q71927099 | Radical cystectomy using endoscopic stapling devices: preliminary experience with a simple and reliable technique |
Q74393999 | Radical cystectomy versus alternative treatments for muscle-confined bladder cancer |
Q36959541 | Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. |
Q38454497 | Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials |
Q86101575 | Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: a case-control study |
Q57113693 | Radical cystectomy with W-shaped orthotopic ileal neobladder constructed with non-absorbable titanium staples-long term follow-up |
Q36750597 | Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results |
Q80274621 | Radical cystectomy with extended lymphadenectomy in the presence of a pelvic kidney |
Q40242869 | Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer |
Q30440856 | Radical cystectomy with ileal conduit diversion: early prospective evaluation of the impact of robotic assistance |
Q67953333 | Radical cystectomy with ileocystoplasty: 30 year experience |
Q71917567 | Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement |
Q43567449 | Radical cystectomy with or without planned preoperative irradiation in the treatment of bladder cancer |
Q67239428 | Radical cystectomy with or without prior irradiation in the treatment of bladder cancer |
Q67587967 | Radical cystectomy with or without prior irradiation in the treatment of bladder cancer |
Q35192404 | Radical cystectomy with or without urethrectomy? |
Q27693214 | Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results |
Q37836461 | Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results |
Q37997967 | Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy |
Q37037025 | Radical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian cohort |
Q70038526 | Radical cystectomy with preservation of sexual and urinary function. Use of the ileocolonic pouch ("Le Bag") |
Q80241026 | Radical cystectomy with preservation of sexual function and fertility in patients with transitional cell carcinoma of the bladder: new technique |
Q81473852 | Radical cystectomy with preservation of sexual function and urinary continence: description of a new technique |
Q79165179 | Radical cystectomy with sparing partial prostate for invasive bladder cancer |
Q46344162 | Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes. |
Q80274675 | Radical cystectomy with ultrasound-guided partial prostatectomy for bladder cancer: a complication-preventing concept |
Q70599603 | Radical cystectomy without preoperative radiotherapy for invasive bladder carcinoma--a justified approach? |
Q87616049 | Radical cystectomy, hysterectomy with double adnexectomy and bilateral nephroureterectomy with transvaginal extraction |
Q70892443 | Radical cystectomy--cornerstone or millstone? |
Q68535354 | Radical cystectomy--often too late? |
Q79446071 | Radical cystectomy--often too late? 1987 |
Q80204448 | Radical cystectomy--often too late? Yes, but ... |
Q102155587 | Radical cystectomy-what is the optimal surgical approach? |
Q85038291 | Radical cystectomy: Analysis of postoperative course |
Q37008763 | Radical cystectomy: defining the threshold for a surgeon to achieve optimum outcomes. |
Q30240141 | Radical cystectomy: do we need standardization? |
Q77562187 | Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall |
Q87294225 | Radical cystectomy: how do blood transfusions affect oncological outcomes? |
Q47897931 | Radical cystectomy: minimizing operative blood loss with a "stapling technique". |
Q46141349 | Radical cystectomy: open vs robotic approach |
Q73103957 | Radical cystectomy: posterior dissection following prior therapy |
Q53759383 | Radical cystectomy: the minimally invasive approach. |
Q46157917 | Radical cystectomy: the potential for cure and reconstruction. |
Q64922439 | Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis. |
Q87519975 | Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group |
Q57138336 | Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes |
Q96439271 | Randomized controlled trial to compare outcomes with and without the enhanced recovery after surgery protocol in patients undergoing radical cystectomy |
Q71697223 | Rapid preoperative bowel preparation for patients undergoing radical cystectomy |
Q99567681 | Rates and Patterns of Recurrences, and Survival Outcomes after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium |
Q88279439 | Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy |
Q91561683 | Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades |
Q71588366 | Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women |
Q98183599 | Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations |
Q97677159 | Re-operation within 30 days of radical cystectomy: Identifying high-risk patients and complications using ACS-NSQIP database |
Q84390153 | Re: Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion |
Q91511889 | Re: 90-Day Complication Rate in Patients Undergoing Radical Cystectomy with Enhanced Recovery Protocol: A Prospective Cohort Study |
Q91368773 | Re: A Prospective Randomized Pilot Study Evaluating an ERAS Protocol versus a Standard Protocol for Patients Treated with Radical Cystectomy and Urinary Diversion for Bladder Cancer |
Q88423933 | Re: A Prospective Randomized Trial of the Effects of Early Enteral Feeding after Radical Cystectomy |
Q83904005 | Re: A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy: P. Pillai, I. McEleavy, M. Gaughan, C. Snowden, I. Nesbitt, G. Durkan, M. John |
Q85015158 | Re: A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy: P. Pillai, I. McEleavy, M. Gaughan, C. Snowden, I. Nesbitt, G. Durkan, M. John |
Q92497699 | Re: Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence following Robot-Assisted Radical Cystectomy |
Q99254544 | Re: Acute Kidney Injury Following Enhanced Recovery After Surgery in Patients Undergoing Radical Cystectomy |
Q53051702 | Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. |
Q91766108 | Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated with Neoadjuvant Chemotherapy |
Q48871104 | Re: Adjuvant Cisplatin-Based Combined Chemotherapy for Lymph Node (LN)-Positive Urothelial Carcinoma of the Bladder (UCB) after Radical Cystectomy (RC): A Retrospective International Study of >1500 Patients |
Q88344554 | Re: Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial |
Q90705579 | Re: Adjuvant Sandwich Chemotherapy plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomy: A Randomized Phase 2 Trial |
Q88331423 | Re: Alvimopan for Recovery of Bowel Function after Radical Cystectomy |
Q87410440 | Re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163 |
Q100750716 | Re: Bansal D, Nayak B, Singh P, Nayyar R, Ramachandran R, Kumar R, et al. Randomized controlled trial to compare outcomes with and without the enhanced recovery after surgery protocol in patients undergoing radical cystectomy. Indian J Urol 2020;36: |
Q84593339 | Re: Beat Roth, Frédéric D. Birkhäuser, Pascal Zehnder, et al. Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.201 |
Q91360409 | Re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71: Can the Pattern of Cancer Recurrence |
Q86955472 | Re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45 |
Q82736998 | Re: Changes in body composition: muscle function and energy expenditure after radical cystectomy |
Q91852493 | Re: Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients |
Q85694309 | Re: Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur urol 2014;66:265-72 |
Q98612621 | Re: Cigarette Smoking is Associated with Adverse Pathological Response and Increased Disease Recurrence amongst Patients with Muscle-Invasive Bladder Cancer Treated with Cisplatin-Based Neoadjuvant Chemotherapy and Radical Cystectomy: A Single-Centr |
Q50069819 | Re: Clinical and Therapeutic Factors Associated with Adverse Pathological Outcomes in Clinically Node-Negative Patients Treated with Neoadjuvant Cisplatin-Based Chemotherapy and Radical Cystectomy |
Q86729886 | Re: Comparing Open Radical Cystectomy and Robot-Assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial |
Q50627178 | Re: Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. |
Q91479642 | Re: Comparing Survival Outcomes and Costs Associated with Radical Cystectomy and Trimodal Therapy for Older Adults with Muscle-Invasive Bladder Cancer |
Q87408715 | Re: Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer |
Q49689188 | Re: Complications and Quality of Life in Elderly Patients with Several Comorbidities Undergoing Cutaneous Ureterostomy with Single Stoma or Ileal Conduit after Radical Cystectomy |
Q88056831 | Re: Complications and Quality of Life in Elderly Patients with Several Comorbidities Undergoing Cutaneous Ureterostomy with Single Stoma or Ileal Conduit after Radical Cystectomy |
Q40904142 | Re: Conditional Survival after Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time |
Q58560094 | Re: Contemporary Use Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy or Bladder-Preservation Therapy for Muscle-Invasive Bladder Cancer |
Q89221507 | Re: Cost-Effectiveness of Neoadjuvant Chemotherapy before Radical Cystectomy for Muscle-Invasive Bladder Cancer |
Q88762890 | Re: Critical Analysis of Early Recurrence After Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT |
Q52850079 | Re: Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT: S. Albisinni, L. Fossion, M. Oderda, O. M. Aboumarzouk, F. Aoun, T. Tokas, V. Varca, R. Sanchez-Salas, X. Cathelineau, P. Chlosta, F. Gabo |
Q53682182 | Re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399–405 |
Q89357145 | Re: Decreased Overall and Bladder Cancer-specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis |
Q91882311 | Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525-3 |
Q87669371 | Re: Does Radical Cystectomy Outperform Other Bladder Preservative Treatments in Elderly Patients with Advanced Bladder Cancer? |
Q91225810 | Re: Effectiveness of Adjuvant Chemotherapy after Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-Invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis |
Q88765572 | Re: Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion during Open Radical Cystectomy |
Q85312691 | Re: Enhanced Recovery Protocol after Radical Cystectomy for Bladder Cancer: S. Daneshmand, H. Ahmadi, A. K. Schuckman, A. P. Mitra, J. Cai, G. Miranda and H. Djaladat J Urol 2014;192:50-56 |
Q99603380 | Re: Epidural Anesthesia May be Associated with Increased Postoperative Complications in the Elderly Population Undergoing Radical Cystectomy: An Analysis from the National Surgical Quality Improvement Project (NSQIP) Database |
Q90158815 | Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery |
Q88228298 | Re: Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin: J. J. Pariser, S. M. Pearce, B. B. Anderson, V. T. Packiam, V. N. Prachand, N. D. Smith and |
Q92410480 | Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial |
Q93108476 | Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial |
Q91852488 | Re: Extended versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial |
Q97891300 | Re: Extended versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder in Patients Undergoing Radical Cystectomy |
Q40904135 | Re: Factors Influencing the Length of Stay after Radical Cystectomy: Implications for Cancer Care and Perioperative Management |
Q90765443 | Re: Frailty as a Predictor of Complications after Radical Cystectomy: A Prospective Study of Various Preoperative Assessments |
Q54223816 | Re: Gender-Specific Differences in Clinicopathologic Outcomes following Radical Cystectomy: An International Multi-Institutional Study of More than 8000 Patients. |
Q57814255 | Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2 |
Q51871235 | Re: Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill. Laparoscopic and robotic-assisted radical cystectomy for bladder cancer: a critical analysis. Eur Urol 2008;54:54-64. |
Q81581687 | Re: Gynecologic-tract sparing extra peritoneal retrograde radical cystectomy with neobladder |
Q53182468 | Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9 |
Q83934161 | Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300- |
Q84635736 | Re: Hassan Abol-Enein, Derya Tilki, Ahmed Mosbah, et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 2011;60:572-7 |
Q104561756 | Re: Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-institutional Randomized Trial Comparing Robot Versus Open Radical Cystectomy |
Q47907317 | Re: Health-Related Quality of Life after Radical Cystectomy and Neobladder Reconstruction in Women: Impact of Voiding and Continence Status |
Q90227583 | Re: Hospitalisation and Readmission Costs after Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter? |
Q89004525 | Re: Hussein et al.: Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-Year Analysis (Urology 2016;97:124-129) |
Q44444077 | Re: Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens |
Q47617093 | Re: Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial |
Q53238196 | Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial. |
Q99588938 | Re: Impact of Adjuvant Chemotherapy in Patients with Adverse Features and Variant Histology at Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder: Does Histologic Subtype Matter? |
Q93108500 | Re: Impact of Adjuvant Chemotherapy in Patients with Adverse Features and Variant Histology at Radical Cystectomy for Muscle-invasive Carcinoma of the Bladder: Does Histologic Subtype Matter? |
Q58560494 | Re: Impact of Body Mass Index on Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion |
Q88759865 | Re: Impact of Suboptimal Neoadjuvant Chemotherapy on Peri-Operative Outcomes and Survival after Robot-Assisted Radical Cystectomy: A Multicentre Multinational Study |
Q40305609 | Re: Impact of Surgeon Volume on the Morbidity and Costs of Radical Cystectomy in the USA: A Contemporary Population-Based Analysis |
Q82237472 | Re: Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program |
Q88011756 | Re: Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study |
Q87804515 | Re: Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy: R. D. da Silva, E. Xylinas, L. Kluth, J. J. Crivelli, J. Chrystal, D. Chade, G. B. Guglielmetti, A. Pycha, Y. Lotan, |
Q92583490 | Re: Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery after Surgery Protocol |
Q90093997 | Re: Incidence and Microbiology of Post-Operative Infections after Radical Cystectomy and Ureteral Stent Removal; A Retrospective Cohort Study |
Q88032755 | Re: Incidence and risk factors for acute kidney injury after radical cystectomy |
Q80450838 | Re: Increased body mass index predicts increased blood loss during radical cystectomy |
Q89936614 | Re: Influence and Impact of Cognitive Trajectories on Outcome in Patients Undergoing Radical Cystectomy: An Observational Study |
Q85404628 | Re: Intermediate-Term Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Urothelial Carcinoma |
Q100996364 | Re: Intra-operative Ureteral Stent Use at Radical Cystectomy is Associated with Higher 30-Day Complications Rates |
Q90744093 | Re: Intracorporeal Robot-Assisted Radical Cystectomy, Together with an Enhanced Recovery Programme, Improves Postoperative Outcomes by Aggregating Marginal Gains |
Q86965746 | Re: Intraoperative Continuous Norepinephrine Infusion Combined with Restrictive Deferred Hydration Significantly Reduces the Need for Blood Transfusion in Patients Undergoing Open Radical Cystectomy: Results of a Prospective Randomised Trial |
Q87669364 | Re: Intraoperative Continuous Norepinephrine Infusion Combined with Restrictive Deferred Hydration Significantly Reduces the Need for Blood Transfusion in Patients Undergoing Open Radical Cystectomy: Results of a Prospective Randomised Trial |
Q87647104 | Re: Jim C. Hu, Bilal Chughtai, Padraic O'Malley, et al. Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study. Eur Urol 2016;70:195-202: Comparative |
Q91758828 | Re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11 |
Q88983397 | Re: Karl H. Pang, Ruth Groves, Suresh Venugopal, Aidan P. Noon, James W.F. Catto. Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. Eur Urol 2018;73:363-71 |
Q83815829 | Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362) |
Q51580661 | Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362). |
Q50946507 | Re: Lambert et al.: Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer (Urology 2013;81:587-592). |
Q79866991 | Re: Laparoscopic-assisted nephroureterectomy after radical cystectomy for transitional cell carcinoma |
Q84704407 | Re: Liberman et al.: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder (Urology 2011;77:660-663) |
Q54197217 | Re: Long-Term Changes in Renal Function Outcomes following Radical Cystectomy and Urinary Diversion. |
Q96582351 | Re: Long-Term Oncological Outcomes from an Early Phase Randomised Controlled Three-Arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL) |
Q86189377 | Re: Long-term renal function outcomes after radical cystectomy |
Q89118644 | Re: Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer |
Q90677167 | Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensiv |
Q94500894 | Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensiv |
Q89205880 | Re: Marc A. Furrer, Adrian Fellmann, Marc P. Schneider, George N. Thalmann, Fiona C. Burkhard, Patrick Y. Wuethrich. Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Out |
Q57989414 | Re: Marital Status: A Gender-independent Risk Factor for Poorer Survival After Radical Cystectomy |
Q62660609 | Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy. Eur Urol 2007;51:699–708 |
Q96826669 | Re: National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging |
Q74486140 | Re: Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach |
Q80115090 | Re: Nomograms provide improved accuracy for predicting survival after radical cystectomy |
Q47795522 | Re: Oncologic Outcomes following Robot-Assisted Radical Cystectomy with Minimum 5-Year Follow-up: The Roswell Park Cancer Institute Experience |
Q43490250 | Re: Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study |
Q74216627 | Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy |
Q53327879 | Re: Pak et al.: Utilization Trends and Short-term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer (Urology 2017;103:117-123) and Borza et al.: No Differences in Population-based Readmissions After Open and Robotic-assisted Cyst |
Q90987691 | Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study |
Q80601685 | Re: Perineural invasion by transitional cell carcinoma of the bladder in patients submitted to radical cystectomy: what is the prognostic value? |
Q86965744 | Re: Perioperative Complications and 90-Day Mortality of Radical Cystectomy in the Elderly (75+): A Retrospective, Multicentre Study |
Q92540471 | Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial |
Q95500015 | Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial |
Q91632539 | Re: Perioperative Outcomes and Complications after Robotic Radical Cystectomy with Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-Head Comparison from a Single-Institutional Prospective Study |
Q91738735 | Re: Population-Based Assessment of Racial/Ethnic Differences in Utilization of Radical Cystectomy for Patients Diagnosed with Bladder Cancer |
Q52990863 | Re: Potential Impact of 18F-FDG PET/CT on Patients Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. |
Q91479564 | Re: Predicting Local Failure after Radical Cystectomy in Patients with Bladder Cancer: Implications for the Selection of Candidates at Adjuvant Radiation Therapy |
Q53836483 | Re: Preoperatively Dilated Ureters are a Specific Risk Factor for the Development of Ureteroenteric Strictures after Open Radical Cystectomy and Ileal Neobladder: R. E. Hautmann, R. de Petriconi, A. Kahlmeyer, M. Enders and B. Volkmer J Urol 2017;19 |
Q90158841 | Re: Prognostic Significance of Lymphatic, Vascular and Perineural Invasion for Bladder Cancer Patients Treated by Radical Cystectomy |
Q49899429 | Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic |
Q49963356 | Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic |
Q54301217 | Re: Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy. |
Q49609002 | Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study. |
Q44681312 | Re: Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis |
Q91991749 | Re: Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy |
Q50644656 | Re: Recurrence Patterns after Open and Robot-Assisted Radical Cystectomy for Bladder Cancer. |
Q90585308 | Re: Retrosigmoid versus Traditional Ileal Conduit for Urinary Diversion after Radical Cystectomy |
Q84460141 | Re: Richard E. Hautmann, Oliver Hautmann, Börn G. Volkmer, Stefan Hautmann. Nerve-sparing radical cystectomy: a new technique. Eur Urol Suppl 2010;9:428-432 |
Q87156089 | Re: Risk of fracture after radical cystectomy and urinary diversion for bladder cancer |
Q91112266 | Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial |
Q91140162 | Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial |
Q88885385 | Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer |
Q45839944 | Re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 20 |
Q60622175 | Re: Sarcopenia as a Predictor of Complications and Survival Following Radical Cystectomy |
Q54157886 | Re: Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality after Radical Cystectomy. |
Q84590651 | Re: Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. M. K. Tollefson, M. L. Blute, S. A. Farmer and I. Frank J Urol 2010; 183: 81-86 |
Q97891448 | Re: Spillover Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions |
Q45799889 | Re: Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy |
Q98498258 | Re: Stephen B. Williams, Marcus G.K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur |
Q98612623 | Re: Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial |
Q49012358 | Re: Syed Johar Raza, Timothy Wilson, James O. Peabody, et al. Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Eur Urol 2015;68:721-8. |
Q91088757 | Re: Ten-Year Oncologic Outcomes following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium |
Q54296398 | Re: The Association of ABO Blood Type with Disease Recurrence and Mortality among Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. |
Q58563675 | Re: The Cancer of the Bladder Risk Assessment (COBRA) Score: Estimating Mortality after Radical Cystectomy |
Q88036397 | Re: The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes following Radical Cystectomy for Urothelial Cancer |
Q40408296 | Re: The Effect of Broader, Directed Antimicrobial Prophylaxis Including Fungal Coverage on Perioperative Infectious Complications after Radical Cystectomy |
Q42102119 | Re: The Effect of Broader, Directed Antimicrobial Prophylaxis Including Fungal Coverage on Perioperative Infectious Complications after Radical Cystectomy |
Q90158858 | Re: The Feasibility and Safety of Reproductive Organ Preserving Radical Cystectomy for Elderly Female Patients with Muscle-Invasive Bladder Cancer: A Retrospective Propensity Score-Matched Study |
Q90390056 | Re: The Impact of Non-Urothelial Variant Histology on Oncological Outcomes following Radical Cystectomy |
Q53804106 | Re: The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. |
Q88036718 | Re: The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis: C. R. Haas, L. J. Barlow, G. M. Badalato, G. J. DeCastro, M. C. Benson and J. M. McKiernan J Urol 2016;195:1704-1709 |
Q70386084 | Re: The effect of nutritional status and support on morbidity and mortality of bladder cancer patients treated by radical cystectomy |
Q35993984 | Re: The feasibility of radical cystectomy in elderly patients |
Q68080591 | Re: The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2) |
Q68045487 | Re: The role of radical cystectomy in the management of high grade superficial bladder cancer (Pa, P1, PIS and P2) |
Q80983644 | Re: The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy |
Q94551280 | Re: The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy |
Q84114684 | Re: The z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients |
Q51112258 | Re: Udo Nagele, Markus Kuczyk, Aristotelis G. Anastasiadis, Karl-Dietrich Sievert, Jörg Seibold and Arnulf Stenzl. Radical cystectomy and orthotopic bladder replacement in females, Eur Urol 2006;50:249-257. |
Q44407622 | Re: Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients: S. Picozzi, C. Ricci, M. Gaeta, D. Ratti, A. Macchi, S. Casellato, G. Bozzini and L. Carmignani. J Urol 2012; 188: 2046-2054. |
Q46410356 | Re: Ureteroenteric anastomotic strictures after radical cystectomy--does operative approach matter?: C. B. Anderson, T. M. Morgan, S. Kappa, D. Moore, P. E. Clark, R. Davis, D. F. Penson, D. A. Barocas, J. A. Smith, Jr., M. S. Cookson and S. S. Chan |
Q91086942 | Re: Urinary Tract Infections following Radical Cystectomy and Urinary Diversion: A Review of 1133 Patients |
Q88331425 | Re: Use of Adjuvant Chemotherapy in Radical Cystectomy Patients Aged >65 Years: A Population-Based Study from the Surveillance Epidemiology and End Results (SEER)-Medicare Database |
Q89777397 | Re: Use of Indocyanine Green to Minimise Uretero-Enteric Strictures after Robotic Radical Cystectomy |
Q89944686 | Re: Utility and Significance of Ureteric Frozen Section Analysis during Radical Cystectomy |
Q101057842 | Re: Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy |
Q83213309 | Re: bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer |
Q46440068 | Re: does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis |
Q45148808 | Re: effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer |
Q86554623 | Re: impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy: R. D. Da silva, e. Xylinas, L. Kluth, j. J. Crivelli, j. Chrystal, d. Chade, g. B. Guglielmetti, a. Pycha, y. Lotan, |
Q54356244 | Re: incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy. |
Q81634484 | Re: laparoscopic assisted radical cystectomy with ileal neobladder: a comparison with the open approach |
Q33369466 | Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. |
Q46598773 | Re: orthotopic detaenial sigmoid neobladder after radical cystectomy: technical considerations, complications and functional outcomes: K. Xu, C-X Liu, S-B. Zheng, H-L. Li, Y-W. Xu, A-B. Xu, B-S. Chen and H-Y. Shen J Urol 2013; 190: 928–934. |
Q73477354 | Re: orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique |
Q93929960 | Re: orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique |
Q50880699 | Re: outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience. |
Q86548598 | Re: outcomes of laparoscopic and robotic radical cystectomy in the elderly patients |
Q77493823 | Re: pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy |
Q45025917 | Re: perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy: D. J. Parekh, J. Messer, J. Fitzgerald. B. Ercole and R. Svatek J Urol 2013; 189: 474-479. |
Q80548339 | Re: radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1 and carcinoma in situ: defining the risk of initial bladder preservation |
Q85891200 | Re: radical cystectomy over the age of 75 is safe and increases survival |
Q80874731 | Re: results from three municipal hospitals regarding radical cystectomy on elderly patients |
Q85674193 | Re: robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years |
Q80066490 | Re: superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy |
Q83213314 | Re: surgery-related complications of robot-assisted radical cystectomy with intracorporeal urinary diversion |
Q46043466 | Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"? |
Q40070821 | Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol |
Q35606282 | Readmission after robot-assisted radical cystectomy: outcomes and predictors at 90-day follow-up |
Q64078508 | Real-time indocyanine green angiography with the SPY fluorescence imaging platform decreases benign ureteroenteric strictures in urinary diversions performed during radical cystectomy |
Q58577856 | Real-world Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending |
Q92590307 | Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy |
Q90596570 | Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive? |
Q37822392 | Recent advances in robot-assisted radical cystectomy |
Q51093644 | Reconstructed urinary bladder following radical cystectomy for bladder cancer. Multidetector CT evaluation of normal findings and complications. |
Q73328602 | Reconstruction of the urinary tract after radical cystectomy: the case for continent urinary diversion |
Q46357687 | Recoverability of erectile function in post-radical cystectomy patients: subjective and objective evaluations |
Q90946686 | Recovery from Anesthesia after Robotic-Assisted Radical Cystectomy: Two Different Reversals of Neuromuscular Blockade |
Q41837132 | Recurrence of inflammatory myofibroblastic tumor in bladder secondary to prostate treated with laparoscopic radical cystectomy |
Q36505102 | Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. |
Q84797637 | Recurrence patterns of bladder transitional cell carcinoma after radical cystectomy |
Q80404934 | Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection |
Q91646335 | Recurrent Anterior Vaginal Wall Hernia after a Radical Cystectomy |
Q38913953 | Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era. |
Q41457027 | Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol |
Q47567960 | Reducing Overutilization of Preoperative Medical Referrals among Patients Undergoing Radical Cystectomy Using an Evidence-Based Algorithm |
Q91766578 | Reducing Readmissions following Radical Cystectomy: Moving Beyond Enhanced Recovery |
Q86821420 | Reducing readmissions and mortality after radical cystectomy |
Q35556030 | Reducing time to oral diet and hospital discharge in patients undergoing radical cystectomy using a perioperative care plan |
Q30408866 | Refining patient selection for neoadjuvant chemotherapy before radical cystectomy |
Q94940583 | Reframing financial incentives around reducing readmission after radical cystectomy |
Q37342899 | Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal healthcare system |
Q35056471 | Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy |
Q84220476 | Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy |
Q40241451 | Regionalization of radical cystectomy in the United States |
Q53152401 | Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy. |
Q99233208 | Relentlessly make yourself obsolete: Robot-assisted radical cystectomy, the emerging standard of care |
Q79707639 | Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study |
Q84570708 | Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology |
Q100504452 | Renal function outcomes in the early and intermediate phases after radical cystectomy by ileal conduit |
Q40146286 | Renal outcome after radical cystectomy and urinary diversion performed with restrictive hydration and vasopressor administration in the frame of an enhanced recovery program: A follow-up study of a randomized clinical trial |
Q40341466 | Reoperations following Robot-Assisted Radical Cystectomy: A Decade of Experience |
Q62626323 | Reply from Authors re: Bernard H. Bochner. Oncologic Outcomes Achieved by Radical Cystectomy. Eur Urol 2013;64:225–6 |
Q88215052 | Reply from Authors re: Girish S. Kulkarni, Zachary Klaassen. Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? Eur Urol 2017;72:488-9: Using |
Q51241301 | Reply from authors re: Manfred P. Wirth, Johannes Huber. What really matters is rarely measured: outcome of routine care and patient-reported outcomes. Eur Urol 2013;64:58-9: robot-assisted versus open radical cystectomy: beating a dead horse. |
Q85622314 | Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Uro |
Q57296883 | Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2 |
Q97642060 | Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol. In press: |
Q94587653 | Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of |
Q98664340 | Reply to Gianluca Giannarini, Vincenzo Ficarra, and Claudio Valotto's Letter to the Editor re: Stephen B. Williams, Marcus G.K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery |
Q90677173 | Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for S |
Q88983390 | Reply to Mark C. Kendall's Letter to the Editor re: Karl H. Pang, Ruth Groves, Suresh Venugopal, Aidan P. Noon, James W.F. Catto. Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. Eur Urol 2018;73:363-71 |
Q86120921 | Reply to Michael A. Gorin, Arthur I. Sagalowsky and Mark S. Soloway's Letter to the Editor re: S. Picozzi, C. Ricci, M. Gaeta et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. |
Q45839588 | Reply to Samuel Bishara and Jim Adshead's letter to the editor re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:8 |
Q85751063 | Reply to Santosh Kumar and Aditya Prakash Sharma's letter to the editor re: Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled tr |
Q91768801 | Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy |
Q91321972 | Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Ou |
Q87405119 | Reply to Vladimir Novotny, Manfred P. Wirth, Michael Froehner's letter to the editor re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder canc |
Q87416749 | Reply to external validation of a model to predict local failure after radical cystectomy |
Q99254540 | Reply to the Letter to the Editor: Acute Kidney Injury Following Enhanced Recovery After Surgery in Patients Undergoing Radical Cystectomy |
Q91516887 | Reported rates of clostridium difficile following radical cystectomy in national datasets compared to individual institutions |
Q36080543 | Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis |
Q97093026 | Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis |
Q46214248 | Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer |
Q90264598 | Requiem for Open Radical Cystectomy in Bladder Cancer Patients |
Q84067812 | Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer |
Q42117852 | Resolution of hypercalcemia of malignancy following radical cystectomy in a patient with paraneoplastic syndrome associated with urothelial carcinoma of the bladder |
Q85939914 | Response letter to "What can be more prognostic than the pTNM category assessed in radical cystectomy samples?" by Sükösd F, Ivanyi B and Pajor L |
Q46468853 | Response to Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status. |
Q88180013 | Response to Re: Incidence and risk factors for acute kidney injury after radical cystectomy |
Q89930581 | Response to Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer |
Q43283539 | Response to adjuvant chemotherapy after radical cystectomy in patients with infiltrative bladder: Analysis of 397 cases |
Q87222107 | Response to article - Mohanty NK, Kumar A, Vasudeva P, Jain M, Prakash S, Arora RP. Analysis of the perioperative and five-year oncological outcome of two hundred cases of open radical cystectomy: A single center experience. Indian J Cancer 2012;49 |
Q47987489 | Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial |
Q39286593 | Restrictive transfusion in radical cystectomy is safe |
Q52920923 | Results from three municipal hospitals regarding radical cystectomy on elderly patients. |
Q68175047 | Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification |
Q71613004 | Results of radical cystectomy and pelvic lymphadenectomy for bladder cancer with pelvic node metastases |
Q43468531 | Results of radical cystectomy for primary bladder cancer. Retrospective study of more than 200 cases |
Q72313742 | Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy |
Q95812238 | Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer |
Q54301197 | Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer. |
Q97093358 | Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy |
Q92683183 | Retraction notice to "Modified U-shaped ileal neobladder after radical cystectomy: assessment of functional outcomes and complications in Chinese patients" |
Q83437853 | Retraction to: "Outcome of anterior vaginal wall sparing during female radical cystectomy with orthotopic urinary diversion." [ European Journal of Surgical Oncology 34 (2008) 115-121] |
Q41302704 | Retro-ureteral Small Bowel Herniation After Radical Cystectomy |
Q43213489 | Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study |
Q57113884 | Retroperitoneal hernia following radical cystectomy: case report |
Q90849438 | Retrosigmoid Versus Traditional Ileal Conduit for Urinary Diversion After Radical Cystectomy |
Q43988678 | Retrospective analysis of 246 patients after radical cystectomy for treatment of bladder cancer without preoperative radiotherapy |
Q38833958 | Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia |
Q53101669 | Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer. |
Q34551328 | Retrospective review and long-term follow-up of radical cystectomy in a developing country |
Q39812629 | Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy |
Q36069231 | Risk Factors for Developing Metabolic Acidosis after Radical Cystectomy and Ileal Neobladder |
Q98733933 | Risk Factors for Urethral Recurrence in Men After Radical Cystectomy with Orthotopic Urinary Diversion for Urothelial Carcinoma: A Retrospective Cohort Study |
Q39739690 | Risk assessment for occult malignancy in the prostate before radical cystectomy |
Q92137751 | Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study |
Q101117279 | Risk factors and outcomes of myocardial injury after non-cardiac surgery in high-risk patients who underwent radical cystectomy |
Q84838427 | Risk factors and outcomes of urethral recurrence following radical cystectomy |
Q91421670 | Risk factors and reasons for reoperation after radical cystectomy |
Q40537604 | Risk factors and timing of venous thromboembolism after radical cystectomy in routine clinical practice: a population-based study |
Q82536968 | Risk factors for disconcordance between pre and post radical cystectomy stages |
Q36914875 | Risk factors for infectious readmissions following radical cystectomy: results from a prospective multicenter dataset |
Q57175147 | Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy |
Q43693664 | Risk factors for mortality and morbidity related to radical cystectomy |
Q40582570 | Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density |
Q37770477 | Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer. |
Q43485665 | Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure |
Q34143388 | Risk factors for the development of parastomal hernia after radical cystectomy. |
Q41473578 | Risk factors for the development of postoperative paralytic ileus after radical cystectomy: a report of 740 cases |
Q92262374 | Risk factors of calculi in upper urinary tract after radical cystectomy with urinary diversion |
Q53840977 | Risk factors of hospital readmission after radical cystectomy and urinary diversion: analysis of a large contemporary series. |
Q36600514 | Risk factors of postoperative complications after radical cystectomy with continent or conduit urinary diversion in Armenia. |
Q90425946 | Risk factors of postoperative major adverse cardiac events after radical cystectomy: implication of diastolic dysfunction |
Q74511712 | Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females |
Q49200956 | Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients |
Q41049731 | Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: Analysis of a contemporary series |
Q36575727 | Risk groups in bladder cancer patients treated with radical cystectomy |
Q81170454 | Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity |
Q57806040 | Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer |
Q52373193 | Risk of Readmission After Uncomplicated Hospitalization After Radical Cystectomy. |
Q53379340 | Risk of end stage kidney disease after radical cystectomy according to urinary diversion type. |
Q34260524 | Risk of fracture after radical cystectomy and urinary diversion for bladder cancer |
Q37604328 | Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients |
Q71278134 | Risk of local urethral recurrence after radical cystectomy for bladder cancer |
Q41467216 | Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center |
Q87409228 | Risk prediction models of locoregional failure after radical cystectomy for urothelial carcinoma: external validation in a cohort of korean patients |
Q41462223 | Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder |
Q83001143 | Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers |
Q36419132 | Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling |
Q84904080 | Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy |
Q42371550 | Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer |
Q47993535 | Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder. |
Q42681722 | Robot Assisted Extended Pelvic Lymphadenectomy at Radical Cystectomy: Lymph Node Yield Compared With Second Look Open Dissection |
Q102381356 | Robot Assisted Radical Cystectomy Outcomes in Micropapillary and Plasmacytoid Variants |
Q90129682 | Robot Assisted Radical Cystectomy vs Open Radical Cystectomy: Over 10 years of the Mayo Clinic Experience |
Q37720922 | Robot assisted laparoscopic pelvic lymphadenectomy at the time of radical cystectomy rivals that of open surgery: single institution report. |
Q56515977 | Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study |
Q47434693 | Robot assisted radical cystectomy with totally intracorporeal urinary diversion: initial, single-surgeon's experience after a modified modular training |
Q89836209 | Robot-Assisted Radical Cystectomy With Orthotopic Neobladder as a Urinary Diversion for a Kidney Transplant Recipient: A Case Report |
Q39969196 | Robot-Assisted Radical Cystectomy for Bladder Cancer in Octogenarians |
Q88724797 | Robot-Assisted Radical Cystectomy in Men: Technique of Spaces |
Q56200815 | Robot-Assisted Radical Cystectomy in the Management of Bladder Cancer |
Q100994583 | Robot-Assisted Radical Cystectomy with Intracorporeal Ileal Conduit in a Patient with Situs Inversus Totalis |
Q91629955 | Robot-Assisted Radical Cystectomy with Intracorporeal Orthotopic Ileal Neobladder: A Safe Strategy in Elderly Patients? Results of Propensity Score Matching in a Single High-Volume Center |
Q53169212 | Robot-Assisted Radical Cystectomy with Total Intracorporeal Urinary Diversion: Comparative Analysis with Extracorporeal Urinary Diversion. |
Q92322043 | Robot-assisted Laparoscopic Radical Cystectomy and Sigmoid Orthotopic Neobladder Reconstruction for a Bladder Rhabdomyosarcoma Child: Case Report and Literature Review |
Q91661391 | Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes |
Q38654974 | Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study. |
Q94664641 | Robot-assisted intracorporeal orthotopic bladder substitution after radical cystectomy: perioperative morbidity and oncological outcomes - a single institution experience |
Q47219662 | Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience |
Q53021942 | Robot-assisted laparoscopic radical cystectomy with complete intracorporeal urinary diversion. |
Q52564790 | Robot-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: Initial experience and outcomes. |
Q34585914 | Robot-assisted laparoscopic radical cystectomy: initial experience on 27 consecutive patients. |
Q42606731 | Robot-assisted laparoscopic vs open radical cystectomy: comparison of complications and perioperative oncological outcomes in 200 patients |
Q43849212 | Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases |
Q38574487 | Robot-assisted radical cystectomy |
Q47332507 | Robot-assisted radical cystectomy |
Q42619214 | Robot-assisted radical cystectomy (RARC) with intracorporeal neobladder - what is the effect of the learning curve on outcomes? |
Q55019389 | Robot-assisted radical cystectomy - first Polish clinical outcomes. |
Q35078670 | Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure |
Q92587654 | Robot-assisted radical cystectomy and intracorporeal orthotopic neobladder: 1-year functional outcomes |
Q35533840 | Robot-assisted radical cystectomy and intracorporeal urinary diversion - safe and reproducible? |
Q42675199 | Robot-assisted radical cystectomy and pelvic lymph node dissection: a multi-institutional study from Korea. |
Q42615500 | Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute |
Q36046114 | Robot-assisted radical cystectomy and urinary diversion |
Q40528398 | Robot-assisted radical cystectomy and urinary diversion in female patients: technique with preservation of the uterus and vagina |
Q38321027 | Robot-assisted radical cystectomy and urinary diversion: technical recommendations from the Pasadena Consensus Panel. |
Q99726192 | Robot-assisted radical cystectomy for non-metastatic urothelial carcinoma of urinary bladder: a comparison between intracorporeal versus extracorporeal orthotopic ileal neobladder |
Q98191278 | Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer |
Q38145512 | Robot-assisted radical cystectomy in octogenarians |
Q51910797 | Robot-assisted radical cystectomy in the management of bladder cancer. |
Q37140925 | Robot-assisted radical cystectomy in women: technique and initial experience |
Q40081077 | Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians |
Q53620801 | Robot-assisted radical cystectomy using a side-docking technique. |
Q56355790 | Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial |
Q37814637 | Robot-assisted radical cystectomy versus open radical cystectomy: a complete cost analysis |
Q42641091 | Robot-assisted radical cystectomy versus open radical cystectomy: assessment of postoperative pain. |
Q33995446 | Robot-assisted radical cystectomy with intracorporeal neobladder diversion: The Karolinska experience |
Q100441375 | Robot-assisted radical cystectomy with intracorporeal neobladder: impact of learning curve and long-term assessment of functional outcomes |
Q91117162 | Robot-assisted radical cystectomy with intracorporeal urinary diversion - The new 'gold standard'? Evidence from a systematic review |
Q94957457 | Robot-assisted radical cystectomy with intracorporeal urinary diversion decreases postoperative complications only in highly comorbid patients: findings that rely on a standardized methodology recommended by the European Association of Urology Guide |
Q51424718 | Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder. |
Q56516396 | Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study |
Q40974706 | Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol |
Q92261010 | Robot-assisted radical cystectomy with totally intracorporeal urinary diversion: surgical and early functional outcomes through the learning curve in a single high-volume center |
Q92936653 | Robot-assisted radical cystectomy: Review of surgical technique, and perioperative, oncological and functional outcomes |
Q37703837 | Robot-assisted radical cystectomy: an expert panel review of the current status and future direction |
Q45360321 | Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy. |
Q46986868 | Robot-assisted radical cystectomy: extracorporeal vs intracorporeal urinary diversion |
Q42639213 | Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months |
Q91273768 | Robot-assisted radical cystectomy: patient selection and special considerations |
Q37675823 | Robot-assisted radical cystectomy: recent advances and review of the literature |
Q36184429 | Robotic Assisted Radical Cystectomy with Extracorporeal Urinary Diversion Does Not Show a Benefit over Open Radical Cystectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials |
Q103834156 | Robotic Radical Cystectomy Outcomes after Intervention for Prostate Cancer |
Q102219066 | Robotic Radical Cystectomy in the Contemporary Management of Bladder Cancer |
Q92155449 | Robotic Radical Cystectomy with Intracorporeal Studer Pouch Formation for Bladder Cancer: Experience in Ninety-Eight Cases |
Q48059548 | Robotic and conventional open radical cystectomy lead to similar postoperative health-related quality of life |
Q42622597 | Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes |
Q51165953 | Robotic and laparoscopic radical cystectomy for bladder cancer: long-term oncologic outcomes. |
Q33396587 | Robotic and laparoscopic radical cystectomy in the management of bladder cancer |
Q50960510 | Robotic assisted laparoscopic radical cystectomy with stentless intracorporeal modified Ves.Pa neobladder: early experience. |
Q51354888 | Robotic assisted radical cystectomy and urinary diversion. |
Q89639824 | Robotic assisted radical cystectomy: insights on long term oncological outcomes from the International Robotic Cystectomy Consortium |
Q38029495 | Robotic assisted radical cystectomy: oncological safety. |
Q51856416 | Robotic assisted radical cystectomy: short to medium-term oncologic and functional outcomes. |
Q42671810 | Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients |
Q45937288 | Robotic laparoscopic radical cystectomy inhalational versus total intravenous anesthesia: a pilot study. |
Q38226919 | Robotic or open radical cystectomy, which is safer? A systematic review and meta-analysis of comparative studies. |
Q33290630 | Robotic radical cystectomy |
Q92840598 | Robotic radical cystectomy |
Q53756053 | Robotic radical cystectomy - revision and resection: An evolution in operative technique and platforms. |
Q50684312 | Robotic radical cystectomy and enhanced recovery: a new pathway. |
Q33995439 | Robotic radical cystectomy and intracorporeal urinary diversion: The USC technique |
Q34357563 | Robotic radical cystectomy and urinary diversion in the management of bladder cancer. |
Q51786277 | Robotic radical cystectomy for bladder cancer. |
Q51598049 | Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. |
Q55427608 | Robotic radical cystectomy for the management of bladder cancer: Analysis of operative and pathological outcomes of eighteen patient. |
Q41113235 | Robotic radical cystectomy with intracorporeal neobladder: Initial experience and outcomes |
Q46218333 | Robotic radical cystectomy with intracorporeal neobladder: ready for prime time? |
Q95262016 | Robotic radical cystectomy with intracorporeal urinary diversion: beyond the initial experience |
Q46692973 | Robotic radical cystectomy--is the diversion the Achilles' heel? |
Q56928487 | Robotic radical cystectomy: Medium-term oncologic follow-up |
Q47826370 | Robotic radical cystectomy: intracorporeal versus extracorporeal versus orthotopic neobladder-Which is better? |
Q46002326 | Robotic radical cystectomy: so far, so good--what next? |
Q87004663 | Robotic radical cystectomy: technical tips and tricks |
Q51631256 | Robotic radical cystectomy: where are we today, where will we be tomorrow? |
Q24186826 | Robotic versus open radical cystectomy for bladder cancer in adults |
Q91915467 | Robotic versus open radical cystectomy for bladder cancer in adults |
Q67404550 | Robotic versus open radical cystectomy for bladder cancer in adults. |
Q91264184 | Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study |
Q27014781 | Robotic versus open radical cystectomy: an updated systematic review and meta-analysis |
Q42658635 | Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach |
Q42648156 | Robotic versus open radical cystectomy: prospective comparison of perioperative and pathologic outcomes in Japan |
Q34691842 | Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. |
Q35157819 | Robotic vs. open radical cystectomy in bladder cancer: A systematic review and meta-analysis |
Q26782249 | Robotic-Assisted Radical Cystectomy |
Q51833362 | Robotic-assisted laparoscopic radical cystectomy and intra-abdominal formation of an orthotopic ileal neobladder. |
Q47572626 | Robotic-assisted laparoscopic radical cystectomy in the octogenarian |
Q51888164 | Robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience. |
Q38091333 | Robotic-assisted laparoscopic radical cystectomy: history, techniques and outcomes |
Q51327471 | Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes. |
Q51852836 | Robotic-assisted laparoscopic radical cystectomy: where do we stand? |
Q37252123 | Robotic-assisted radical cystectomy |
Q51683099 | Robotic-assisted radical cystectomy and orthotopic ileal neobladder using a modified Pfannenstiel incision. |
Q38666683 | Robotic-assisted radical cystectomy versus open radical cystectomy for management of bladder cancer: review of literature and randomized trials |
Q57471720 | Robotic-assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis |
Q44893721 | Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years |
Q47743164 | Robotic-assisted radical cystectomy with intracorporeal urinary diversion versus open: early Australian experience. |
Q99553026 | Robotic-assisted radical cystectomy with intracorporeal urinary diversion: A new standard of urinary diversion? |
Q38030591 | Robotic-assisted radical cystectomy: current technique and outcomes |
Q89460162 | Robotic-assisted radical cystectomy: the first multicentric Brazilian experience |
Q48192956 | Robotic-assisted versus open radical cystectomy in bladder cancer: A meta-analysis of four randomized controlled trails. |
Q51889307 | Robotically assisted radical cystectomy. |
Q37983515 | Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer |
Q49420756 | Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review |
Q64235301 | Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials |
Q88557874 | Role of bowel suspension technique to prevent early intestinal obstruction after radical cystectomy with ileal orthotopic neobladder: A retrospective cohort study |
Q38059257 | Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection |
Q44472637 | Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study |
Q96606523 | Role of lymph node dissection in radical cystectomy |
Q87904051 | Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer |
Q86177739 | Role of ultrasound in management of long-term complications after to radical cystectomy and orthotopic neobladder construction: case report |
Q40336022 | Root Causes and Modifiability of 30-Day Hospital Readmissions after Radical Cystectomy for Bladder Cancer. |
Q74471151 | Rotundovaginopexy in orthotopic ileal neobladder following radical cystectomy in women |
Q103035641 | Round ligament suspending treatment in orthotopic ileal-neobladder after radical cystectomy in women: A single centre prospective randomized trial |
Q44784583 | Routine postoperative intensive care monitoring is not necessary after radical cystectomy |
Q73589208 | Routine stentograms are not necessary before stent removal following radical cystectomy |
Q46026810 | Routine use of nasogastric tubes after radical cystectomy. |
Q104482334 | Rural Medicare patients less likely to undergo penile prosthesis implantation following radical cystectomy |
Q33909943 | STOP smoking and alcohol drinking before OPeration for bladder cancer (the STOP-OP study), perioperative smoking and alcohol cessation intervention in relation to radical cystectomy: study protocol for a randomised controlled trial |
Q51826346 | Safety and Effectiveness of Robot-Assisted Versus Open Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. |
Q38107986 | Safety and feasibility of laparoscopic radical cystectomy for the treatment of bladder cancer |
Q92026654 | Safety of decreasing ureteral stent duration following radical cystectomy |
Q90783618 | Sanctuary Testicular Bladder Cancer Metastasis 10 Years After Radical Cystectomy and Adjuvant Chemotherapy |
Q51434666 | Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy. |
Q55343308 | Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer. |
Q44125461 | Sarcopenia as a predictor of complications and survival following radical cystectomy |
Q60622176 | Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality |
Q61454769 | Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer |
Q57210275 | Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer |
Q96342183 | Sarcopenia predicts prognosis of bladder cancer patients after radical cystectomy: A study based on the Chinese population |
Q53081590 | Scoring system for prediction of lymph node metastasis in radical cystectomy cohort. |
Q91060389 | Screening logs from a pilot randomized controlled trial of radical cystectomy versus chemoradiation therapy for muscle-invasive bladder cancer |
Q80450581 | Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely? |
Q55040059 | Selecting candidates for early discharge after radical cystectomy for bladder cancer. |
Q88627400 | Selection Effects May Explain Smoking-related Outcome Differences After Radical Cystectomy |
Q63984741 | Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer |
Q44648476 | Selection of the type of urinary diversion in conjunction with radical cystectomy |
Q57823507 | Semi-competing risk model to predict perioperative and oncologic outcomes after radical cystectomy |
Q35663298 | Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy. |
Q45106800 | Separated pyelocolocutaneous diversion after bilateral ureterectomy and radical cystectomy for transitional cell carcinoma |
Q84551001 | Sequential resection of malignant ureteral margins at radical cystectomy: a critical assessment of the value of frozen section analysis |
Q89861698 | Sex-Sparing Robot-Assisted Radical Cystectomy with Intracorporeal Padua Ileal Neobladder in Female: Surgical Technique, Perioperative, Oncologic and Functional Outcomes |
Q68198885 | Sexual Function In Men After Radical Cystectomy With or Without Urethrectomy |
Q45112722 | Sexual function after male radical cystectomy in a sexually active population |
Q43516456 | Sexual rehabilitation and male radical cystectomy |
Q44185472 | Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer |
Q78834002 | Shockwave lithotripsy for urinary stones in patients with urinary diversion after radical cystectomy |
Q97563637 | Short- and Long-Term Evaluation of Renal Function after Radical Cystectomy and Cutaneous Ureterostomy in High-Risk Patients |
Q92668765 | Short- and long-term survival has improved after radical cystectomy for bladder cancer in Québec during the years 2000-2015 |
Q40301356 | Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy |
Q92089709 | Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer |
Q44101567 | Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy. |
Q43360024 | Short-term patient reported health-related quality of life (HRQL) outcomes after robot-assisted radical cystectomy (RARC). |
Q48452611 | Short-term patient-reported quality of life after robot-assisted radical cystectomy using the Convalescence and Recovery Evaluation |
Q34436028 | Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database |
Q51862787 | Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysis. |
Q87866549 | Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy? |
Q52997167 | Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer? |
Q92487456 | Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy? |
Q73635640 | Sigmoid neobladder in women after radical cystectomy |
Q51120471 | Sigmoid orthotopic neobladder after radical cystectomy for bladder tumour: an Indian experience. |
Q48141343 | Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy. |
Q45359897 | Significance of anaerobic bacteria in postoperative infection after radical cystectomy and urinary diversion or reconstruction |
Q79852480 | Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy |
Q84902422 | Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma |
Q36601038 | Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer |
Q38252649 | Significance of perivesical lymph nodes in radical cystectomy for bladder cancer |
Q88124559 | Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy |
Q99204373 | Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer |
Q79327199 | Significance of radical cystectomy for bladder cancer in patients over 80 years old |
Q80215499 | Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder |
Q52852837 | Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. |
Q81669163 | Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center: in regard to Kotwal et al. (Int J Radiat Oncol Biol Phys 2008;70:456-463) |
Q51843225 | Simplified laparoscopic radical cystectomy with orthotopic ileal neobladder creation in a porcine model. |
Q37839400 | Simplified technique for parastomal hernia repair after radical cystectomy and ileal conduit creation |
Q38827749 | Simultaneous en-bloc robot-assisted radical cystectomy and nephro-ureterectomy: technique description, outcomes, and literature summary |
Q73698933 | Simultaneous prepubic urethrectomy with radical cystectomy for transitional cell carcinoma of the bladder |
Q34761127 | Simultaneous radical cystectomy and colorectal cancer resection for synchronous muscle invasive bladder cancer and cT3 colorectal cancer: Our initial experience in five patients |
Q34195098 | Simultaneous robot assisted laparoscopic radical nephroureterectomy; genital tract and paravaginal nerve sparing radical cystectomy; superextended lymph node dissection and intracorporeal Studer pouch reconstruction for bladder cancer: Robotic hat-t |
Q50989882 | Single Center Experience with Secondary Urinary Diversion after Initial Radical Cystectomy and Primary Urinary Diversion. |
Q95262006 | Single port robotic radical cystectomy with intracorporeal urinary diversion: a case series and review |
Q47230254 | Single stage pancreaticoduodenectomy (Whipple's procedure), radical cystectomy and bladder substitution with the urethral Kock reservoir. Case report |
Q92011335 | Single-center experience of robot-assisted radical cystectomy (RARC) and extended pelvic lymph node dissection |
Q92970693 | Single-port Robotic Intracorporeal Ileal Conduit Urinary Diversion During Radical Cystectomy Using the SP Surgical System: Step-by-step Technique |
Q47433212 | Size and volume of metastatic and non-metastatic lymph nodes in pelvis and lower abdomen in patients with carcinoma of the bladder undergoing radical cystectomy |
Q93098835 | Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy |
Q89038183 | Small bowel obstruction due to internal hernia caused by the ureter after laparoscopic radical cystectomy and ileal conduit: A case report |
Q47107056 | Smoking and alcohol cessation intervention in relation to radical cystectomy: a qualitative study of cancer patients' experiences |
Q87417530 | Smoking and survival after radical cystectomy for bladder cancer |
Q90875839 | Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy |
Q39328902 | Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer |
Q84072813 | Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients |
Q83569855 | Solitary skin metastasis adjacent to ureterocutaneostomy 4 years after radical cystectomy for bladder cancer |
Q35756004 | Sources of variation in follow-up expenditure after radical cystectomy |
Q35921559 | Sparing radical cystectomy - How much is enough? |
Q88545804 | Speeding up recovery from radical cystectomy: how low can we go? |
Q91219811 | Spillover Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions |
Q100993328 | Spontaneous bladder rupture due to bladder carcinoma: A case report required emergency radical cystectomy |
Q67758755 | Squamous carcinoma of the bladder: treatment by radical cystectomy |
Q67722037 | Stage B () transitional cell carcinoma of bladder highly curable by radical cystectomy |
Q64998827 | Stage pT0 after radical cystectomy: are all patients equal? |
Q51552001 | Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. |
Q79907964 | Stage specific lymph node metastasis mapping in radical cystectomy specimens |
Q45083997 | Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy |
Q59649538 | Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy |
Q36606951 | Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective? |
Q92114411 | Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients |
Q84797055 | Standard or extended lymphadenectomy in radical cystectomy: what metric of surgical quality for lymph node dissections matters in improving patient outcomes? |
Q43686707 | Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? |
Q79907956 | Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report |
Q80491711 | Standardization of radical cystectomy: time to count and be counted |
Q34962483 | Standardized analysis of complications after robot-assisted radical cystectomy: Korea University Hospital experience |
Q47567424 | Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy |
Q46128940 | Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy |
Q40990493 | Stapled orthotopic ileal neobladder after radical cystectomy for bladder cancer: Functional results and complications over a 20-year period. |
Q101478517 | Stapled versus robot-sewn ileo-ileal anastomosis during robot-assisted radical cystectomy: a review of outcomes in urinary bladder cancer patients |
Q51414933 | Stapleless laparoscopic assisted radical cystectomy with ileal neobladder in a male and with ileal loop in a female: initial report from Brazil. |
Q39408804 | Status of Robot-Assisted Radical Cystectomy (RARC) in 2012. |
Q37692565 | Status of robot-assisted radical cystectomy. |
Q92348716 | Step-by-step technique for single-port robot-assisted radical cystectomy and pelvic lymph nodes dissection using the da Vinci® SP™ surgical system |
Q48263400 | Stomal varices: a cause for intermittent haematuria post-radical cystectomy |
Q98181820 | Strangulated internal hernia beneath the obturator nerve after laparoscopic radical cystectomy with extended pelvic lymph node dissection |
Q92487518 | Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle? |
Q37003991 | Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study |
Q74322493 | Subtotal radical cystectomy after radical prostatectomy: a source of pelvic recurrence of bladder cancer with life threatening bleeding |
Q41233325 | Successful Treatment with Paclitaxel, Carboplatin, and Gemcitabine as Second-line Chemotherapy for Recurrent Urothelial Carcinoma of the Bladder with Glandular Differentiation After Radical Cystectomy: A Case Report |
Q91944706 | Successful transitional cell carcinoma of bladder underwent laparoscopic radical cystectomy with orthotopic intracorporeal Y pouch neobladder using a 3D digital printing model for surgical post op pouch evaluation |
Q41458011 | Summary of complications of ureteroileal conduit with radical cystectomy: review of 336 cases (by Jerry W. Sullivan, MD, Harry Grabstald, MD, and Willet F. Whitmore, Jr). 1980. |
Q44818814 | Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study |
Q46448114 | Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy |
Q91193427 | Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer |
Q57108355 | Superior functional outcome after radical cystectomy and orthotopic bladder substitution with restrictive intraoperative fluid management: a followup study of a randomized clinical trial |
Q38012243 | Surgeon controlled robot-assisted laparoscopic radical cystectomy: current review of oncologic and functional outcomes |
Q49076859 | Surgery illustrated--Surgical Atlas. Robotic radical cystectomy in the male. |
Q36872303 | Surgery insight: advantages and disadvantages of laparoscopic radical cystectomy to treat invasive bladder cancer |
Q44907736 | Surgery-related complications of robot-assisted radical cystectomy with intracorporeal urinary diversion |
Q47549011 | Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes? |
Q57099466 | Surgical High-risk Patients With ASA ≥ 3 Undergoing Radical Cystectomy: Morbidity, Mortality, and Predictors for Major Complications in a High-volume Tertiary Center |
Q101052588 | Surgical Outcomes of Transvaginal Neobladder-Vaginal Fistula Repair After Radical Cystectomy with Ileal Orthotopic Neobladder: A Case-Control Study |
Q96644226 | Surgical Pathology Findings in Patients Who Have Undergone Radical Cystectomy/Cystoprostatectomy With Extended Versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder: A Contemporary Analysis |
Q92476927 | Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial |
Q38610919 | Surgical and pathological outcomes of robotic-assisted radical cystectomy for bladder cancer in the community setting |
Q44788553 | Surgical apgar outcome score: perioperative risk assessment for radical cystectomy |
Q91719984 | Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? |
Q46046308 | Surgical atlas. Radical cystectomy |
Q44284097 | Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study |
Q46658638 | Surgical complications following radical cystectomy and orthotopic neobladders in women. |
Q46892902 | Surgical complications of radical cystectomy in a teaching hospital |
Q88171821 | Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years |
Q51697311 | Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. |
Q89943601 | Surgical outcomes and learning curve of totally intracorporeal ileal conduit urinary diversion following laparoscopic radical cystectomy at a single institution |
Q92762780 | Surgical safety in radical cystectomy: the anesthetist's point of view-how to make a safe procedure safer |
Q41548059 | Surgical site infections in patients who undergo radical cystectomy: Excess mortality, stay prolongation and hospital cost overruns |
Q73688686 | Surgical treatment after radical cystectomy |
Q49720931 | Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy |
Q40582698 | Surgical waiting time for radical cystectomy: a New Zealand experience |
Q83883699 | Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience |
Q38002454 | Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. |
Q92752570 | Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer |
Q96682013 | Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant Chemotherapy |
Q40918085 | Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec |
Q45109470 | Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience |
Q84152353 | Survival after pelvic lymphadenectomy and radical cystectomy in patients with lymph-node metastatic transitional-cell carcinoma of the bladder |
Q98190665 | Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches |
Q70710625 | Survival after radical cystectomy for invasive transitional cell carcinoma of bladder |
Q59649540 | Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis |
Q104469059 | Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer |
Q92778018 | Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study |
Q38710592 | Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment |
Q37495636 | Survival impact of followup care after radical cystectomy for bladder cancer. |
Q43861990 | Survival in patients treated with radical cystectomy for bladder carcinoma |
Q52946719 | Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. |
Q35921521 | Survival up to 5-15 years in young women following genital sparing radical cystectomy and neobladder: oncological outcome and quality of life. Single-surgeon and single-institution experience |
Q38611346 | Symptom clusters and related factors in bladder cancer patients three months after radical cystectomy |
Q100728146 | Systematic Review and Meta-Analysis of the Efficacy and Safety of Enhanced Recovery After Surgery vs. Conventional Recovery After Surgery on Perioperative Outcomes of Radical Cystectomy |
Q90264529 | Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer |
Q38976435 | Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy |
Q86015304 | Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of age |
Q26785757 | Systematic methods for measuring outcomes: How they may be used to improve outcomes after Radical cystectomy |
Q38308227 | Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. |
Q38308230 | Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. |
Q34527111 | Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy. |
Q38653852 | Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit |
Q36143668 | Systematic review and meta-analysis of randomised trials of perioperative outcomes comparing robot-assisted versus open radical cystectomy |
Q64082534 | Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions? |
Q100384269 | Systematic review of neoadjuvant therapy by Immune checkpoint inhibitors before radical cystectomy: where do we stand? |
Q39026360 | Systematic review of perioperative outcomes and complications after open, laparoscopic and robot-assisted radical cystectomy |
Q38950782 | Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. |
Q91177661 | Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy |
Q81941900 | Systemic treatment for invasive bladder cancer: neoadjuvant chemotherapy and laparoscopic radical cystectomy |
Q95477424 | T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. Con |
Q45126392 | T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro. |
Q61454762 | T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate |
Q35710421 | T1G3 bladder tumours: the case for radical cystectomy |
Q39577347 | THE FIRST REPORT OF LAPAROSCOPIC RADICAL CYSTECTOMY IN GEORGIA. |
Q93368125 | TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy |
Q41240378 | Taking it to the HILT: High-intensity local treatment with radical cystectomy for metastatic bladder cancer. |
Q40796362 | Takotsubo stress-induced cardiomyopathy following robotic radical cystectomy |
Q42370134 | Technical steps of open radical cystectomy and orthotopic neobladder to achieve the goals of "minimally invasive surgery"? |
Q42839374 | Technical steps of open radical cystectomy and orthotopic neobladder to achieve the goals of "minimally invasive surgery"? |
Q33724289 | Technique and results in total laparoscopic radical cystectomy with sigmoidorectal pouch (Mainz pouch II) - an initial experience |
Q46555284 | Technique for radical cystectomy |
Q70377735 | Technique of radical cystectomy |
Q70891129 | Technique of radical cystectomy |
Q45958409 | Technique of radical cystectomy and simultaneous repair of an abdominal aortic aneurysm. |
Q50510641 | Temporal trends in perioperative morbidity for radical cystectomy using the National Surgical Quality Improvement Program database. |
Q89050645 | Temporal trends in venous thromboembolism after radical cystectomy |
Q92682851 | Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium |
Q88950615 | The Association of Aspirin Use with Survival Following Radical Cystectomy |
Q98724495 | The CanMoRe trial - evaluating the effects of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer: the study protocol of a randomised controlled trial |
Q97517535 | The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort |
Q92763332 | The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients |
Q40053390 | The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy |
Q87621622 | The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder |
Q91284984 | The Complexity of Complications: How Do We Estimate Morbidity and Target Improvements Following Radical Cystectomy? |
Q40499120 | The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes Following Radical Cystectomy for Urothelial Cancer |
Q100938559 | The Effect of Body Mass Index on Oncological and Surgical Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Multicenter Study of the Association of Urooncology, Turkey |
Q92018064 | The Effect of Complexity of the Surgical Field on Perioperative Outcomes of Robot-Assisted Radical Cystectomy |
Q89728018 | The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery |
Q91213384 | The Endo GIA stapler in the paravaginal dissection during radical cystectomy |
Q40932384 | The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens |
Q54958097 | The Extent of Lymphadenectomy at the Time of Radical Cystectomy for Bladder Cancer and its Impact on Prognosis and Survival. |
Q91315128 | The Factors Significantly affecting the Quality of Life of Patients Who undergo Radical Cystectomy due to Bladder Cancer |
Q40045710 | The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission Interval |
Q93174764 | The Feasibility and Safety of Reproductive Organ Preserving Radical Cystectomy for Elderly Female Patients With Muscle-Invasive Bladder Cancer: A Retrospective Propensity Score-matched Study |
Q91266634 | The Feasibility of a Health Care Application in the Treatment of Patients Undergoing Radical Cystectomy |
Q38831046 | The Future of Enhanced Recovery for Radical Cystectomy: Current Evidence, Barriers to Adoption and Next Steps |
Q66892968 | The Ileocecal Bladder: A New Method for Urinary Diversion After Radical Cystectomy (A Preliminary Report) |
Q101129890 | The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy |
Q38843683 | The Impact of Health Literacy and Clinicodemographic Factors on Use of Discharge Services after Radical Cystectomy |
Q41582174 | The Impact of Health Literacy on Surgical Outcomes Following Radical Cystectomy |
Q98163998 | The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy |
Q57297392 | The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy |
Q41596016 | The Impact of Pelvic Venous Pressure on Blood Loss during Open Radical Cystectomy and Urinary Diversion: Results of a Secondary Analysis of a Randomized Clinical Trial |
Q88555459 | The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status |
Q40103969 | The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy. |
Q40198256 | The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer |
Q41687794 | The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy |
Q92184013 | The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic |
Q37530382 | The July Effect in Radical Cystectomy: Mortality, Morbidity, and Efficiency |
Q58124380 | The LACE Score as a Tool to Identify Radical Cystectomy Patients at Increased Risk of 90-Day Readmission and Mortality |
Q39445173 | The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis |
Q89986153 | The PT2D-Score: a novel tool to predict complications and economic outcome after radical cystectomy |
Q85551705 | The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy |
Q90528049 | The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy |
Q91244732 | The Role and Importance of Timely Radical Cystectomy for High-Risk Non-muscle-Invasive Bladder Cancer |
Q40094310 | The Role of Surgery in Local Recurrences after Radical Cystectomy for Bladder Cancer. |
Q38114718 | The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. |
Q90798882 | The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy |
Q57634284 | The Timing of Radical Cystectomy after Recent Myocardial Infarction |
Q87153533 | The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis |
Q39448663 | The Treatment of Recurrent Urothelial Tumors of the Upper Urinary System and at Urostomy Site following Radical Cystectomy with Intraureteral Bacillus Calmette-Guérin and Cryotherapy |
Q47632287 | The Upper Limits of Hopeful Application of Radical Cystectomy for Vesical Carcinoma: Does Nodal Metastasis Always Indicate Incurability? |
Q52571489 | The Use of a Metal Stent in the Treatment of Ureteral Stricture in a Patient Who Had Undergone Radical Cystectomy with the Creation of an Ileal Conduit. |
Q98292479 | The Use of a Polytetrafluoroethylene Membrane-Covered Stent in the Management of Urine Extravasation After Radical Cystectomy and Ileal Conduit Formation |
Q94601445 | The Usefulness of the Modified Frailty Index for Muscle-Invasive Bladder Cancer Patients Treated with Radical Cystectomy |
Q96591915 | The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer at a Single Institution |
Q83167971 | The Z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients |
Q83956307 | The adverse consequences of delaying radical cystectomy |
Q89770695 | The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy |
Q44085530 | The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy |
Q49331695 | The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol |
Q90729979 | The association between patient body mass index and perioperative outcomes following radical cystectomy: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database |
Q41432872 | The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy |
Q45935262 | The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. |
Q42004216 | The case for prostate capsule-sparing radical cystectomy in selected patients |
Q73485953 | The changing pattern of mortality and morbidity from radical cystectomy |
Q92487440 | The clinical and economic burden of perioperative complications of radical cystectomy |
Q38438246 | The clinical significance of intra-operative ureteral frozen section analysis at radical cystectomy for urothelial carcinoma of the bladder |
Q84009579 | The clinical significance of urine cytology after a radical cystectomy for urothelial cancer |
Q45201281 | The clinical study of radical cystectomy for lymph node positive bladder cancer |
Q71886863 | The colonic neobladder: a stoma-free bladder substitute after radical cystectomy--preliminary results in six patients |
Q95523057 | The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients |
Q100524972 | The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer |
Q44043763 | The connection between selective referrals for radical cystectomy and radical prostatectomy and volume-outcome effects: an instrumental variables analysis |
Q97068548 | The cost of obesity in radical cystectomy |
Q71238218 | The curability if invasive bladder cancer treated by radical cystectomy |
Q40310251 | The diagnosis and treatment of urethral recurrence after radical cystectomy |
Q90211510 | The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis |
Q38634440 | The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy. |
Q72923055 | The effect of intermittent pneumatic compression devices on intraoperative blood loss during radical prostatectomy and radical cystectomy |
Q50479490 | The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder. |
Q57108042 | The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomy |
Q41652070 | The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder |
Q87211852 | The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study |
Q70328796 | The effect of nutritional status and support on morbidity and mortality of bladder cancer patients treated by radical cystectomy |
Q35643316 | The effect of preoperative clinical variables on the 30- and 90-day morbidity and mortality after radical cystectomy: A single-centre study |
Q90342476 | The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder |
Q100511761 | The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis |
Q40170786 | The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis |
Q44321234 | The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial |
Q80212558 | The effects of adjusting for case mix on mortality and length of stay following radical cystectomy |
Q81712644 | The effects of stage divergence on survival after radical cystectomy for urothelial cancer |
Q77666583 | The experiences of rectosigmoid pouch as a continent urinary diversion after radical cystectomy |
Q50533060 | The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer. |
Q35994006 | The feasibility of radical cystectomy in elderly patients |
Q82258546 | The frequency of prostatic involvement in radical cystectomy specimens for transitional cell carcinoma of the bladder |
Q44228564 | The impact of co-morbid disease on cancer control and survival following radical cystectomy |
Q92618802 | The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy |
Q51031663 | The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients. |
Q97646933 | The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre |
Q37371241 | The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer |
Q91356196 | The impact of minimal invasive surgery on early complications and mortality after radical cystectomy for muscle-invasive urothelial bladder cancer |
Q91445231 | The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy |
Q60054615 | The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol |
Q50496600 | The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. |
Q50502382 | The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma. |
Q49407223 | The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients |
Q92665251 | The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy |
Q46426113 | The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer |
Q40951362 | The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder |
Q96232924 | The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature |
Q45055946 | The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy. |
Q104558313 | The impact of smoking on radical cystectomy complications increases in elderly patients |
Q39014520 | The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy |
Q84389717 | The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma |
Q40217833 | The impact of stapling devices use on patients with increased body mass index treated with radical cystectomy |
Q53574858 | The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. |
Q38235228 | The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review |
Q92243767 | The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy |
Q51382687 | The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. |
Q38760806 | The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy |
Q45110574 | The importance of lymphovascular invasion in patients undergoing radical cystectomy for bladder cancer |
Q50714743 | The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy. |
Q46005364 | The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy. |
Q30433190 | The learning curve for robot-assisted radical cystectomy |
Q37740535 | The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. |
Q91305866 | The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study |
Q42647608 | The lymph node yield during robot-assisted radical cystectomy |
Q41524268 | The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report). |
Q41058954 | The management of locally recurrent invasive bladder cancer following radical cystectomy |
Q46084165 | The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer |
Q40775537 | The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology |
Q52853811 | The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer. |
Q53193063 | The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer. |
Q43770148 | The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer |
Q91406662 | The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer |
Q37529160 | The oncologic results of laparoscopic radical cystectomy are not (yet) equivalent to open cystectomy |
Q81174187 | The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour |
Q89639833 | The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer |
Q46051123 | The potency-sparing radical cystectomy: does it compromise the completeness of the cancer resection? |
Q81305143 | The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer |
Q42500371 | The preoperative activity of Th1 and Th17 cytokine axes in prediction of sepsis after radical cystectomy. |
Q52946591 | The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. |
Q82222981 | The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy |
Q33335296 | The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis |
Q74259334 | The present position of radical cystectomy in the surgical management of carcinoma of the urinary bladder |
Q91571268 | The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy |
Q35348927 | The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy |
Q90235552 | The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis |
Q39657030 | The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy |
Q79805517 | The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy |
Q35591618 | The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder |
Q53521807 | The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy. |
Q36264797 | The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer |
Q38698128 | The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy |
Q80967866 | The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy |
Q73393234 | The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy |
Q37859664 | The prognostic value of hydronephrosis in bladder cancer treated by radical cystectomy. |
Q47296178 | The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis |
Q35677849 | The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy |
Q91060380 | The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy |
Q90627464 | The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC) |
Q51041030 | The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? |
Q95761529 | The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? |
Q80382927 | The rationale for radical cystectomy as primary therapy for T4 bladder cancer |
Q39729147 | The regionalization of radical cystectomy to specific medical centers |
Q35659154 | The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer |
Q85529210 | The results of implementing a fast-track protocol in radical cystectomy in a tertiary hospital |
Q37480548 | The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder |
Q38866956 | The risk of radical cystectomy |
Q68006975 | The risk of urethral recurrence after radical cystectomy |
Q37852269 | The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer. |
Q58804638 | The role of antibiotic prophylaxis after radical cystectomy in preventing urinary tract infections and readmission for sepsis |
Q100537039 | The role of extended lymph node dissection in patients undergoing radical cystectomy |
Q36790175 | The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer |
Q92318183 | The role of metastatic burden in cytoreductive/consolidative radical cystectomy |
Q37832899 | The role of pelvic lymph node dissection during radical cystectomy for bladder cancer. |
Q52883937 | The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. |
Q40717335 | The role of perioperative blood transfusion on postoperative outcomes and overall survival in patients after laparoscopic radical cystectomy |
Q50693158 | The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy. |
Q104470906 | The role of radical cystectomy in patients with T1 variant histology bladder cancer |
Q34180038 | The role of radical cystectomy in patients with clinical T4b bladder cancer |
Q46430607 | The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2) |
Q53541209 | The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy. |
Q101131351 | The role of surgical experience in patient selection, surgical quality, and outcomes in robot-assisted radical cystectomy |
Q85240152 | The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy |
Q90657670 | The significance of preoperative estimated glomerular filtration rate on survival outcomes in patients who underwent radical cystectomy and non-continent urinary diversion |
Q58113023 | The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy |
Q35028256 | The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres - results of CysTiming Poland study |
Q61454775 | The timing of radical cystectomy following neoadjuvant chemotherapy |
Q53530261 | The type of urinary diversion after radical cystectomy significantly impacts on the patient's quality of life. |
Q91632875 | The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec (Canada), 2000-2016 |
Q52944650 | The utility of CT and MRI in detecting male urethral recurrence after radical cystectomy. |
Q39480721 | The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy |
Q79205729 | The value of frozen-section analysis of ureteric margins on surgical decision-making in patients undergoing radical cystectomy for bladder cancer |
Q40915250 | The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate |
Q33743740 | The volume-mortality relation for radical cystectomy in England: retrospective analysis of hospital episode statistics |
Q45101898 | The volume-outcome relationship for radical cystectomy in England: an analysis of outcomes other than mortality |
Q50077471 | Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy |
Q86320999 | There is a place for radical cystectomy and urinary diversion, including orthotopic bladder substitution, in patients aged 75 and older: Results of a retrospective observational analysis from a high-volume center |
Q41598640 | Thoracic epidural analgesia for radical cystectomy improves bowel function even in traditional perioperative care: a retrospective study in eighty-five patients. |
Q91458144 | Threading the cost-outcome needle after radical cystectomy |
Q43780562 | Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy |
Q92759460 | Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy |
Q38123652 | Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer |
Q92176272 | Timing of adjuvant chemotherapy and overall survival following radical cystectomy |
Q53185271 | Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. |
Q104135736 | Timing of lymphadenectomy during robot-assisted radical cystectomy: before or after cystectomy? Fifteen cases with totally intracorporeal urinary diversions |
Q35533822 | Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients |
Q100508693 | Timing, Patterns and Predictors of 90-days Readmission Rate after Robotic Radical Cystectomy |
Q45234655 | Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxis |
Q38064272 | Tips and tricks to robot-assisted radical cystectomy and intracorporeal diversion |
Q44673534 | Tissue-engineered tubular graft for urinary diversion after radical cystectomy in rabbits |
Q36422857 | Total Psoas Area Predicts Complications following Radical Cystectomy |
Q91820830 | Totally intracorporeal 3D laparoscopic orthotopic neobladder reconstruction following radical cystectomy for infiltrative bladder tumors: the experience of modified Studer and modified Y-shaped ileal reconstruction techniques |
Q38162247 | Totally intracorporeal robot-assisted radical cystectomy: optimizing total outcomes |
Q38028591 | Towards bloodless cystectomy: a 10-year experience of intra-operative cell salvage during radical cystectomy |
Q37983494 | Toxicity comparison of neoadjuvant versus adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in radical cystectomy patients |
Q52714988 | Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial. |
Q91630106 | Trans-Fascial Placement of a High, Sub Muscular Reservoir in Patients Following Radical Cystectomy: Safety, Efficacy, and Predictability of Final Reservoir Location Verified With Abdominal Imaging |
Q68463980 | Transitional Cell Carcinoma of the Urethra in Men after Radical Cystectomy for Bladder Cancer. Is Prophylactic Urethrectomy Indicated? |
Q73638168 | Transitional cell carcinoma in a prostatic remnant 10 years after radical cystectomy |
Q43449548 | Transitional cell carcinoma in orthotopic ileal neobladder 12 years after radical cystectomy |
Q77435739 | Transitional cell carcinoma in the ileal conduit following radical cystectomy and nephroureterectomy |
Q45423885 | Transitional infiltrating carcinoma of the bladder. Local recurrence and metastases. Analysis of 175 cases treated with radical cystectomy |
Q35642963 | Transobturator vaginal tape (inside-out) for stress urinary incontinence after radical cystectomy and orthotopic reconstruction in women |
Q94584806 | Transperitoneal uretercutaneostomy with use of mesosigmoid colon peritoneum in patients with bladder cancer after radical cystectomy |
Q47344752 | Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study |
Q82416460 | Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer |
Q96120870 | Transurethral resection of bladder and radical cystectomy: Concordance of histology. Are we good enough? |
Q92518189 | Transurethral-Assisted Transumbilical Laparoendoscopic Single-Site Radical Cystectomy: Initial Short-Term Experience |
Q96430225 | Transvaginal Enterocele and Evisceration Repair After Radical Cystectomy Using Porcine Xenograft |
Q37319840 | Transvaginal bowel evisceration following robot-assisted radical cystectomy |
Q85825964 | Transvaginal neobladder vaginal fistula repair after radical cystectomy with orthotopic urinary diversion in women |
Q55054251 | Transversus Abdominis Plane Blockade as Part of a Multimodal Postoperative Analgesia Plan in Patients Undergoing Radical Cystectomy. |
Q53461353 | Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases. |
Q40331821 | Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy |
Q73160695 | Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study |
Q44687557 | Treatment of invasive bladder cancer: robot-assisted radical cystectomy and intracorporeal urinary diversion |
Q51631315 | Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. |
Q43727130 | Treatment outcome of radical cystectomy during a 10-year period (June 1984-September 1994) at Department of Urology, Fukui Medical School |
Q90504189 | Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy |
Q91246135 | Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy |
Q91957816 | Trends in Management and Outcomes Among Patients with Urothelial Carcinoma Undergoing Radical Cystectomy from 1995 to 2015: The Memorial Sloan Kettering Experience |
Q91951260 | Trends in Regionalization of Care and Mortality For Patients Treated With Radical Cystectomy |
Q90643590 | Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis |
Q41661097 | Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010. |
Q46118519 | Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. |
Q93136319 | Trends in quality of life reporting for radical cystectomy and urinary diversion over the last four decades: A systematic review of the literature |
Q39604746 | Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. |
Q50993637 | Trends in renal function after radical cystectomy and ileal conduit diversion: new insights regarding estimated glomerular filtration rate variations. |
Q35905142 | Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea. |
Q47211582 | Trends in urinary diversion after radical cystectomy for urothelial carcinoma. |
Q44258882 | Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? |
Q101403876 | Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis |
Q38540660 | Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy? |
Q41743687 | Tube gastrostomy after radical cystectomy and urinary diversion: surgical technique and experience in 709 patients |
Q44018497 | Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center |
Q42378252 | Tumor-infiltrating CD8+ lymphocytes predict different clinical outcomes in organ- and non-organ-confined urothelial carcinoma of the bladder following radical cystectomy |
Q45948761 | Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre. |
Q77449304 | Two cases of nonocclusive mesenteric ischemia after radical cystectomy |
Q40793039 | Two-Port Approach Compared to Standard Laparoscopic Radical Cystectomy |
Q86098856 | Two-port laparoscopic radical cystectomy with reusable umbilical system: a feasibility study |
Q81170790 | Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costs |
Q43645973 | Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costs. |
Q36956211 | UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy |
Q38152780 | USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer |
Q39397592 | Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades |
Q41752954 | Understanding hospital readmission intensity after radical cystectomy |
Q90255224 | Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy: a qualitative interview study |
Q98775666 | Understanding psychosocial and sexual health concerns among women with bladder cancer undergoing radical cystectomy |
Q38655139 | Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer |
Q90348106 | Unexpected Early Oncologic Mortality after Open Radical Cystectomy for Bladder Cancer: Who Is to Be Blamed? |
Q90116681 | Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study |
Q91421685 | Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer |
Q51609548 | Unpredicted neurological complications after robotic laparoscopic radical cystectomy and ileal conduit formation in steep trendelenburg position: two case reports. |
Q55502151 | Unusual complication of bladder prolapse with subsequent diagnosis of urothelial carcinoma leading to a necrotizing soft tissue infection after radical cystectomy. |
Q64093363 | Unusual lymphocele following radical cystectomy with orthotopic neobladder |
Q83176749 | Unusual occurrence of neuroleptic malignant syndrome in urological surgery: a case report following radical cystectomy for invasive bladder cancer |
Q37179666 | Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort |
Q46348087 | Upholding Rigorous Standards: Comparable Patterns and Rates of Recurrence Between Open and Robot-assisted Radical Cystectomy |
Q73091086 | Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation |
Q35914225 | Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors |
Q46980038 | Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup |
Q38027302 | Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols |
Q44703119 | Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk? |
Q82702566 | Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors |
Q36860951 | Upper urinary tract recurrence following radical cystectomy for bladder cancer |
Q38053552 | Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. |
Q71252237 | Upper urinary tract transitional cell cancer after radical cystectomy for bladder cancer |
Q36788586 | Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments |
Q50967045 | Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. |
Q77299574 | Ureter and bladder replacement following radical cystectomy |
Q85208591 | Ureteral and urethral frozen sections during radical cystectomy or cystoprostatectomy: an analysis of denudation and atypia |
Q90807515 | Ureteral and urethral recurrence after radical cystectomy: a systematic review |
Q73589206 | Ureteral carcinoma in situ at radical cystectomy: does the margin matter? |
Q37291060 | Ureteral frozen section analysis during radical cystectomy: Do margins matter? |
Q42116093 | Ureteral frozen sections at the time of radical cystectomy: reliability and clinical implications |
Q83205099 | Ureteric frozen sections during radical cystectomy for transitional cell carcinoma of the bladder--to do or not to do? |
Q90922477 | Ureteric stricture rates and management after robot-assisted radical cystectomy: a single-centre observational study |
Q97551613 | Uretero-Enteric Anastomotic Stricture Following Radical Cystectomy: A Comparison of Open, Robotic Extracorporeal, And Robotic Intracorporeal Approaches |
Q56973698 | Uretero-caval fistula after radical cystectomy with bricker ileal conduit: a case report |
Q41253604 | Ureteroarterial Fistulas After Robotic and Open Radical Cystectomy |
Q38490370 | Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience |
Q85764965 | Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? |
Q86141150 | Ureteronenteric Anastomotic Strictures After Radical Cystectomy - Does Operative Approach Matter? |
Q35830361 | Urethral 'recurrence' found 14 years after radical cystectomy |
Q100466648 | Urethral Recurrence of Urothelial Carcinoma of the Bladder Following Radical Cystectomy: An Unusual Imaging Pattern |
Q51231387 | Urethral pressure profile following orthotopic neobladder: differences between nerve sparing and standard radical cystectomy techniques. |
Q49357528 | Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis |
Q44661985 | Urethral recurrence following radical cystectomy |
Q72768695 | Urethral recurrences following radical cystectomy for invasive transitional cell carcinoma of the bladder |
Q68550814 | Urethrectomy is harmful for preserving potency after radical cystectomy |
Q69128561 | Urethrogluteal fistula occurring after radical cystectomy for bladder cancer |
Q51368435 | Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014. |
Q92297144 | Urinary Diversion Disparity Following Radical Cystectomy for Bladder Cancer in the Hispanic Population |
Q87921054 | Urinary Reconstruction after Radical Cystectomy |
Q39189375 | Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database. |
Q34795731 | Urinary diversion after radical cystectomy |
Q38170537 | Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. |
Q34670583 | Urinary diversion and morbidity after radical cystectomy for bladder cancer |
Q43509975 | Urinary diversion following radical cystectomy: ileal conduit or ileal replacement bladder? |
Q33605475 | Urinary diversion-related outcome in patients with pelvic recurrence after radical cystectomy for bladder cancer |
Q55474720 | Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction. |
Q89639814 | Urinary tract infection after radical cystectomy: a vexing problem despite prophylactic antibiotics |
Q49670710 | Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients |
Q92756450 | Urinary tract infections following radical cystectomy with enhanced recovery protocol: A prospective study |
Q90292333 | Urinary tract infections in patients undergoing radical cystectomy and urinary diversion: challenges and considerations in antibiotic prophylaxis |
Q51289799 | Urinary tract management after radical cystectomy for rhabdomyosarcoma in children--what is the best option? |
Q91671603 | Urinary undiversion from a sigma-rectum pouch to a cutaneous urinary stoma as a treatment for severe metabolic disorders post-radical cystectomy: A case report |
Q40324182 | Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion |
Q34538937 | Urodynamic and continence assessment of orthotropic neobladder reconstruction following radical cystectomy in bladder cancer; a prospective, blinded North Indian tertiary care experience |
Q51563453 | Urodynamic features of the gastric pouch after radical cystectomy and the relationship to oral intake. |
Q67560022 | Urodynamic findings in patients with a urethral Kock pouch after radical cystectomy |
Q89079286 | Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy |
Q35072460 | Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer |
Q39065861 | Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy |
Q86514957 | Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy |
Q71013831 | Urothelial lesions associated with bladder carcinoma. Histological study of 18 radical cystectomy specimens |
Q92679522 | Usage of Intravenous Lidocaine Infusion with Enhanced Recovery Pathway in Patients Scheduled for Open Radical Cystectomy: A Randomized Trial |
Q92367387 | Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series |
Q40412278 | Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database |
Q44954690 | Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy |
Q91995005 | Use of indocyanine green to minimise uretero-enteric strictures after robotic radical cystectomy |
Q40833210 | Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer |
Q84928196 | Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis |
Q35632786 | Use of radical cystectomy for patients with invasive bladder cancer. |
Q74783099 | Use of the endoscopic gastrointestinal anastomosis stapler in radical cystectomy |
Q48309063 | Use of urostomy bags in the management of perioperative urine leakage after radical cystectomy |
Q46953676 | Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report |
Q40735589 | Usefulness of catheter pyelography in ileal diversions and continent bladder replacement after radical cystectomy |
Q38162637 | Usefulness of the Memorial Sloan Kettering Cancer Center nomogram in the prognosis of patients treated with radical cystectomy for invasive bladder cancer |
Q41844308 | Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy |
Q37053787 | Using Analytic Morphomics to Understand Short-Term Convalescence after Radical Cystectomy |
Q38076927 | Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer |
Q41432488 | Utility and significance of ureteric frozen section analysis during radical cystectomy |
Q93375375 | Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer |
Q93375184 | Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer-Reply |
Q64113942 | Utility of Routine Intraoperative Ureteral Frozen Section Analysis at Radical Cystectomy: Outcomes from a Regional Australian Center |
Q90062227 | Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET/CT) in Identifying Pathologic Lymph Node Metastases at Radical Cystectomy |
Q85273738 | Utility of biomarkers in the prediction of oncologic outcome after radical cystectomy for squamous cell carcinoma |
Q91253490 | Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer |
Q93049952 | Utility technique of a totally intracorporeal ileal conduit after robot-assisted radical cystectomy |
Q89256162 | Utilization Trends and Short-term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer |
Q38606579 | Utilization and Outcomes of Radical Cystectomy for High-grade Non-muscle-invasive Bladder Cancer in Elderly Patients. |
Q104288842 | Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers |
Q41400238 | VIP neobladder (Padovana) reconstruction following radical cystectomy for bladder cancer Complications, functional outcome and quality of life evaluation in 95 cases |
Q90330991 | Vaginal Dehiscence and Evisceration After Robotic-assisted Radical Cystectomy: A Case Series and Review of the Literature |
Q47564539 | Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse |
Q98614241 | Vaginal sparing in laparoscopic radical cystectomy for females: feasibility and technical notes |
Q57020336 | Validating the predictors of outcomes after radical cystectomy for bladder cancer |
Q89017427 | Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy |
Q53035018 | Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy. |
Q96429875 | Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy |
Q102218497 | Validation of the Khorona Score for Prediction of Venous Thromboembolism After Robot- Assisted Radical Cystectomy |
Q38654958 | Validation of the Preoperative Score to Predict Postoperative Mortality in Patients Undergoing Radical Cystectomy |
Q88437593 | Validation of the nomogram for predicting 90-day mortality after radical cystectomy in a Japanese cohort |
Q34629576 | Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder. |
Q68325166 | Value of Radical Cystectomy in Bladder Cancer with Pelvic Node Involvement |
Q47124306 | Value of evaluating procalcitonin kinetics in diagnosis of infections in patients undergoing laparoscopic radical cystectomy |
Q84958595 | Value of routine frozen section analysis of urethral margin in male patients undergoing radical cystectomy in predicting prostatic involvement |
Q39471762 | Variability in complications and operative mortality after radical cystectomy in Spain |
Q36149365 | Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder |
Q82823020 | Variation in use of lymph node dissection during radical cystectomy for bladder cancer |
Q38941333 | Variations in Preoperative Use of Bone Scan Among Medicare Beneficiaries Undergoing Radical Cystectomy |
Q35622834 | Variations in reconstruction after radical cystectomy |
Q88762895 | Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA |
Q91923963 | Venous thromboembolism after radical cystectomy and urinary diversion: a single-center experience with 1737 consecutive patients |
Q36620325 | Venous thromboembolism after radical cystectomy: Experience with screening ultrasonography. |
Q39140746 | Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. |
Q34275009 | Videoendoscopically assisted transvaginal radical cystectomy |
Q49579746 | Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial. |
Q87250339 | Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study |
Q50726763 | W-pouch With Modified Non-isolated Extra Limb for Continence in Cutaneous Diversion After Radical Cystectomy. |
Q46396554 | Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival |
Q42624859 | What about conventional laparoscopic radical cystectomy? Cost-analysis of open versus laparoscopic radical cystectomy |
Q53370054 | What can be more prognostic than the pTNM category assessed on radical cystectomy specimens? |
Q90927783 | What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy? |
Q41453791 | What is the best urinary diversion after laparoscopic radical cystectomy? |
Q42039017 | What is the role of adjuvant chemotherapy in locally advanced and lymph node-positive bladder cancer after radical cystectomy? |
Q46386437 | What is the role of risk-adjusted funnel plots in the analysis of radical cystectomy volume-outcome relationships? |
Q37391921 | What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospital |
Q78319842 | When should quality of life be measured after radical cystectomy? |
Q91566367 | Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy? |
Q49464739 | Which is better in patients with hydronephrosis before radical cystectomy-percutaneous nephrostomy versus internal ureteral stents. |
Q36867886 | Which urinary diversion is best after radical cystectomy? The case for "incontinent" diversion. |
Q92444574 | Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy |
Q45189701 | Will Rogers and the results of radical cystectomy for invasive bladder cancer |
Q61454782 | Will long term oncologic follow-up make the case for robotic assisted radical cystectomy? |
Q87449138 | Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control Study |
Q83637774 | Words of Wisdom. Re: potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience |
Q87248844 | Words of Wisdom. Re: robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients |
Q85236392 | Words of Wisdom. Re: urinary diversion and morbidity after radical cystectomy for bladder cancer |
Q83637769 | Words of Wisdom. Re: use of radical cystectomy for patients with invasive bladder cancer |
Q85754753 | Words of wisdom. Re: A new concept for early recovery after surgery in patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study |
Q50991777 | Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy. |
Q51929034 | Words of wisdom. Re: Evaluating the learning curve for robot- assisted laparoscopic radical cystectomy. |
Q80183996 | Words of wisdom. Re: Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy |
Q83009539 | Words of wisdom. Re: Outcome after radical cystectomy with limited or extended pelvic lymph node dissection |
Q84708783 | Words of wisdom. Re: Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM |
Q80951986 | Words of wisdom. Re: Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy |
Q80184001 | Words of wisdom. Re: radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cases |
Q80607834 | Words of wisdom. Re: the role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy |
Q84028534 | Words of wisdom: Re: Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study |
Q51280476 | Working capacity and well-being after radical cystectomy with continent cutaneous diversion. |
Q96126841 | Xanthogranulomatous Ureteritis Mimicking Ureteral Involvement by Cancer in a Radical Cystectomy Specimen |
Q53028971 | [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy. |
Q67994908 | [10 years' experience with radical cystectomy in malignant tumors of the urinary bladder] |
Q91165227 | [A Case Of cT3bN2M0 Pleomorphic Giant Cell Carcinoma of the Bladder without Recurrence after Neoadjuvant Chemotherapy and Radical Cystectomy for 4 Years] |
Q73662869 | [A case of bilateral upper urinary tract tumors after radical cystectomy] |
Q50514384 | [A case of late recurrence of urothelial carcinoma in an ileal conduit after radical cystectomy and ileal conduit diversion for bladder cancer]. |
Q57109427 | [A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder] |
Q40469982 | [A case of ureteral carcinoma at 11 years after radical cystectomy and rectal bladder reconstruction: a case report]. |
Q50915382 | [A clinicopathological study of 218 patients with bladder carcinoma treated by radical cystectomy] |
Q85241898 | [A method for forming a urinary bladder from the sigmoid after radical cystectomy in patients with bladder cancer] |
Q81643148 | [A stage-dependent follow-up strategy after radical cystectomy for bladder carcinoma] |
Q69552469 | [A study on 52 patients with bladder cancer treated with radical cystectomy--pathological findings, lymph node metastasis and prognosis] |
Q74762868 | [Abdominal pain in patients undergoing radical cystectomy for bladder cancer] |
Q83375682 | [Acute normovolemic hemodilution to reduce allogenic blood transfusion in patients undergoing radical cystectomy] |
Q81442664 | [Acute peritonitis after radical cystectomy. Experience at our hospital and bibliographic review] |
Q73822207 | [Adenocarcinoma of the renal pelvis and transitional cell carcinoma of the ureter occurring 11 years after radical cystectomy for bladder cancer: a case report] |
Q71594008 | [Adjuvant chemotherapy after radical cystectomy in bladder carcinoma] |
Q69574834 | [Adjuvant chemotherapy for high-stage and/or high-grade bladder cancer following radical cystectomy. A preliminary report] |
Q72399340 | [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer] |
Q104568740 | [Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer] |
Q83040407 | [An analysis of upper urinary tract recurrence following radical cystectomy for bladder cancer] |
Q91885626 | [Analysis of influencing factors of ureteral anastomotic stenosis following urinary diversion after laparoscopic radical cystectomy] |
Q84773207 | [Analysis of perioperative complications of laparoscopic radical cystectomy for bladder cancer] |
Q89461897 | [Analysis of the results of ERAS protocol in real-life clinical practice AFTER radical cystectomy (the first prospective multicenter study in Russia)] |
Q84894120 | [Application of tube gastrostomy in radical cystectomy with ileal conduit: a retrospective, comparative study] |
Q98949314 | [Applying the ERAS (Enhanced Recovery After Surgery) protocol in radical cystectomy.] |
Q71517399 | [Benefits and adverse effects of post-operative radiation therapy after radical cystectomy for patients with advanced bladder cancer] |
Q77589390 | [Bilateral ureter within single nipple for cutaneous ureterostomy after radical cystectomy] |
Q71831800 | [Bladder tumors treated with radical cystectomy. Results of 78 cases] |
Q87271814 | [C-reactive protein prior to radical cystectomy: preoperative determination of CRP] |
Q79670215 | [Cae of double cancer involving of the bladder and prostate which was treated by radical cystectomy 8 years after radical prostatectomy] |
Q95486605 | [Characteristics of lymph node metastasis in patients undergoing radical cystectomy for bladder cancer: a retrospective single-center study of 522 cases] |
Q69806391 | [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy] |
Q69192173 | [Clinical experience on the use of total parenteral nutrition in patients subjected to radical cystectomy intervention for infiltrating neoplasms of the bladder] |
Q93078329 | [Clinical experiences of laparoscopic radical cystectomy and urinary diversion in the elderly patients with bladder cancer] |
Q84276430 | [Clinical outcomes after modified radical cystectomy in the treatment of 188 patients with invasive bladder cancer] |
Q84773220 | [Clinical significance of radical cystectomy with extended lymphadenectomy] |
Q74623027 | [Clinical study of radical cystectomy and urinary reconstruction in elderly patients with bladder cancer] |
Q83464257 | [Comment to: "Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results"] |
Q84629232 | [Comment: «laparoendoscopic radical cystectomy with orthotopic ileal neobladder through umbilical single port»] |
Q83964546 | [Comments on radical cystectomy - laparoscopic versus robotic] |
Q92651183 | [Comparative analysis of results in laparoscopic radical cystectomy with extracorporeal and intracorporeal neobladder formation] |
Q57131625 | [Compare of laparoscopic and open surgery for radical cystectomy with orthotopic ileal neobladder] |
Q74400724 | [Complications after radical cystectomy in patients with bladder carcinoma] |
Q54728767 | [Complications and late sequelae following radical cystectomy and supravesicle urinary diversion] |
Q83758575 | [Critical analysis on risk factors of postoperative in-hospital complications in radical cystectomy of bladder cancer] |
Q89461935 | [Current trends in the method used for urine derivation after radical cystectomy for muscle-invasive bladder cancer] |
Q84706212 | [Diagnosis and treatment of urethral recurrence after radical cystectomy in the male] |
Q50522625 | [Does chewing gum improve postoperative results in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis]. |
Q83623410 | [Ductal Adenocarcinoma of the prostate with infiltration of the bladder. Can radical cystectomy and antiandrogen therapy cure the disease?] |
Q90910605 | [Early complications after robot-assisted laparoscopic radical cystectomy and their risk factors] |
Q81306491 | [Early postoperative complications of radical cystectomy and urinary diversion in elderly patients] |
Q82497956 | [Early vs delayed radical cystectomy compared in highgrade superficial bladder tumors] |
Q84446186 | [Editorial comment on: Laparoscopic radical cystectomy. The new gold standard for bladder carcinoma?] |
Q54084114 | [Editorial comment on: Laparoscopic radical cystectomy. Where do we stand?]. |
Q84622180 | [Editorial comment: robotic assisted radical cystectomy: oncological safety] |
Q51767178 | [Effect of gum chewing on bowel function recovery in patients after radical cystectomy with urinary diversion]. |
Q85467795 | [Effects of age, gender and urinary diversion category on perioperative complications of radical cystectomy] |
Q95495409 | [Effects of performing pelvic lymph node dissection before versus after radical cystectomy] |
Q81410216 | [Evaluation of 126 radical cystectomy with orthotopic ileal or sigmoidocolic neobladder] |
Q90719675 | [Evaluation of the learning curve of laparoscopic radical cystectomy for cancer: Morbidity and oncological results] |
Q83160689 | [Experience of laparoscopic nerve-sparing radical cystectomy and construction of ileal neobladder at Kansai Medical University] |
Q79274528 | [Experiences with radical cystectomy combined with urinary diversion by ureteral sigmapouch (Mainz-pouch II) in bladder cancer patients] |
Q80060250 | [Extended lymphadenectomy in radical cystectomy: margins, scope, methodology] |
Q83239221 | [Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results] |
Q70833629 | [Extensive rectal cancer--preserved intestinal and urinary continence after en-block rectal resection and radical cystectomy] |
Q85465127 | [Factors associated with increased blood loss in patients undergoing radical cystectomy in a contemporary series] |
Q70482191 | [Factors determining the survival rate after radical cystectomy] |
Q84617771 | [Fast track approach in radical cystectomy] |
Q83183731 | [Fast-track concepts in the perioperative management of patients undergoing radical cystectomy and urinary diversion: review of the literature and research results] |
Q81672029 | [First experience with the laparoscopic radical cystectomy] |
Q86641310 | [First experiences of laparoscopic radical cystectomy] |
Q73830076 | [Follow up of patients with bladder cancer treated with radical cystectomy] |
Q68828254 | [Four cases of bladder replacement by enterocystoplasty after radical cystectomy for bladder cancer] |
Q68010089 | [Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer] |
Q96768842 | [Frequency of occurrence and risk factors for acute kidney injury after radical cystectomy] |
Q95474636 | [Henoch-Schönlein purpura developed after radical cystectomy] |
Q80623047 | [Hyperammonaemic encephalopathy, possible complication after urinary diversion in radical cystectomy. Review of the literature with regard to a clinical case] |
Q92052067 | [INITIAL EXPERIENCE WITH ROBOT-ASSISTED RADICAL CYSTECTOMY AND INTRACORPOREAL URINARY DIVERSION ~COMPARISON WITH THE CONVENTIONAL METHOD~] |
Q54117561 | [Immediate complications of radical cystectomy. Intestinal fistula: our experience in the treatment with somatostatin] |
Q81272122 | [Impact of comorbidity on perioperative mortality after radical cystectomy] |
Q95440299 | [Impact of different surgical methods of radical cystectomy on the perioperative complications in patients over 75 years] |
Q95513802 | [Impact of different surgical methods of radical cystectomy on the perioperative complications in patients over 75 years] |
Q89573600 | [Impact of neoadjuvant chemotherapy on the peri-operative morbidity of radical cystectomy for muscle invasive bladder cancer] |
Q95451072 | [Impact of preoperative nutritional risk on complications after radical cystectomy] |
Q69806394 | [Implant operation of penile inflatable prosthesis for a patient with erectile impotence due to radical cystectomy: a case report] |
Q70816759 | [Indication of neobladder replacement in patients undergoing radical cystectomy for bladder cancer] |
Q81109381 | [Indications and current results of substitution enteroplasty following radical cystectomy] |
Q79348228 | [Indications for one-stage and delayed urethrectomy after radical cystectomy in patients with invasive cancer of the urinary bladder] |
Q68002580 | [Indications for urethrectomy in male patients undergoing radical cystectomy in bladder carcinoma] |
Q67881235 | [Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and |
Q77623119 | [Influence of neoadjuvant treatment on bladder infiltrating tumors treated with radical cystectomy] |
Q83459805 | [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder] |
Q91566010 | [Intraoperative complications of radical cystectomy with various types of urinary diver- sions] |
Q80082473 | [Invasive bladder carcinoma after prostatic carcinoma -- radical cystectomy has high morbidity rate] |
Q84390665 | [Is it possible to predict postoperative ileus following radical cystectomy?] |
Q70219182 | [Is radical cystectomy indicated for the treatment of patients with bladder carcinoma N+ M0?] |
Q81359876 | [Is radical cystectomy justified in patients over 75 years old?] |
Q77734747 | [Is there still a role for radical cystectomy in localized, infiltrating bladder cancers in 1998?] |
Q95343104 | [Is total parenteral nutrition necessary in patients subjected to radical cystectomy?] |
Q91130353 | [LAPAROSCOPIC RADICAL CYSTECTOMY AT HIROSHIMA CITY ASA HOSPITAL] |
Q57115536 | [Laparoendoscopic radical cystectomy with orthotopic ileal neobladder through umbilical single port] |
Q51905438 | [Laparoendoscopic single-site surgery radical cystectomy with orthotopic taenia myectomy sigmoid neobladder: initial report]. |
Q50618541 | [Laparoscopic radical cystectomy and detenial sigmoid colon orthotopic neobladder reconstruction for bladder tumor in a 3-year-old boy]. |
Q83843205 | [Laparoscopic radical cystectomy and orthotopic urinary diversion in the male patient: technique] |
Q50775268 | [Laparoscopic radical cystectomy and sigmoid colon orthotopic neobladder reconstruction: report of 26 cases]. |
Q82247162 | [Laparoscopic radical cystectomy for 43 patients with invasive bladder carcinoma] |
Q81558681 | [Laparoscopic radical cystectomy in clinically localized (T2) bladder tumors] |
Q83192375 | [Laparoscopic radical cystectomy in elderly patients with bladder cancer: feasibility and evaluation of morbidity] |
Q81614217 | [Laparoscopic radical cystectomy with enteric urinary diversion. Alternative to open cystectomy?] |
Q52957715 | [Laparoscopic radical cystectomy with intracorporeal creation of a continent urinary diversion. Future or present?] |
Q82993195 | [Laparoscopic radical cystectomy with orthotopic ileal neobladder: report of 108 cases] |
Q84490923 | [Laparoscopic radical cystectomy with vaginal specimen extraction. Case report] |
Q51921280 | [Laparoscopic radical cystectomy. The new gold standard for bladder carcinoma?]. |
Q50789935 | [Laparoscopic radical cystectomy: analysis of a single-surgeon learning curve of 60 cases]. |
Q79894729 | [Laparoscopic radical cystectomy: initial experience] |
Q89461893 | [Laparoscopic radical cystectomy: novel technique with late dividing of the ureters] |
Q74803283 | [Local recurrence after radical cystectomy for cancer of the bladder] |
Q81484043 | [Local recurrence following radical cystectomy for bladder cancer. Diagnostic and therapeutic options] |
Q82532837 | [Local recurrence of micropapillary bladder tumor after radical cystectomy : successful treatment with radiation therapy : a case report] |
Q53777548 | [Long-term outcome of radical cystectomy in urinary bladder carcinoma] |
Q77346741 | [Long-term results and quality of life of hemi-Kock orthotopic ileal neobladder after radical cystectomy] |
Q73418347 | [Long-term results of short-course preoperative radiotherapy and radical cystectomy for bladder cancer] |
Q82777642 | [Lymphatic dissection in radical cystectomy] |
Q78118334 | [Lymphatic metastases in bladder carcinoma. Is radical cystectomy indicated?] |
Q95549899 | [MARKERS OF KIDNEY DAMAGE AND NEPHROPROTECTIVE THERAPY IN RADICAL CYSTECTOMY] |
Q78867031 | [Modified intestinal in situ neobladder in functional reconstruction of lower urinary tract after radical cystectomy: report of 15 cases] |
Q87140905 | [Morbidity, mortality, and overall survival after radical cystectomy: comparison of single-center results with the literature and a nomogram] |
Q82765032 | [Mortality and morbidity of radical cystectomy for bladder cancer in patients over the age of 75] |
Q77773180 | [Necrotizing pancreatitis following radical cystectomy for infiltrating bladder carcinoma] |
Q87132644 | [Negative prognostic impact of female gender on oncological outcomes following radical cystectomy] |
Q64911967 | [Neoadjuvant cisplatin chemotherapy and radical cystectomy in bladder carcinoma] |
Q53026798 | [Neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer]. |
Q90789759 | [Nerve-sparing robot-assisted laparoscopic radical cystectomy: Clinical application and effect] |
Q80953340 | [On 10-year experience in the use of direct and antireflux techniques of anastomosis of ureter and orthotopic intestinal neobladder after radical cystectomy] |
Q50489633 | [Oncologic and perioperative outcomes of robot-assisted radical cystectomy: A single-center prospective series]. |
Q86874624 | [Oncological outcome of radical cystectomy for BCG failure compared to primary invasive disease] |
Q92724164 | [Open vs Laparoscopic Radical Cystectomy: Comparison of perioperative and Mid-term oncological outcomes.] |
Q74150625 | [Orthotopic bladder from the small intestine following radical cystectomy according to Studer's procedure] |
Q86606702 | [Orthotopic ileal neobladder - robot-assisted radical cystectomy standard soon?] |
Q93021435 | [Orthotopic neobladder reconstruction for bladder cancer: robotic-assisted versus open-radical cystectomy for perioperative outcomes, functional results and quality of life] |
Q68054590 | [Partial bladder resection--truly an alternative to radical cystectomy?] |
Q81769048 | [Pelvic recurrence after radical cystectomy for bladder cancer] |
Q68694466 | [Penile implantation surgery for organic impotence due to radical cystectomy or prostatectomy] |
Q84523047 | [Peritoneal carcinomatosis after robotic-assisted radical cystectomy] |
Q81254559 | [Place of laparoscopic radical cystectomy in the treatment of invasive bladder urothelial carcinoma] |
Q69183460 | [Planned preoperative radiotherapy and radical cystectomy in the management of bladder cancer] |
Q86492623 | [Prediction of local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. A novel risk stratification] |
Q81786063 | [Prevalence of lymph node metastases in non-muscle-invasive bladder cancer. Delay of radical cystectomy and upstaging in the cystectomy specimen as risk factors] |
Q84572133 | [Prognosis of local recurrence after radical cystectomy for bladder cancer] |
Q84083343 | [Prognostic factors for survival in patients with transitional bladder cancer treated with radical cystectomy] |
Q51030221 | [Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy]. |
Q84962051 | [Prognostic significance of vascular invasion in patients with urothelial carcinoma treated with radical cystectomy] |
Q81466029 | [Prognostic value of lymph node dissections in bladder cancer treated with radical cystectomy] |
Q92669129 | [Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer] |
Q84341374 | [Quality of life after radical cystectomy - an overview and analysis of a contemporary series] |
Q83987314 | [Radical cystectomy - pro laparoscopic] |
Q51790967 | [Radical cystectomy - pro robotic]. |
Q72606227 | [Radical cystectomy and laparoscopic ileal conduit] |
Q80347910 | [Radical cystectomy and urinary diversion in elderly patients with increased comorbidity] |
Q57100841 | [Radical cystectomy and urinary diversion-what is important ?] |
Q83220209 | [Radical cystectomy and urinary diversion: assistance to patient choice] |
Q81959535 | [Radical cystectomy as a muscle-invasive bladder cancer treatment in elderly patients] |
Q81437631 | [Radical cystectomy early postoperative complications and mortality rate] |
Q81219506 | [Radical cystectomy for invasive bladder carcinoma in patients 75 years old or older] |
Q77953777 | [Radical cystectomy for superficial tumors in the BCG era] |
Q69552490 | [Radical cystectomy for transitional cell carcinoma of the bladder] |
Q85014199 | [Radical cystectomy for urothelial bladder cancer: prognostic impact of lymph node metastasis and soft tissue surgical margins] |
Q72753231 | [Radical cystectomy in bladder carcinoma] |
Q83178939 | [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy] |
Q95440277 | [Radical cystectomy in patients with pathological non-muscle invasive bladder cancer] |
Q53033127 | [Radical cystectomy in patients with pathological non-muscle invasive bladder cancer]. |
Q74396886 | [Radical cystectomy in superficial bladder carcinoma] |
Q53738113 | [Radical cystectomy in the therapy of bladder tumors]. |
Q79893717 | [Radical cystectomy in the treatment for bladder carcinoma: results of 125 operated patients] |
Q80738355 | [Radical cystectomy in the treatment of bladder cancer always in due time?] |
Q73092134 | [Radical cystectomy in the treatment of cancer of the bladder] |
Q76380994 | [Radical cystectomy in the treatment of invasive bladder cancer] |
Q88303984 | [Radical cystectomy vs. chemoradiation for the treatment of T2-4a N0 M0 bladder cancer] |
Q73612041 | [Radical cystectomy with ileoneocystoplasty] |
Q53053796 | [Radical cystectomy with orthotopic neobladder replacement: Comparison of robotic assisted and open surgical route]. |
Q73976462 | [Radical cystectomy with orthotopic urinary diversion in patients older than 70 years of age] |
Q68713424 | [Radical cystectomy with preservation of sexual function] |
Q45942269 | [Radical cystectomy with secondary epithelialization. Considerations and personal experience] |
Q78876468 | [Radical cystectomy. Bladder substitution (in women)] |
Q75237415 | [Radical cystectomy. Comparison of "Hautmann" and "Studer-neobladder"] |
Q90176076 | [Radical cystectomy: therapeutic aspects of preoperative and early postoperative management] |
Q90240907 | [Relationship between Early Complications after Radical Cystectomy and Psoas Muscle Mass] |
Q80342308 | [Reliable surgical procedure. Orthotopic bladder replacement in radical cystectomy] |
Q83168488 | [Research of laparoscopic radical cystectomy and urinary diversion] |
Q72390589 | [Results of radical cystectomy for bladder cancer] |
Q77186681 | [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion] |
Q53965629 | [Retrograde radical cystectomy. Advantages of our "vesico-rectal tunnel" method]. |
Q83041443 | [Retrospetive analysis of early postoperative complications of radical cystectomy and urinary diversion performed during a 17-year period] |
Q84773215 | [Risk factor analysis of post-operative complications in radical cystectomy for bladder transitional cell cancer: retrospective assessment from 208 consecutive cases] |
Q84587568 | [Robot-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion] |
Q80855622 | [Robot-assisted laparoscopic radical cystectomy] |
Q102055283 | [Robot-assisted radical cystectomy with neobladder formation] |
Q50536877 | [Robot-assisted radical cystectomy. Pilot study for the prospective evaluation of perioperative parameters compared to open radical cystectomy]. |
Q83326727 | [Robot-assisted radical cystectomy: do we actually need a robot?] |
Q91747236 | [Robotic versus open radical cystectomy for adults with bladder cancer] |
Q83464259 | [Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results] |
Q79406140 | [Sexual-nerve-Sparing radical cystectomy: experience with 32 cases] |
Q73868569 | [Short-term results of radical cystectomy] |
Q74366752 | [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy] |
Q79321299 | [Stage pT0 bladder tumors after radical cystectomy: a review of our series] |
Q83706880 | [Stress urinary incontinence after radical cystectomy: neobladder construction and placement of the functional retrourethral sling] |
Q68424012 | [Substitute bladder following radical cystectomy] |
Q81306524 | [Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report] |
Q73413334 | [Survival in stage T2-T3A bladder cancer treated with radical cystectomy] |
Q68841751 | [Technical comparison: uretero-ureterocutaneostomy with Y and ileal shunt after radical cystectomy] |
Q86214188 | [Technique of the urethral anastomosis in orthotopic neo-bladder following robot-assisted radical cystectomy (RARC)] |
Q92614623 | [The Development of the Preoperative Nomogram Predicting Major Perioperative Complications after Radical Cystectomy with Ileal Conduit or Orthotopic Neobladder] |
Q92418602 | [The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort] |
Q80935980 | [The Studer orthotopic bladder after radical cystectomy--observation of more than 40 patients] |
Q68711812 | [The alternative of substitution enterocystoplasty after radical cystectomy] |
Q85869527 | [The analysis of perioperative complications during radical cystectomy using a standardized reporting system] |
Q96689141 | [The impact of radical cystectomy on health-related quality of life and potential for optimisation] |
Q68539724 | [The quality of life in patients with bladder cancer after radical cystectomy with ileal conduit: I. Results of questionnaire surveys] |
Q68539727 | [The quality of life in patients with bladder cancer after radical cystectomy with ileal conduit: II. Results of questionnaire surveys to compare the impact of treatments] |
Q82229329 | [The radical cystectomy with different methods of the urine derivation in urinary bladder carcinoma] |
Q69479780 | [The role of radical cystectomy in the treatment of invasive bladder carcinoma] |
Q84743707 | [The urethral anastomosis in orthotopic neobladder following robot-assisted radical cystectomy (RARC) at German-speaking centres] |
Q87705450 | [The value of surgical margins for clinical predictions and decisions following radical cystectomy for bladder cancer] |
Q81699520 | [Transitional cell carcinoma relapse in uretero-ileal conduit after radical cystectomy] |
Q77489331 | [Treatment of locally advanced carcinoma of the urinary bladder with preoperative radiotherapy and radical cystectomy versus radical cystectomy alone] |
Q50711833 | [Treatment outcome of laparoscopic radical cystectomy at a single institution]. |
Q73808357 | [Unusual complications after radical cystectomy] |
Q50648276 | [Upper urothelium tumor in patients treated with radical cystectomy for transitional carcinoma of the bladder] |
Q85741289 | [Urinary diversion after radical cystectomy - What is the long-term renal function after ileal conduit and neobladder?] |
Q95563865 | [Urine derivation after radical cystectomy] |
Q95578516 | [Usefulness of cold ureteral biopsy during radical cystectomy as a predictor of recurrence risk: Review of our series.] |
Q92019367 | [Usefulness of frozen section exams during radical cystectomy for urothelial carcinoma] |
Q68044088 | [Value of radical cystectomy in the treatment of infiltrating bladder cancer] |
Q83329890 | [Wound complications after radical cystectomy] |
Q42373335 | miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy |
Q59649613 | p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy |
Search more.